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INTRODUCTION
The Annual Stoneburner Lecture series this
year has been devoted to clinical adult and pediatric
urology. The purpose of the papers presented was to
give the urologist and the primary care physician an
overview of the problems and the latest developments and advances in technique. We were fortunate
to have as the Stoneburner Lecturer, Dr. John K.
Lattimer, Professor of Urology and Chairman of the
Department of Urology at the Columbia-Presbyterian
Hospital in New York. Dr. Lattimer's talks on "The
Optimum Treatment of the Undescended Testis" and
"Carcinoma of the Prostate: The Great WidowMaker" were extremely timely. This series of lectures
was co-sponsored by the Mid-Atlantic Section of the
American Urological Association.
Included in this group of papers is the First Annual Carl Bunts Lecture in Urology. Dr. Bunts retired as Chief of the Urological Service at the McGuire Veterans Administration Hospital in June of
1972 and was a pioneer in the management of the
urinary tract of the spinal cord injury patient. Dr.
John Hutch was the first Carl Bunts Lecturer and
was the fourth resident whom Dr. Bunts trained in
urology. Dr. Hutch was born in the State of Iowa
where he attended the University of Iowa undergraduate school and the School of Medicine. Following an internship at Salt Lake County General
Hospital, he completed a residency in Urology at the
Veterans Administration Hospital in Richmond.
After returning to Iowa for one year, he then became
associated with the University of California at San
Francisco where he was Associate Professor of
Urology. He was a pioneer in ureteral antireflux
surgery and was a world authority on the anatomy
and physiology of the lower urinary tract, urinary
control and urinary incontinence. Dr. Hutch met an
untimely death on September 14, 1972. This paper
is unique in that it is an expression of the experience
of a pioneer through the development of a surgical
procedure which has been a real contribution to
the management of the patient with urinary tract
infections.
Warren W. Koontz, Jr. , M.D.
Professor and Chairman
Division of Urology
Medical College of Virginia
Virginia Commonwealth University
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A Twenty-Year Experience with Surgery for
Ureteral Reflux*
JOHN HUTCH, M.D.

It is a real honor to be asked to return to Richmond, particularly for a Northern boy, to give the
first R . Carl Bunts Lecture. Many in the audience
will wonder why all this fuss about the retirement
of the head of a small department in a VA Hospital
in Richmond. Those who wonder only do so because
they did not have the privilege of knowing Bunts
well. I could say that Bunts was a great leader, a
great scientist, and a great physician. I could say
that Bunts had no children and that he and his lovely
wife, Dori, have made Bunts' residents their lives
and family. While all these things are true, they fall
woefully short of the mark in describing or attempting to explain why there is all this fuss about Carl
Bunts. Bunts is being honored because he is a rare
human being, the kind of person that most of us
meet only once or twice in a lifetime. I had the honor
of being Bunts' fourth resident from 1948 to 1951.
He cast his spell over me then, and as I have met
the other residents through the '50's and through the
'60's and now into the '70's, I sense in talking to
them that he has done the same thing to them now
that he did to me and to my contemporaries 25
years ago. Maybe it is magic, maybe Bunts has congenital charisma, maybe Bunts has a quality that our
young people strive to achieve, namely, being a warm
human being.
With this introduction, I will move on to the
scientific part of the presentation which deals with
22 years of experience in vesicoureteral .reflux, most
of which, of course, started right here in Bunts' department.
When I began my residency in Richmond, Vir-

* This is a transcription, edited by Dr. Warren W.
Koontz, Jr., of a lecture presented by Dr. Hutch at the
First Annual R . Carl Bunts Lecture in Urology, May 25,
1972. Dr. Hutch met an untimely death on September
14, 1972.
MCV QUARTERLY 9(3) : 207-211, 1973

ginia in 1948, urologists were aware of vesicoureteral
reflux as an entity. It was known to occur in patients
with badly distorted urinary tracts, particularly those
with obstruction at or below the bladder neck, and
those with urinary tract tuberculosis or neurogenic
bladders. No one sought out reflux per se, and if it
was found, it was not considered to be causative but
rather the result of the distorted urinary tract. Certainly, no one thought of treating reflux per se but
rather in treating the disease that was causing the
reflux. This apathy towards reflux is reflected in the
fact that during the five-year period from 1943 to
1948 no articles on reflux appeared in the Journal
of Urology. Since our hospital in Richmond was a
paraplegic center, we were more aware of reflux
than most urologic departments throughout the
country. We were doing two-film cystograms on all
of our paraplegic patients when I arrived there in
June, 1948, and we had been doing this for some
years. We felt great concern about the progressive
dilatation of the upper urinary tract that we were
observing in some paraplegic patients. The theory
was that these urinary tracts were dilating because
of an obstruction at the ureterovesical junction,
and our therapy was aimed at cutting out this obstructive segment and reimplanting the ureter into
the bladder in such a way that the obstruction could
not occur. We used the same technique in paraplegics
that we used in patients with bladder tumors in whom
we did a partial cystectomy with ureteral reimplantation into the bladder. We kept groping for a better
method of performing ureteral reimplantation. We
used the fish-mouth technique; we also tried the direct
mucosal-to-mucosal type of anastomosis that Cordonnier was then popularizing in ureteral sigmoid anastomosis. We made some abortive attempts at tunnel
formation by passing the ureters through the bladder
wall obliquely, but it must be remembered that we
were operating to overcome obstruction and that
207
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our main effort was to secure the ureter in its new
location in an unobstructed manner. The results of
these operations were disappointing. Improvement
was rarely demonstrated either clinically or by x-ray.
Early in my residency, we performed five consecutive
operations based on these principles. In three patients, all function was lost from the involved kidney,
and in two, function was preserved only by nephrostomy drainage. We now know that these operations failed because they did not stop the reflux, but
this was not appreciated then. At this time, the
prevailing feeling among urologists was that operation for megaloureter at the ureterovesical junction
was contraindicated because the results were often so
disastrous.
Dr. Bunts suggested that I attempt to find out
what was happening to the urinary tracts of patients
with neurogenic bladders with the passage of time.
We had a wealth of material to draw from, including
the records and x-rays of several hundred paraplegics
taken since the founding of the department in 1945.
These x-rays were mostly IVP's, some retrogrades,
and a large number of cystograms. Reviewing this
material case by case, I became aware that some of
the paraplegic patients were developing a specialized
type of saccule or diverticulum that was located at
the point where the ureter was entering the bladder.
Certainly these bladders contained many saccules
and diverticula, but there was something different
in the appearance about this particular saccule and
its consistent location. I set aside a number of
cystograms demonstrating this saccule and showed
them to Dr. Bunts. After reviewing these x-rays,
we arranged to cystoscope these patients to determine whether there was any connection between the
saccule and the ureteral orifice. Cystoscopy proved
that the saccule was always above and lateral to
the trigone; the ureter always ran down the floor
of the saccule. In each case the catheter passed
through this segment with no obstruction, and there
was no thickening of the intravesical ureter to account for obstruction of any type. From these observations it was apparent that the ureteral hiatus was
dilating. In the process of dilation, the intravesical
ureter was falling into the saccule that resulted and
was losing the support of the bladder muscle behind
it. It seemed that the logical method to correct this
was to excise the saccule surgically and to push the
ureter into the bladder and then to close the bladder
behind the ureter.
We knew that we had to repair the bladder
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muscle behind the saccule, but we did not know
what to do with the mucosa. At that time, I felt that
was not very important. We decided to sew the
mucosa under the ureter. Unfortunately, this proved
to be a mistake and was the technical defect that
caused some of the early operations to obstruct.
The simple logic involved was appealing, and since
our efforts to correct the dilated upper urinary tract
of the paraplegic had produced such poor results,
Dr. Bunts was more than willing to try this new
operation. Therefore, on May 17, 1950, with Dr.
Bunts as my assistant, we did a left ureterovesicoplasty on a 28-year-old paraplegic patient with left
reflux . We believe that this was the first time any person was ever operated on specifically to correct
reflux. To our joy and amazement, three-week and
six-week postoperative cystograms showed no reflux, and the postoperative intravenous pyelogram
looked better than the preoperative one. Encouraged
by our success, we performed our second operation
on June 23, 1950. It, too, was successful. Our first
bilateral ureteral vesicoplasty was done on August
31 , 1950. By April 1951, we had operated on 9
patients and 11 ureters and had successfully stopped
the reflux in 8 of the ureters and had encountered
no obstruction.
Dr. Austin Dodson, our consultant, had been
watching our series develop, and he suggested that
it be presented to the prize essay contest sponsored
by the American Urological Association, rather than
submitting it to the Journal of Urology through
regular channels. This essay was awarded first prize
and was presented before the American Urologic
Association in Chicago in June 1951. This resulted
in the elimination of Dr. Bunts' name as co-author
since he was not eligible under the rules of the essay
contest. If the paper had been submitted to the
Journal of Urology through regular channels, Dr.
Bunts would have been a co-author, and the operation would have been the Hutch-Bunts operation
from the first. While this did not seem particularly
important at the time, it resulted in the fact that
many urologists do not appreciate the vital role
played by Dr. Bunts in the development of the
original ureteral vesicoplasty.
Dr. Ruben Flocks then asked me to spend
a year at my alma mater, the University of Iowa,
and to try the operation on some of his patients
with meningomyeloceles and primary reflux. It was
at Iowa City that I became aware of the tremendous
difference in reflux in children with primary reflux
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and in paraplegics. The children with primary reflux had none of the gross changes in the bladder
wall that were so characteristic of the paraplegic
patients, nor could I find saccules at the ureterovesical junction. This was distressing because my explanation of the etiology of reflux in paraplegics was
that the changes in the bladder wall created a saccule at the ureterovesical junction which damaged
the valve mechanism resulting in reflux. This theory
could be extended to include reflux in patients with
true infravesical obstruction such as prostatic hypertrophy, urethral strictures or urethral valves because
these patients, like the paraplegic, had vesical trabeculation and saccule formation, but it could not
possibly explain the most common type of reflux
(primary reflux). Cystoscopically, these children
had normal appearing bladders. The only positive
cystoscopic finding was golf-hole orifices which we
could not explain satisfactorily at that time. The
results of our surgical experience in Iowa City were
published in the Journal of Urology by Dr. Raymond
G. Bunge, Dr. Ruben Flocks, and me and reported
the first series of antireflux surgery in nonparaplegics. This series contained several brilliant successes, but our enthusiasm was dampened somewhat
by the appearance of the most feared complication:
obstruction at the operative site. In looking back on
this series, we got our good results in the patients
with primary reflux and our failures in the meningomyelocele group. During the next five years antireflux surgery gained some advocates. Eugene St.
Martin and his group published reports of a favorable nature. Dr. Bunts, on the East Coast, and I,
on the West Coast, continued to use the operation,
but its acceptance was impeded by fear of obstruction at the operative site. Dr. Bunts and I felt a
personal responsibility for this operation and polled
the members of the American Urologic Association
who had used the operation to determine the results
they had obtained. During this period, many of the
operative failures were sent to me for a second
operation. Actually, this proved to be a blessing in
disguise, because it was in re-operating on the patients that I realized that the basic defect in the
original operation was sewing the mucosa under the
transplant.
The first modification of the original operation
came in 1958. This was by Dr. Wyland Leadbetter
and Dr. Victor Politano. It included all the features
of the original operation and did so without a suture
line under the transplant. It also handled the mucosa
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correctly by passing the ureter through a submucosal
tunnel. The second operation or modification was presented by Dr. Al Paquin. Here the ureter was cut
off outside the bladder and brought through a new
opening high up in the bladder wall and down
through a submucosal tunnel. The Paquin operation
originally incorporated a Vest nipple to prevent stenosis of the cut end of the ureter. This operation was
highly successful and is widely used today with a
number of modifications. I believe at the time of
Dr. Paquin's untimely death, he felt that the nipple
was no longer necessary.
It is my belief that when we successfully stop the
reflux, we stop all further attacks of acute pyelonephritis, and we make the patients clinically well. On
the other hand, the pyelonephritic changes on the
IVP preoperatively never change; they will remain
forever. Any hydroureter or hydronephrosis present
preoperatively, however, will slowly return to normal. When we stop the reflux, we stop any further
progression of the renal deterioration. We are converting active pyelonephritis into healed pyelonephritis. No function loss prior to surgery can ever be
regained. Successful antireflux surgery does not assure that the bacteriuria will not recur. I believe that
the source of the bacteriuria is the urethra flora and
that when the reflux is present those bacteria have
immediate access to the kidney. Following successful
antireflux surgery, the bacteria still have easy access
to the bladder urine, but if there is no longer any
reflux the infection will be limited to the bladder.
To evaluate antireflux surgery fairly, we must
discuss three different time periods. The first time
period runs from 1950 to 1958. The second period
runs from 1958 to 1968, and the third period runs
from 1968 to the present. The reported results in
the 1950 to 1958 period, when the Hutch I was the
only operation available, were about 80% completely satisfactory (defining completely satisfactory
as stopping the reflux without causing obstruction at
the operative site) . During the second period, due
to the efforts of many urologists working to improve
the operation, 90% were completely successful.
During the last five years over 95% were completely
successful. Fortunately, from the first, antireflux
surgery has been evaluated against solid x-ray criteria; by this I mean preoperative IVP's and cystograms and postoperative IVP's and cystograms. This
has given a validity to the reported results in the
antireflux surgery not present in many types of
surgery.
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During the last 15 years, we have lived through
what I like to call the cystogram explosion. During
my residency we rarely did cystograms on anyone.
Then all of a sudden we did many cystograms, and
we learned a lot about the role of reflux in all types
of urinary disease. If we do an IVP we get a lot of
information, but the IVP alone is not enough to be
certain that a serious urological disease is present.
We also get a lot of information from the cystogram,
but the cystogram alone is not enough to give urologic clearance. I have the feeling that if we have the
combination of a normal IVP and a normal cystogram in a patient with urinary tract infection that
this patient has almost no chance of going on to
uremia from pyelonephritis. If we could screen
everyone in the United States with urinary tract
infections with an IVP and cystogram, we could
eliminate those patients in whom both studies were
negative. Almost all of the patients in whom the
possibility of progressive pyelonephritis exists will
have a positive cystogram or a positive IVP, or both,
on the initial screening examination. All of us have
been giving urologic clearance on the basis of a negative pyelogram and a negative cystogram, and it is
very rare that a patient whose first work-up shows a
negative cystogram and negative pyelogram will ever
get into serious trouble subsequently. These patients
may have more attacks of urinary tract infections,
but they will be limited to the bladder.
Any patient with a proven urinary tract infection
should be worked up and classified as in Table 1. A
careful history should be obtained, and if the urinary
tract infections are occurring without fever, the history is classified as cystitis. If the infections are occurring in the presence of fever, the history is classified as pyelonephritis. The cystogram is read as
showing or not showing reflux, and the pyelogram is
read as showing or not showing the changes of
pyelonephritis. A patient classified in this manner
falls into one of five groups. The overwhelming ma-

PANEL DISCUSSION

TABLE 1

CLASSIFICATION
Cystitis
Pyelonephritis
Grade I
Grade II
Grade III
Grade IV

REFLUX

PYELONEPHRITIC
CHANGES

Cystitis

No

No

Pyelonephritis
Pyelonephritis
Pyelonephritis
Pyelonephritis

No
Yes
No
Yes

No
No
Yes
Yes

HISTORY

jority will be in the cystitic group. They will have a
cystitis history, a negative cystogram, and a negative
pyelogram. A smaller group of patients will have a
history of pyelonephritis, yet their x-ray work-up is
negative. This is classified as Grade I pyelonephritis.
Patients with Grade II pyelonephritis have a positive
cystogram, yet the pyelogram is still normal. In
Grade III pyelonephritis, the cystogram shows no reflux, but the pyelogram shows pyelonephritis. In
Grade IV pyelonephritis, both the cystogram and
the pyelogram are positive.
Once your patient has been properly classified, a
logical plan of management is easy. The patient who
has cystitis and Grade I pyelonephritis has in common a negative pyelogram and negative cystogram.
This is the group of annoying but basically harmless
urinary tract infections. This type of patient can be
given intermittent antibacterial therapy with confidence that the patient does not have a serious urological disease. Patients with Grade II pyelonephritis
may be treated with constant antibacterial therapy
or with antireflux surgery. Patients with Grade III
pyelonephritis have a positive IVP but no reflux.
Most of them are adults, and most of them got their
pyelonephritis because they had reflux when they
were children. I have pointed out that changes of
pyelonephritis stay in the kidneys forever. Fortunately, most of the Grade III pyelonephritis represents a healed pyelonephritis and no treatment is
warranted. However, there are some sleepers in this
group. These are patients in whom the initial cystogram shows no reflux, not because the reflux has
actually disappeared but because it has become intermittent. When this possibility is suspected you
must repeat the cystogram until the reflux is found.
The classification then changes to those patients
with Grade IV pyelonephritis. Patients with Grade
IV pyelonephritis have a pyelonephritic history,
pyelonephritis on the pyelogram, and reflux on the
cystogram. I believe that all of these patients should
have antireflux surgery.

Dr. Paul Langlois: Dr. Hutch, you did not mention the adult female with symptoms only of cystitis,
without chills or fever, without high back pain, flank
pain and so forth, who does have reflux.
Dr. Hutch: This would be a patient with a cystitic
history who has reflux on the work-up. We studied
patients who had a cystitic history and found normal
pyelograms and cystograms in all but seven. It is
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very rare to have a cystitic history and a positive
finding on either the cystogram or the pyelogram.
When this does happen, the patient should be graded
not according to the history but according to the
x-ray findings, so that your patient in spite of her
cystitic hisfory should be Grade II pyelonephritis.
Dr. Joseph Fiveash: The child with the golf-hole
ureter is no problem in management nor is the child
with tl~e wisp of reflux who has no changes in the
upper tracts. Do you still believe in the maturation
of the intravesical ureter, and if so, do you have any
hints to tell us which child will mature the ureter arid
which will not?
Dr. Hutch: We have all had many patients who outgrow their reflux due to some process of maturation.
We all have our own criteria. In patients with Grade
II pyelonephritis where we have normal kidneys and
proven reflux, we have two courses- 1) const<1nt
antibacterial therapy or 2) antireflux surgery. We
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all develop our own methods to determine which
ones we are going to follow. We have to individualize
these cases and each patient is so different.
Questioner: I would like to ask you if you go along
with Lyons urethral ring?
Dr. Hutch: Yes, I think that it is the urogenital diaphragm.
Questioner: Are there cystoscopy changes in patients
with primary reflux .
Dr. Hutch: TP.ere is no question that in primary :reflux there are two things that are actual facts; one is
that the trigones are very large. This means that the
orifice is abnormally lateral, and they also have golfhole orifices. Thus, any theory that is going to explain primary reflux has to explain the golf-hole, and
it also has to explain the megatrigone and the gradations that Dr. Lyons and Dr. Tanagho t<1lk about
which are excellent in bringing this information into
an organized form .

Medical Management of Stone Disease*
M. J. V. SMITH, M.D., Ph.D.
Associate Professor of Urology, Division of Urology, Medical College of Virginia, Health
Sciences Division of Virginia Commonwealth University, Richmond, Virginia

The purpose of this review is to try to take
a practical approach toward the management of patients with renal calculous disease. This will be a
personal approach; I will, however, try to avoid
injecting my prejudices and research interests. I
want to show that proper management can be
achieved even in the most unsophisticated environment.
Clinical Evaluation. It is often true that the
first evaluation is the most important in giving a
clue to underlying cause. Therefore, every effort
must be made to avoid failure and thus discourage
both clinician and patient. Patients with renal stones
generally seek help when they are experiencing
symptoms which may be due to partial obstruction
with loss of appetite and perhaps partial dehydration. This is not the time to investigate one's patient as the underlying metabolic disorder may be
completely obscured. Thus, delay until the patient
has resumed his normal state is important.
I do not believe that it is worthwhile in this
area to submit a patient to an evaluation who has
passed and/or made a single stone. We live in a
stone belt. In this area, 80% of the patients who
have made only one stone will not make another.
In the remaining percentage of patients who have
made one stone, there is nearly an 80% chance that
they will make another within a year. As yet we
have no test available to us that will allow us to
distinguish the true stone former.
A careful history must probe for previm.is episodes and associated conditions such as urinary infections, excessive dehydration, diarrhea, fractures
with prolonged immobilization, high alkali, Vitamin
D or milk intake. Certain drugs, for example
Diamox® and steroids, are associated with stone

* Presented by Dr. Smith at the 26th Annual Stoneburner Lecture Series, February 22, 1973, at the Medical
College of Virginia, Richmond.
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formation. A family history of calculi is often present
and may be so prominent, as in cystinuria or oxaluria,
that the patient already knows the diagnosis.
A careful urinalysis with recording of the pH,
crystal content, and presence of bacteria is still the
best single test in the management of these patients.
The following · laboratory evaluations are important and can be done while in the hospital or as
an out-patient:
1) Urine for culture and sensitivity.
2) Urine for cyanide-nitroprusside test (screening for cystine).
3) Teach the patient to test the pH of every
voided specimen of urine with nitrazine
paper (Lilly Company).
4) Three determinations of serum calcium,
phosphorus, uric acid, and creatinine and
additional routine determinations of total
protein, albumin, alkaline phosphatase, and
·
electrolytes.
5) Three ·24-hour urines for calcium, phosphorus, magnesium, uric acid, and creatinine.
6) Analysis of stones should include x-ray
diffraction or crystallographic analysis which
is readily available. This is very important
because, at this time, medical management
is directed toward the crystalline components.
7) Plain film of the abdomen with an intravenous pyelogram. The roentgenographic
appearance of calculi with particular attention to the position in the parenchyma
or collecting system and also evidence of
layering of calcium over a possibly radiolucent nidus are most important in arriving
at the diagnosis for a specific cause of a
stone and thus planning the therapy. It
goes without saying that it is necessary to
exclude all forms of obstruction, and atMCV QUARTERLY 9(3): 212-215, 1973
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tention should be paid to whether there is
parenchymal calcification which can take
various forms . A peppering of small calculi
outlining the renal papilla often suggests
renal tubular acidosis; however, if this is
confined to only one papilla then one would
think more of a medullary sponge kidney.
If there is evidence of infection of the
urinary tract, then I believe that a voiding
cystourethrogram should always be carried
out to detect the presence of vesicoureteral
reflux.
Calculi.
Uric Acid Calculi. In this area, uric acid
calculi make up 15% of all calculi seen. They are
the only truly radiolucent stones and are not necessarily associated with hyperuricemia and hyperuricosuria. They are most often associated with
excretion of unusually acid urine and repeated bouts
of dehydration. One may see these types of stones
in patients with chronic diarrhea. Certain cytotoxic
drugs, particularly those used in the treatment of
lymphomas and leukemia, the thiazides, salicylates,
and steroids will cause uricosuria, and in the presence of low urinary pH, uric acid stones can form.
Patients will respond very rapidly to a program
of high urinary output and alkalization. The patient
must continually check his urine, particularly the
morning specimen, and adjust the dosage of bicarbonate so that the pH is above 6.0.
In some patients it may be necessary to add
allopurinol to the regimen, and the dosage will vary
from 100-800 mg daily. This potent enzyme inhibitor will prevent further uric acid calculi formation, but there is the theoretical possibility of
xanthine stone formation so alkalization must be
continued to prevent this possibility.
At present, it is possible to completely prevent
uric acid calculi. Surgery should play a minimal
part in the management of these patients even when
stones are present in the urinary tract. It has long
been known that high output of alkaline urine will
sometimes dissolve these stones. The introduction
of allopurinol to the armamentarium has provided
some dramatic cures. I have five patients in whom
uric acid staghorns have completely dissappeared
after an average of six months.
Cystine Calculi. The diagnosis of this familial
disease will usually follow from the routine testing
noted above and the finding of hexagonal crystals
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in acid urine. One should stress again that these
stones are radio-opaque because of their 27% content of sulphur and that they have a typical ground
glass appearance.
At the Medical College of Virginia, we have
an unusually high incidence of cystine stones because of the presence of this inherited metabolic
disease in the Chickahominy Indians. Usually, the
incidence is only 0.5-1 % of all stones.
Therapy is directed toward maintaining the
urinary volume in excess of 2,500 ml per day, including an intake of at least 500 ml of fluids in the
mid-sleep hours. The urine is, maintained alkaline,
and the patient is instructed to check his urine and
adjust the dosage of his alkalizing medication in
order to keep the pH of the urine above 6.5. If the
patient follows such a regimen conscientiously, the
solubility of cystine in urine will increase and further
stone formation may not occur. This can readily be
checked by routine urinalysis. Patients who are unsuccessful in such therapy may require the addition
of n-penicillamine to the treatment program. This
drug is given in dosages of 1-4 g per day guided
by the screening tests for cystine (nitroprusside
tests).
n-Penicillamine is not completely without its
complications; a rash may occur but can be abated
by stopping the medication for two weeks and then
resuming it by gradually increasing it from 250 mg
per day to the required daily dose. Nephrotic syndrome has occurred and requires cessation of the
therapy along with prolonged medical observation.
There is an increasing number of reports of patients
losing their sense of taste while on this drug.
Reappearance of the stones or failure of the
stones to dissolve might imply failure of therapy.
On several occasions, however, we have found that
this was due to the production of stones of other
chemical makeup; therefore, these patients must be
very carefully followed and watched in case such an
event occurs.
It is extremely important when treating these
patients with penicillamine to keep the dose as low
as possible, that is, to keep the urinary cystine level
below 250 mg per day by the minimum dose of
o-penicillamine possible. It is conceivable, and we
have seen it here on two occasions, that prolonged
high doses of penicillamine will interfere with collagen maturation and thus give rise to bruising and
striae formation; great care must be exercised in the
management of these patients.
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Calcium Calculi. The stones that contain calcium are found in a wide spectrum of conditions
that can be broken down into individual management
problems once the proper diagnosis has been made.
The principal breakdown is into those patients with
or without infection. One should not lose sight of
the fact that many so-called infectious stones may
have had as a nucleus an uninfected stone so one
should adjust the therapeutic attack accordingly.
Triple Phosphate Calculi. Stones associated
with infection imply the presence of stones containing
varying amounts of calcium magnesium ammonium
phosphate. Their roentgen appearance is variable as
they may have a high content of so-called matrix.
Therapy is directed toward eliminating the infection.
It is essential to correct obstruction, diabetes and
hyperparathyroidism, and to remove all foreign bodies; otherwise, any therapy directed toward the infection will be doomed to failure.
Appropriate antibiotic therapy must be intensive
and often prolonged until the urine is sterile and
stays that way. Acidification of the urine is certainly
very helpful. A regimen using methenamine and
ascorbic acid is helpful. We have found that in some
patients methylene blue will lower the urinary pH,
and it seems to prevent organization of the matrix
and prevents it from binding the calcium ions.
Oral use of magnesium or phosphates is contraindicated. If one can lower the urinary phosphorus
by use of a low phosphorus-containing diet and
Basaljel®, then success has been achieved. It is often
extremely difficult to insure that patients remain on
this regimen, however, and I no longer use it except
with very compulsive patients.
I believe it can rarely be said that a stone is
purely secondary to infection.
Calcium Oxalate and Calcium Phosphate. Prior
to discussion of the management of these common
stones, a few general observations should be made.
Pure calcium phosphate stones are most commonly
found in association with metabolic diseases; for
example, hyperparathyroidism, renal tubular acidosis,
immobilization syndrome, and stones associated with
the hypercalcemia of malignant disease and sarcoidosis; a more intensive investigation by a metabolic unit is indicated. Many patients will alternate
calcium oxalate and phosphate stones, presumably
due to the variation in urinary pH, as calcium phosphate precipitates at high urinary pH. Hyperoxaluria
should be suspected in children or young patients
with recurrent stone formation.
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Calcium oxalate and/ or phosphate calculi represent a disease complex which has many factors associated with it, and therefore, it seems that one
should direct attention and therapy toward the most
prominent biochemical abnormality that the preliminary investigation turns up; always remember
that continuous monitoring and flexibility are essential.
Hypercalciuria. There is still considerable
controversy as to the best therapy for this common
problem. The following therapies are recommended:
Thiazides. If given in a dosage of 500 mg twice
daily, they will reduce the urinary calcium and elevate the magnesium. There are certain side effects,
however, which may be potentially harmful. Metabolic acidosis and potassium deficiency have been
reported. Citrate excretion is practically abolished
and hyperuricemia may occur. Rarely, this will cause
hypercalcemia unmasking that group of people who
exhibit normocalcemic hyperparathyroidism. All of
these patients must be warned to keep their sodium
intake low, or the effect of the thiazides will be nullified . It is questionable whether this form of therapy
should be combined with the phosphate type as there
exists the potential of exacerbating the renal damage
that can occur from phosphate ingestion.
Neutral Orthophosphate. In 1958 and 1959,
Drs. Howard and Thomas made a crucial observation concerning "evil urine" and its ability to calcify
rachitic rat cartilage while good urine would not
do this. This led to the discovery that neutral orthophosphate taken orally will consistently lower urinary
calcium and convert evil to good urine. Subsequent
work by others in the field has confirmed that a
dosage of 1.3-1.5 g per day is sufficient to stop stone
formation. Unfortunately, this dosage is sometimes
limited by the diarrhea which may occur.
Uricosuria. There is a group of patients whose
only detectable metabolic abnormality was a relative
uricemia and uricosuria. Interestingly, these patients
often belong to the so-called "young executive stone
former." It has been possible to control their oxalate
stone formation with a low dosage of allopurinol
(50 mg) and alkalization.
Calcium/Magnesium Ratio. There is a group
of stone formers who have a ratio of these ions to
each other greater than three and who appear to
benefit from magnesium oxide therapy usually administered as Milk of Magnesia® tablets. I should
stress that some workers have not been able to
demonstrate these differences so that if one uses
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this therapy, very careful monitoring and study is
essential.
Lack of Detectable Abnormality. There is a
group of people in whom there is no detectable abnormality on the biochemical survey. A variety of
therapeutic approaches is currently under study.
Dr. Prien is presently conducting a study on
the effect of magnesium oxide (300 mg per day)
and pyridoxine (10 mg per day) in the.management
of recurrent stone formers. He will provide the
protocol and therapy in return for follow-up results.
Studies on methylene blue by Boyce and by
Smith have been reported previously. At this time,
methylene blue ( 65 mg three times a day) would
seem to be effective in preventing the formation of
stones in uninfected calcium oxalate stone formers.
I admit that it may also be helpful in "urine watchers" in that they will tend to keep up an adequate
fluid intake.
Discredited Therapy. Aspirin, hyaluronidases,
and cranberry juice have fallen into disrepute as
forms of therapy.
General Measures. As has been indicated, each
patient will require individualized therapy. It is extremely important to be prepared to evaluate patients
continually as to their response to a particular
therapy and, if necessary, to shift to another.
Dietary therapy is not emphasized; however, all
patients are instructed in a simple low calcium diet.
There are a few people who can remain on diets
and successfully reduce the urinary calcium levels.
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All patients are taught to measure their urine volume and to aim to maintain an output above 100
ml in one hour. It is probably wise to advise patients
to avoid excessive consumption of soft drinks, since
a carbohydrate load has been shown to induce hypercalciuria of frightening proportions. I believe the
intelligent participation by a patient in his medical
management is probably the single most important
facet in the management of recurrent urinary calculi.
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Some Important Factors 1n a Community
Dialysis Program*
ALLAN A. HOFFMAN, M.D.
Danville, Virginia

The purpose of this paper is to acquaint physicians who are not nephrologists with the experience
of one of their colleagues in the operation of a
hemodialysis service as a part-time endeavor. My
intention is not to present detailed or advanced
scientific data on dialysis techniques or on the care
of chronic renal failure but to discuss how and under
what circumstances the urologist, internist, or general
physician might significantly augment the present
treatment care system for end-stage chronic renal
disease. I will attempt to describe a mode and
philosophy of operation applicable to the community
hospital and private practice setting which is derived
from our experience in providing care for acute and
chronic renal failure in a city of 50,000 with a
service area of 300,000 people located more than one
hour from the nearest large medical center. Our unit
started with one machine and one patient five years
ago and now has seven dialyzers serving an average
case load of 13 patients.
The need for increased personnel and facilities
for the care of patients with end-stage renal disease
is well established. It is generally estimated that each
year 40-60,000 patients die from chronic renal disease; 8,000 might benefit from chronic dialysis and/
or renal homotransplantation.
The January 1973 report of the N ational
Dialysis Registry showed 7 ,498 patients on dialysis
at 424 centers in the United States in contrast to
100 patients at 25 centers in 1964. The statistics
indicate a fairly rapid development of facilities for
dialytic therapy in the United States, but obviously
the system cannot provide treatment to many
more than 25 % of the patients who might offer

* Presented by Dr. Hoffman at the 26th Annual Stoneburner Lecture Series, February 22, 1973, at the Medical
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themselves for care. Historically, of course, most
of our dialysis centers have been established at
our university hospitals. Because of shortages of
space and funds at these institutions, however, in
addition to their limited geographic distribution,
it is not reasonable to expect that the very substantial increase in facilities needed can occur at
these centers. The university hospital can, however, be of great assistance in training patients
for home dialysis and in the direct or indirect
technical support of smaller units in other communities. It certainly is reasonable to expect that community dialysis centers, their costs lessened by more
freely available space, decreased transportation expenses and greater flexibility in personnel, might provide a significant opportunity for expansion of our
treatment capability. In our smaller cities the case
material may not be sufficient to support a full-time
nephrologic practice where the urologist or other interested physician might consider establishing a dialysis unit. The decision must be predicated on a
number of factors; the first is the need in a general
geographic area. It is generally estimated that there
are about 38 patients per 1,000,000 persons per year
who will benefit from chronic dialysis or transplantation. A small part-time service can probably be justified by an influx of four patients per year considering
that some patients may be on chronic dialysis without
consideration for transplantation, and even those
registered for cadaveric transplants in a very active
organ exchange program will usually have waiting
periods of about six months before a transplant. We
will discuss cost factors of importance in determining
the practicability of small dialysis units in some detail later.
Another factor that must be considered, of course,
is the distance patients must travel to existing facilities. If a patient must travel more than two hours
MCV QUARTERLY 9(3): 216-222, 1973
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round trip for a dialysis, the actual cash cost of
dialysis to the patient may be increased as much as
$2,000 to $3,000 per year and, more importantly,
the burden on him and his family in terms of fatigue
and time lost from work can be prohibitive. If such
a situation exists in your community it might provide
further encouragement to attempt to establish dialysis
facilities locally. Another factor to be cqnsidered is
the availability of space suitable for dialysis. The
physical requirements of a unit are not elaborate,
requiring only electricity and hot and cold running
water. It should be convenient to the director and
his staff and, ideally, adjacent to the physician's office
so that his staff might relieve each other for lunch or
assist in the event of mechanical or clinical difficulties. The natural tendency is, of course, to consider
using hospital space for a unit. With current hospital

Fig. 1
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construction costs of $55-75.00 per square foot,
however, the general shortage of space in our hospitals, and the fact that empty space that might be used
for patient care is a potential source of income of
$25-40,000.00 per bed per year, it may not take
long before either the hospital wishes to use some of
the allocated space for other purposes or one fi ds
that space needed to expand the dialysis unit is not
available. In our experience, the undeveloped basement of our offic~s provided, with relatively minor
alterations at a cost of $8,000, a satisfactory facility
to dialyze seven pati~nts at a time with room to
expand easily to I}ine, and at a negligible fixed overhead (fig. 1). Similar flexible low cost faciHties might
be established iI} empty apartments, stores, or in
uµused portions of medical offices.
An additional factor to consider is the coverage
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available when the director is away on holiday or at
medical meetings. This is generally not as great a
problem as it sounds because a technician with six
months of fairly active experience can deal with all
but true medical emergencies and another physician
can usually be found who will take at least a periphedl interest in one's unit. The most important medical support necessary is advice at a distance from an
experienced nephrologist, preferably from an institution with an active dialysis and transplantation program. It is unlikely that the urologist or other general
physician by virtue of his training will share all the
knowledge of a nephrologist, and contact from time
to time is most helpful. I have shared patients with
the renal and transplantation units at the University
of Virginia Hospital, Medical College of Virginia,
and Duke University Medical Center and found
without exception that they were most enthusiastic
about having another facility in their general geographic area and anxious to be of assistance. In fact,
half of our new patients in the last two years were
referred from these hospitals for treatment. The other
advantage of close liaison is that it is important for
a fair proportion of patients in a small dialysis unit
to be registered in an active transplant unit. It is
obvious that unless patients are transplanted with
some regularity and with an attrition rate of about
10% per year on dialysis, one's unit will rapidly fill
and have no room for next year's patients.
Lastly, the most important factor to consider is
your own enthusiasm and the firmness of your commitment. Supervising a dialysis unit can be a most
satisfying avocation. Yet, it requires a rather substantial and permanent commitment, and certainly,
it is not the sort of thing that one would choose in
making the transition between flying lessons and
finger painting. If one would anticipate that the day
to day supervision of dialytic therapy would probably become a tedious matter, it is probably best
not to start. There are few other fields, however,
which can provide the personal satisfaction of supplying a vitally needed medical service. In all our
offices from time to time, we feel progressively
estranged from our patients by the demands of third
party payers, the Columbia Broadcasting Company,
and ever increasing case loads. Chronic dialysis is one
. field in which the doctor-patient relationship is
closer and more direct than in almost any other area
in medical practice, and this itself can be most rewarding.
Having decided to commit oneself to starting a
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unit, there are two further pitfalls to avoid. The first
is the tendency to start too elaborately. I know of at
least two instances in Virginia where hospitals considered establishing a dialysis unit involving plans
calling for major remodeling with complex central
dialysate delivery systems and quite a large number
of dialyzers. The cost estimates ran into six figures
and the institutions abandoned their plans before
getting started. While I am sure that central delivery
systems and other refinements in the physical plant
can be of distinct economic benefit in large established units, their cost and the loss of flexibility incurred by having a substantial initial capital investment are distinct disadvantages in starting a small
unit. At the present time, it is possible to purchase
an entirely adequate new dialyzer for as little as
$1,800 and sufficient supplies to dialyze a patient
for six weeks with an additional $330. This general
type of equipment is rather portable, requiring only
a water source and drain and a grounded electrical
supply, thus giving one the opportunity to move the
unit at will if larger and otherwise more suitable
quarters become available. Additionally, a prudently
used dialyzer can be sold much in the manner of a
used car if the physician involved becomes disenchanted. The point is that there is no need to make
a large and fixed real estate or equipment investment
with the sort of commercial equipment that is available from a number of sources. Another reason for
starting small is that an area not previously serviced
by a hemodialysis unit will not be oriented toward
referring patients for care of chronic renal failure. The
number of new patients in the first year or two may
be smaller than one might anticipate. As time goes
on, even drawing from the same geographic area, the
number of new patients seems to increase each year
as internists, family physicians, and pediatricians become oriented toward optimum treatment of those
afflicted with chronic renal failure. We had three
new patients in our first year of operation and seven
new patients in our fifth year.
The second detour to avoid is to start with the
idea that one will do acute or emergency dialyses and
avoid taking care of c)lronically ill patients. As a
practical matter, it is virtually impossible to maintain
equipment and achieve a standard of excellence
in the performance of technicians unless they are
dialyzing regularly. Quite a large number of community and university hospitals, having attempted
to start in this manner, almost invariably have found
it necessary to begin at least some chronic dialyses
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to avoid loss of their equipment or having it fall into
disrepair and the personnel need continual practice
to maintain their competence. The primary reason
for this is that the patients requiring emergency
dialysis are relatively few and in most instances are
best treated by peritoneal dialysis. The indications
for acute dialysis might be simply summarized as
follows:
1) Temporary dysfunction or hypofunction of
the kidneys because of acute and potentially
reversible renal disease.
2) Correction of intractable edema or severe
electrolyte disturbances.
3) Removal of potentially toxic substances.
In the first two categories above, peritoneal
dialysis is generally preferred in the absence of a
relative contraindication to that procedure, such as
abdominal wall sepsis, advanced pregnancy, bleeding
diathesis and so forth . Patients in category 3 are
usually best treated by hemodialysis. A considerable
body of evidence is emerging, however, that dialysis
is of little benefit in intoxications particularly when
due to lipid soluble or protein bound agents and is
generally not indicated except in the gravest
circumstances. To illustrate this point, in the past
three years we have performed approximately 2,400
chronic hemodialyses and only 34 acute hemodialyses on 14 patients; the types of cases encountered in these 14 patients were as follows:
1 ) Intractable edema, two (one died) .
2) Thrombotic thrombocytopenic purpi.Jra,
three (one died).
3 ) Glutethimide intoxication, two (one died).
4) Interstitial nephritis secondary to ampicillin,
orie patient.
5) Acute tubular necrosis post surgery, five
(four died).
6) Polyarteritis nodosa, one patient.
While one might gather that some of the most
rewarding experiences were found in the group
treated with acute hemodialysis, the need to perform
this procedure is rather infrequently encountered
and would probably not, in our context, permit the
effective functioning of a dialysis team. In performing chronic dialysis regularly, the maintenance of our
staff's skill and equipment permits us to begin an
emergency hemodialysis within 25 minutes providing
adequate vascular access is attained. Interestingly
enough, the more active a chronic service becomes,
the greater becomes the skill and confidence of the
paramedical personnel, and the directing physician is
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less burdened with the technical aspects of dialysis.
Our experience is that it requires less time to supervise the care of thirteen patients now than it took to
supervise four patients three years ago.
The choice of patients to be offered care is
obviously a matter which must be faced. Many institutions maintain dialysis selection committees,
often including laymen, to determine which patients
are to be treated. In my experience there are a number of disadvantages to this approach. First, it is
contrary to the basic traditions of our civilization to
try to place a relative value on a given patient's continued existence, and as a practical matter, there is
no one, neither physician nor layman, who is very
accurate in determining who will be a cooperative
and conscientious chronic dialysis patient. Two of the
very best patients I have been privileged to look after
were turned down at other ceriters, one because of
lower than average intelligence and the other because of a criminal record some years before. Finally,
since many chronic renal failure patients appear
rather suddenly and in dire straits, it is often difficult
to learn much about them socially and psychologically before one has to make the medical decision as
to the desirability of chronic maintenance. Our policy
is to offer chronic dialysis to all patients who do not
have other medical conditions which preclude rehabilitation. When selecting by medical criteria alone,
one will find a somewhat higher attrition rate than in
highly selective centers because a number of patients
will opt out either voluntarily or involuntarily as they
find they are unable to conform to the rather rigorous
discipline which is part of the daily life of a successful chronic dialysis patient. This mode of operation is
bound to lead to some disappointments, but in most
circumstances it is vastly preferable to leave the
ncinmedical decisions to the patient and his Maker
than to another human being who is really illequippeci to decide.
The next problem that faces the small unit
director is the establishment of satisfactory vascular
access for once- or twice-weekly treatment. Historically, of course, chronic dialysis emerged as a practical treatment system with the development of the
Scribner-Quinton teflon-silastic shunt in the early
1960's, and many chronic dialysis patients still use
these devices. They provide ease and rapidity of
connection to the dialyzer and rather predictable
flows; effective care generally requires average flows
in excess of 200 ml per minute. However, they are
subject to disruption and the possibility of exsangui-
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nation. They are also susceptible to infection and
clotting and require a substantial inventory of expensive tubes and tools. Many large centers and most
home dialysis patients use shunts, but in small dialysis units such as ours, the internal A-V fistula as
developed by Brescia may be the preferred method
for providing access. Although starting a dialysis on
a patient with a fistula is slightly slower and requires
a higher level of training, fistulas are rather free of
clotting and infection and require only needles or
cannulas as ancillary equipment. In our unit, fistula
flows have been comparable to those of shunts once
the fistula has been established for a month or two.
A third technique, percutaneous puncture of the
femoral vein as developed by Shaldon, has been
used very effectively in chronic patients in other
units and in ours as a temporary measure while
awaiting maturation of a fistula. The venipuncture
required is more difficult than in a fistula and is less
-easily relegated to one's staff in our experience.
As far as dialysis is concerned, I have referred
above to the desirability of having a small self-contained unit. We started using the recirculating single
pass twin coil unit such as is available commercially
through Travenol Laboratories. The merits of various
dialysis apparatus are a subject for hours of debate
and beyond the scope of this discussion. The versatility of the Travenol unit, however, is advantageous
for a small program because it is able to remove both
excess metabolites and fluid, has a single source for
. all components and technical assistance and has ease
of assembly and disassembly, thus reducing training
time and, of course, cost of operation. There are,
certainly, many other effective commercial dialyzers
available with very competent support for the small
unit. Our last two dialyzers are made up of Life Med
control equipment and Dow capillary kidneys for
which we have fine outside support and which provide some technical advantages with certain patients.
One of the factors that might influence the final
choice of equipment is the kind of hardware in use
at the nearest large center. If one is going to have
his personnel trained at or exchange patients with a
nearby center it might be beneficial to use similar
equipment as both staff and patients will profit. At
any rate, I think one can anticipate a great deal of
help from any of the major equipment sources.
One matter that must be considered is the
financial support of your patient's care. Each health
insurance company and state has its own policy. In
general, even in states with conservative fiscal tra-
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ditions, however, patients who are totally disabled
from chronic renal failure will find at least partial
support from Medicaid or the Vocational Rehabilitation Departments. Cost control is of prime importance. The three factors most amenable to
control are personnel, disposable equipment, and
physical overhead. I have previously stressed the
advisability of having dialysis technicians with a
variety of skills as being of great importance for a
small unit. Experience has indicated that the optimum
cost-effective and clinically efficient patient-to-technician ratio is three or four to one. Therefore, since
dialyzers per se are rather inexpensive, in a threeor four-patient service, it is usually less costly to
dialyze four persons twice per week than two persons four times per week, assuming your technicians
can work elsewhere as office nurses or in some other
capacity on the remaining days. The critical factor is
flexibility in personnel and a constant evaluation of
the most cost-effective way to organize their activities
from tlme to time as the patient load of one's unit
varies.
With respect to disposable equipment, the single largest element in cost is the coils. There has
been a progressive decrease in the cost of commercial coils from $22 to $15 each over the past
two years, and further decreases to just over $10
per coil are anticipated in the next few years. To
parallel this, there has been considerable interest
in reusing coils, and there are a variety of techniques described in the literature for cleansing and
preserving them for reuse. Our experience would
indicate that often in small units, the personnel costs
involved in preserving coils do not permit highly significant savings.
The third area where cost reduction may be
effected is in decreasing the actual physical overhead
of dialysis as I mentioned previously. The detailed
cost analyses are available in the literature, the best
one of which, in my opinion, indicates a cost of $130
per dialysis for hospital units and $69 and $46 for
satellite and home dialysis, respectively. These reductions reflect, of course, lowered physical overhead
and travel expenses and, in the case of home dialysis,
lowered personnel costs. While there is considerable
enthusiasm for home dialysis in many quarters, I
doubt that home therapy will be the method used to
bring dialysis to the majority of patients who need it.
While it is highly effective in selected patients, there
are simply large numbers of patients or patients'
families who either by virtue of their timidity or
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limited background cannot perform dialysis at home.
Also, there are still significant numbers of patients in
rural areas and in lower class urban America whose
living quarters simply do not permit the installation
of a dialyzer. At one time, we surveyed our service
of ten patients and found that three had no indoor
plumbing in their living quarters; an additional two
did not have hot water and one other patient was
illiterate. Of the two chosen for training for home
dialysis, one refused the opportunity and the other,
atter a considerable amount of training, requested
that he be allowed to continue coming to our unit.
One factor that must be faced is that many rural
counties in the southeast have adult populations with
an educational level of less than seven years, and
this places a substantial limitation on the number
of people who can be trained efficiently to care for
themselves. One cannot help but be impressed with
the results of our colleagues in the state of Washington who are training large numbers of patients for
home dialysis. It is obvious, however, that they are
working in a different social milieu and are able to
commit rather large amounts of money to evaluate
special techniques for training large numbers of home
dialysis patients. Additionally, while all dialysis patients are subject to depression and other rather
serious psychiatric problems, home dialysis patients
and families seem to have very high rates of divorce,
suicide, and secondary spouses. In any event, twothirds of all dialysis patients in the United States are
in centers as opposed to home dialysis programs, thus
indicating that the latter may not be as universally
applied as has been indicated in some quarters.
If one's unit continues to grow in size, the point
will be reached where its demands will exceed the
skill and energy of a part-time director. In our case,
that point was reached 12 months ago, at which time
we had grown to eight patients being dialyzed on
four machines. We were able at that time to add a
highly qualified nephrologist to our group. Our unit
has since grown to 13 patients and seven machines,
and we are presently performing 100 dialyses per
month. Five of our patients had cadaveric transplants
this past year through the Southeastern Regional
Donor Program; three of them retained kidneys at
this time. The development of our dialysis service to
the level where a nephrologist was required has, of
course, resulted in the addition of considerable expertise in the management of renal disease and hypertension in our community.
In closing, I hope I have imparted some valua-
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ble information not easily available in the literature
based on our own practical experience in the operation of a small part-time dialysis unit. I think I can
assure interested physicians that as one's knowledge
and skill develop in this area, the operation of such
a unit will be a progressively rewarding and stimulating experience.
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Surgery of the Adrenal Glands*
ARTHUR W. WYKER, JR., M.D.
Professor of Urology, Department of Urology, University of
Virginia School of Medicine, Charlottesville, Virginia

This paper is a surgical overview of adrenal
gland disorders and emphasizes new developments
in diagnosis and management. Adrenal disorders are
relatively rare but clinically, they are very important.
If they go undetected, they can produce severe metabolic disturbances which may be fatal.
Indications for Adrenal Surgery. (Table 1)

Metastatic Breast Cancer. Today, the most common indication for adrenal surgery is metastatic
breast cancer. At our institution 10'-15 bilateral adreilalectomi.es are performed each year for this reason.
Breast cancer is the number one cancer in women.
There are approximately 70,000 new cases each
year; unfortunately, 60 % of these cases, or 42,000,
will develop metastases at some time and will become candidates for palliative treatment. Some of
these tumors are estrogen dependent, and this is the
rationale for removing the two main sources of
estrogen-the ovaries and the adrenals. If the ovaries
are still present at the time of the adrenalectomy,
they are removed. This procedure is not performed
if the patient has hepatic or pulmonary insufficiency
or advanced brain metastases. Forty percent of the
patients with metastatic breast cancer experience a
clear-cut response with a decrease in the size of all
lesions and no new disease. This status has been
maintained for at least six months. Five percent have
an arrest of their tumors and the remaining 55%
have had no response. In the responder group, 55 %
are still alive two years after adrenalectomy. In the
non-responder group, almost all of the patients have
died; only 4 % have survived for two years.
Metastatic Prostatic Cancer. In metastatic prostatic cancer, bilateral adrenalectomy never gained
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wide acceptance by urologists, and it is rarely performed today. Its effectiveness is difficult to assess
since there are only a few widely scattered reports
in the literature. Although this operation was used
occasionally as a primary form of treatment in patients with advanced prostatic cancer, it was usually
employed in those patients who relapsed after an
initial favorable response to orchidectomy-estrogen
treatment. In these proven androgen-dependent tumors, it was hoped that a further lowering of androgen production might produce a second clinical
remission. This hope was never realized, but it is
reported that more than one-half of those patients
treated with adrenalectomy experienced a transient
response, usually relief of bone pain.
Adrenal Cysts. The most common type of
adrenal cyst seen clinically is the pseudocyst due to a
hemorrhage into a normal adrenal gland or into an
adrenal tumor. One interesting form of this cyst, for
which one should be on the lookout, is calcified
adrenal hemorrhage in the newborn. These newborns are found to have a mass above one or both
kidneys often outlined by a rim of calcification.
Usually, there is no evidence of adrenal insufficiency
or excessive blood loss. The etiology is thought to
be trauma since most of these babies are the product
of a difficult breech delivery. If the diagnosis is
secure, surgery is not necessary.
Pheochromocytoma. Pheochromocytoma, a neural crest tumor, is the best defined cause of curable
hypertension today and accounts for about 0.5% of
all cases of hypertension. At the present time, we
have the capability of diagnosing 100% of these
tumors with relatively simple, safe and inexpensive
biochemical tests. Despite the ability to diagnose
these tumors, however, an estimated 1,000 persons
die each year in the United States from complications of unrecognized pheochromocytoma. Surgery
is particularly hazardous in patients with unsuspected
223
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TABLE 1.
INDICATIONS FOR ADRENAL SURGERY

1. Palliation of hormonally dependent tumors
A. Metastatic breast cancer
B. Metastatic prostatic cancer
2. Adrenal cysts
hyperplasia
3. Hyperfunction of the adrenal cortex due to ~ade~oma
carcinoma
A. Cushing's syndrome
B. Primary aldosteronism
C. Virilization (adrenogenital syndrome)
D. Feminization in men
4. Tumors of the adrenal medulla
A. Benign-pheochromocytoma, ganglioneuroma
B. Malignant-neuroblastoma

pheochromocytoma, and the death rate in one such
series was 50%. Before the availability of adrenolytic drugs, elective removal of a pheochromocytoma
carried a mortality rate of 25 % . Today, with careful
management, the mortality rate is around 1 % .
Conditions Requiring Chemical Screening for
Pheochromocytoma. Table 2 shows the chemical
tests that are now used as screening tests. These tests
are replacing the pharmacologic tests, regitine and
histamine, that were used regularly until just a few
years ago.
Most patients have intermittent rather than
persistent symptoms, and these so-called "spells" or

TABLE 2.
CONDITIONS REQUIRING CHEMICAL SCREENING FOR
PHEOCHROMOCYTOMA

1. Hypertension-sustained or paroxysmal
2. Sudden attacks or spells precipitated by physical exertion
or excitement
A. Symptoms accompanying attacks-headaches, perspiration, pallor or flushing, nausea or vomiting, dizziness, fainting
3. Hyper- or hypotension associated with trauma, anesthesia, or parturition
4. Hypermetabolic state
5. Relative with proven pheochromocytoma
6. Neurqcutaneous syndrome (von Hippe! Lindau's or von
Recklinghausen's)

attacks have certain characteristics. They appear
suddenly and usually last less than an hour, often
for only 15-30 minutes. Usually two or more symptoms are experienced together, and each spell tends
to be a carbon copy of the previous one. The most
common symptoms are headache, perspiration, palpitation and pallor. The frequency of these attacks
is quite variable, and about one-quarter of the patients will have one or more each day and about
two-thirds will have one or more each week.
With .the chronic outpouring of catecholamines
causing a hypermetabolic state, these patients may
be hiding under the diagnosis of hyperthyroidism or
diabetes mellitus. The hypermetabolic state results
in many of these patients being on the thin side in
marked contrast to the majority of patients with
essential hypertension who are overweight.
This disease is frequently familial and in our
somewhat atypical series about one-half are of this
type. One family in particular, the McCoys, has been
particularly productive with 10 of 28 members having pheochromocytoma. The famous Hatfield-McCoy feud was probably fueled by the high incidence
of this tumor in the combatants.
The association of this tumor with neurocutaneous diseases and with other tumors of neuroectodermal origin, such as thyroid and parathyroid,
is well established and probably results from their
common embryological origin.
Diagnosis. The diagnosis of pheochromocytoma
today hinges on biochemical confirmation of the over
production of catecholamines. Urine normally contains small quantities of the free catecholamines and
their metabolites-the metanephrines and 3-methoxy-4-hydroxy-mendelic acid (VMA). The excretion
of all three of these compounds is persistently high
in almost every patient with pheochromocytoma,
even those with paroxysmal hypertension. Each test
is more than 90% accurate, with the free catechol
determination being the most accurate, around 99 % ;
metanephrine is 97 % accurate, and VMA is 90%
accurate. There are no reported cases of pheochromocytoma with negative tests for all three determinations. At the University of Virginia, we rely on free
catechols and VMA.
Pharmacological tests are not recommended
because they are more hazardous, more expensive,
and less accurate than urinary assays. In a series of
patients from the National Institute of Health, 25 %
of the patients with proven pheochromocytoma had
negative pharmacological tests. Since the diagnosis
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of pheochromocytoma depends upon the accuracy
of biochemical tests, it is important to take a careful
drug history, for all three determinations are subject
to error if certain drugs have been taken.
Location of Tumor. The pheochromocytoma
is known as the 10% tumor-10% multiple, 10%
extra-adrenal, and 10% malignant. Multiple tumors
are mote apt to occur in children and in familial
pheochromocytoma with reported incidences of 2050%.
Extra-Adrenal Chromaffin Tumors. The chest
is the most common site of the tumors, except for
the abdomen, and accounts for 1-2% of them. These
tumors usually present as posterior, mediastinal,
paravertebral masses readily detected by appropriate
chest x-rays. The rare tumors in the neck are palpable. Bladder pheochromocytomas are of particular
interest. Patients often complain of headache with
or after voiding. Fifty percent of the patients with
bladder pheochromocytomas have hematuria. These
tumors are usually not visible on cystoendoscopy,
since they are located in the muscle wall.
Localization of the Tumor. Once the diagnosis
of pheochromocytoma is established by chemical
means, we do not make a special effort to localize
the site of the tumor. There are two reasons for this
approach: 1) At surgery, we always examine both
the adrenal glands and the para-aortic and pelvic
regions, the usual sites for intra-abdominal pheochromocytomas, 2) All of our efforts are directed
at avoiding stimulation of the tumor with catecholamine release, and diagnostic procedures such as
angiography and retroperitoneal gas insuffiation often
stimulate the tumor and have caused some deaths.
Our radiological work-up consists of chest
x-rays to rule out the 1-2% intrathoracic tumors,
and a double dose IVP with tomography to look for
depression and flattening of the upper pole of the
kidney. We do not perform arteriography, venography, or gas studies. If arteriography is planned,
be sure your patient is on protective pharmacologic
blockade with alpha blocker phenoxybenzamine
(dibenzyline) and have an i.v. in place with both
alpha and beta blockers available in the x-ray suite.
We get some help in localization from our
urinary catechol determinations. If the urine contains
increased amounts of epinephrine, as well as norepinephrine (NE), 90 % will be found in the adrenal
gland, 10% in the organs of the Zuckerkandl, those
tiny chromaffin bodies near the origin of the inferior
mesenteric artery. If the urine contains increased
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TABLE 3.
MANAGEMENT OF PATIENTS WITH PHEOCHROMOCYTOMA

Preoperatively
1. Phatmacologic blockade
A. Partial alpha adrenergic blockade using long-acting
phenoxybenzamine (dibenzyline)
1) Blood pressure is lowered to normal or near
normal levels.
2) Symptoms are lessened.
3) Plasma volume is expanded with resultant drop in
hema tocrit of 5-10%.
4) Surgical course is smoother and less hazardous.
B. Beta adrenergic blockade is used only in selected cases.
1) Persistent tachycardia or arrhythmia despite
adequate alpha adrenergic blockade

2. Transfusion of packed RBC's as indicated by the fall
in hematocrit

TABLE 4.
MANAGEMENT OF PATIENTS WITH PHEOCHROMOCYTOMA

Surgery
1. Continuous monitoring of blood pressure, central venous
pressure and cardiac activity is established prior to inductien.
A. Arterial pressure-intra-arterial catheter for a continuous readout and recording when desired
B. Central venous pressure- catheter is inserted in
the external jugular vein.
C. Cardiac activity- continuous ECG observation

2. Minimize or avoid stimuli known to cause tumor to
release catecholamines.
A. Positioning of the patient
B. Muscle twitching
C. Hypercarbia ot hypoxia
D . Intubation
E. Drugs- curare, cyclopropane
3. Premedication
A. Drying agent- atropine or scopolamine
B. Narcotic- morphine
C. Tranquilizer-Valium ®
4. Anesthetic technique
A. General anesthesia rather than block
B. Induction- thiopental (Sodium Pentothal ®)
C. Intubation- succinylcholine following small dose of
pancuroiiium to avoid muscle fasciculations
D. Agent of choice-halothane
E. Maintenance of relaxation during surgery- pancuronium
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amounts of NE only, however, be prepared for a
more extensive search of the abdomen, for only
60-70% of these tumors reside in the adrenal gland.
This reflects the fact that extra-adrenal chromaffin
tissue elaborates NE almost exclusively. Plasma
catechol determinations via vena cava sampling at
different levels are reserved for those patients requiring a second surgical exploration for pheochromocytoma-either for recurrent tumor or for a
previously missed tumor.
Management of Patients with Pheochromocytoma-Preoperative. (Table 3) The primary aini
of the preoperative preparation and the anesthetic
management is to minimize stimuli to the pheochromocytoma to prevent sudden and dangerous alterations in heart rate, rhythm, and arterial pressure.
The key point of preoperative preparation is partial
alpha adrenergic blockade. This usually takes folirto-five days tb accomplish, but it is well worth the
effort primarily because it takes most of the risk out
of surgery. I emphasize the word partial, for if you
had total blockade, you would lose two very helpful
diagnostic signs-a rise in blood pressure on manipulation of the tumor and a drop in blood pressure
after the removal of the tumor. Sometimes extraadrenal tumors are difficult to locate, and it is very
helpful to be able to gently palpate the para-aortic
and pelvic areas seeking a blood pressure respcmse.
Beta blockade is not useful for preoperative preparation.
Management of Patients with Pheochromocytoma-Surgery. (Table 4) Surgery is our current
way of handling pheochromocytoma patients, but I
would like to emphasize that there is no single
anesthetic agent or technique which is the sine qua
non of anesthesia for pheochromocytoma. It is important to establish your monitoring prior to induction, for this is almost as tumor-stimulating as
manipulation of the . tumor itself during surgery.
We have been happy with halothane. It elicits
no sympathoadrenal activity and it decreases the
peripheral vasculature response to NE. There is
some evidence that it may make the heart more
irritable and more prone to cardiac arrhythmia, but
this has not been our experience. Methoxyflurane was
touted as the anesthetic agent of choice for several
years, but it is infrequently used nowadays because
of some reports that it caused high output renal
failure.
I think the use of pancuronium during intubation is an excellent example of the very careful
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anesthetic technique required. Commonly during
intubation with succinylcholine, there are transient
muscle fasciculations which may stimulate the tumor,
so to avoid this possibility, pancuronium is given
ahead of time.
We always use a subcostal incision in these
patients, inspecting and palpating the pelvic and
para-aortic region and both adrenal glands. We try to
manipulate the tumor as little as possible. The single
adrenal vein is ligated first if feasible. If only one
adrenal is involved, the entire adrenal gland is removed. If this is the oµly tumor, there is generally
a significant drop in arterial pressure which is usually
corrected by volume replacement. If arterial pressure
does not drop or if, after a short period of hypotensiori, it bounces back up to supernormal levels, you
had better look around for a second tumor. Remember that 10% of patients will have more than one
tumor, and if your patient is a child or has familial
pheochromocytoma; the probability of a second tilmor increases to 20-50%.
Management of Patients with Pheochroniocytoma-Problems in the Operating Room. (Table
5) When manipulatiori of the tumor causes arterial
pressure to shoot up to levels of 250/150 or higher,
the surgeon's catechol level is not far behind. We
rely primarily on phentolamine drip in this situation,
but if we are at all worried, we do not hesitate to

TABLE 5.
MANAGEMENT OF PATIENTS WITH PHEOCHROMOCYTOMA

Cardiovascular Problems During Surgery
1. Hypertension

A. Phentolamine drip-short-acting alpha adrenergic
blocker
B. Sodium nitroprusside-direct smooth muscle relaxant
C. Deepen anesthesia with halothane.
2. Hypofension after removal of the tumor
A. Volume expansion with blood, plasma, albumin and
lactated Ringer's solution
B. Neo-synephrine ® or norepinephrine drip- alpha
adrenergic stimulators
3. Arrhythmias
A. Lidocaine intravenously, bolus or drip
B. Propanolol intravenously, bolus or drip- beta adrenergic blocker
C. Reduce halothane concentration.
D. Check blood gases to rule out hypercarbia and / or
hypoxia.
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use nitroprusside. Sodium nitroprusside effectively
lowers arterial pressure by direct action on smooth
muscle allowing you to titrate the pressure down to
the level you desire.
Hypotension is not the problem it used to be
thanks to preoperative alpha adrenergic blockade.
In most cases, volume expansion, usually with albumin and Ringer's lactate, corrects the hypotension.
Cardiac arrhythmias worry me a lot· more than
hyper- or hypotension. We reduce the halothane
concentration and give lidocaine initially and if this
solves the problem-fine. Lidocaine, though, is
really a minor league drug in this situation and if
the arrythmia does not respond fairly promptly to
lidocaine plus the decreased halothane concentration,
1-2 mg of the beta blocker, propanolol, often gives
dramatic relief.
Primary Aldosteronism. This interesting syndrome, first identified by Conn in 1954, is another
cause of curable hypertension, probably accounting
for 2-3 % of all ·hypertension. Unlike the hypertension seen with pheochromocytoma, it is always sustained and usually benign with diastolic pressures
usually less than 130 mm.
Physiology Na·-K·-H+. The phenomenon of
renal escape is important because of its clinical
implications. Aldosterone acts primarily on the distal
renal tubule causing retention of Na• and H 2 0 while
enhancing the excretion of K• and H•. If this ion
exchange continued unchecked, the- retention of Na•
and H 20 would necessarily result in massive edema,
but this does not take place. Patients with primary
aldosteronism do not have edema. After two-tothree days of a'ldosterone, the kidneys escape from
the Na• retaining effect but they do not escape from
the K• losing effect of the hormone. Initially, salt
and H 2 0 retention take place, the ECF compartment
is expanded, and the patient gains around 2 kg. At
this point, however, three-to-five days ·after administration of aldosterone, renal escape is complete and
urinary Na• levels, initially low, go back up to normal and Na• equilibrium is established at a higher
level. The exact mechanism of renal escape has not
been clarified. Aldosterone does not lose its Na•
retaining effect on the distal tubµle but there is
decreased reabsorption of Na• by the proximal
tubule, probably secondary to the action of volume
sensitive salt-losing hormone referred to as the third
factor. The decreased reabsorption of Na• by the
proximal tubule throws an added load on the distal
tubule, and this added load balances out the en-
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hanced Na• reabsorption due to aldosterone. The net
result is normal urinary Na•.
Aldosterone is an unusually potent hormone.
Each day, only 0.1 mg is produced, and chronic
production of as little as 0.2 mg per day, only two
times the usual output, can cause primary aldosteronism. This amount can be produced by a tiny
adenoma less than 2 mm in size. Because of the
hormone's potency, most adenomas found at surgery are small. Whereas the average size of a pheochromocytoma is around 100 g, 85 % of these 1adenomas are less than 10 g and 75% are less than
3 cm in diameter.
Renal-Adrenal Interaction. There are only three
direct stimuli to aldosterone production, adrenocorticotropic hormone (ACTH), K+, and angiotensin II. ACTH is of little importance in the day-today aldosterone output, since it stimulates aldosterone release only in emergency or acute situations and
for only a short period of time. In normal man, the
renin-angiotensin system and K+regulate aldosterone
secretion through negative feedback loops. If hyperkalemia is present, the increased aldosterone production enhances the urinary excretion of K+, returning
plasma K• levels toward normal, thereby removing
the stimulus. When the effective blood volume is reduced, the renin-angiotensin system increases aldosterone production and the resultant retention of Na•
and H 20 returns the blood volume toward normal
and shuts off the renin-angiotensin system.
In patients with malignant hypertension or in
other disorders associated with chronic underperfusion of the kidneys, renin, angiotensin II, and aldosterone levels are chronically high and the induced
alqosteronism is unable to shut off the renin mechanism. This is called secondary flldosteronism.
Classification of Aldosteronism. (Table 6)
Until fairly recently, primary aldosteronism was a
pretty clear-cut syndrome. The patients, more commonly women 30- 50 years old, had longstanding
hypertension with associated hypokalemia and
muscle weakness. Surgical removal of a small adenoma almost invariably corrected the hypertension
and the hypokalemia.
The first cloud on the horizon was the report
of many patients with normokalemic primary aldosteronism. Some of these represent milder forms of
the syndrome, but many times these patients remain
normokalemic because they have been placed on a
low salt diet. The magnitude of the K•/ Na• exchange
is directly related to the number of Na• reaching the
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TABLE 6.
CLASSIFICATION OF ALDOSTERONISM

Primary Aldosteronism
1. Benign adrenocortical adenoma-75%
2. Adrenocortical hyperplasia or hyperfunction-25 %
A. Idiopathic
B. DOCA-remediable
C. Glucocorticoid-re~ediable
3. Adrenocortical carcinoma
Secondary Aldosteronism
angiotensin II

1. Physiologic via three known

direct~ potassium

stimuli

ACTH

A. Renin-angiotensin system

1) Reduced plasma volume-hemorrhage, dehydration, low salt diet, upright posture
B. Potassium
1) High potassium diet
C. ACTH
1) Stress-surgery, trauma, anxiety
2. Pathologic
A. With hypertension
1) Malignant hypertension
2) Renal vascular hypertension
3) Oral contraceptive hypertension
8. Without hypertension
1) Juxtaglomerular hyperplasia
2) Cirrhosis with ascites
3) Nephrosis

distal tubule. A low salt diet would limit this ion
exchange and blunt or obscure the clinical picture.
Many of these normokalemic patients exhibit hypokalemia after several weeks on a high salt diet.
In the last few years, it has become apparent
that hyperplasia is responsible for many cases of
primary aldosteronism, and current estimates suggest that 25 % are due to hyperplasia or hyperfunction, and the final figure may go even higher. This
relatively high incidence of hyperplasia is very important, for these patients are treated medically, not
surgically. If bilateral adrenalectomy is performed
on these patients, the hypokalemia is corrected but
the hypertension is not.
At present, the idiopathic and DOCA remediable forms of hyperplasia are treated with spironolactone, · an aldosterone antagonist which blocks
aldosterone at the renal tubule. The gluco-corticoid
remediable form, or A-G syndrome, is treated with
dexamethasone.

In the secondary forms of aldosteronism,
either physiologic or pathologic, the aldosterone is
elevated because the renin-angiotensin system is fn
high gear. As a result, patients with this condition
have higher levels of renin, angiotensin II, and
aldosterone.
Diagnostic Studies. (Table 7) Before performing the screening test, the patient should be off all
medication, particularly the thiazide diuretics, for a
minimum of two weeks.
A high salt diet is used for two reasons. In
normal people, a high salt diet expands the ECF
volume, thereby suppressing the renin-angiotensin
mechanism and decreasing the secretion of aldosterone. With low secretion rates of aldosterone,
urinary K• levels are low and plasma K• levels remain
unchanged. In patients with primary aldosteronism,
the autonomous production of aldosterone is not
suppressed by the high salt diet, and the availability
of plenty of Na• permits the aldosterone present to
exert its maximal effects. With the K•/Na• exchange
operating maximally, the resultant high urinary excretion of K• causes hypolmlemia.
The first step in making the definitive diagnosis
is to prove that the patient has excess aldosterone in
the urine. To widen the gap between normal patients
and those with primary aldosteronism, this determination is performed while the patient is on a high
salt diet. Once you have established that the patient
is overproducing aldosterone, you then must separate
primary from secondary forms. The high aldosterone

TABLE 7.
STUDIES TO DETECT PRIMARY ALDOSTERONISM

I. Screening Test
A. Determine plasma potassium concentration after two
weeks on a high salt, moderate potassium diet.
1) If plasma potassium is <3.5 mEq/ L, patient may
have aldosteronism.
2) If plasma potassium is >3.5 mEq / L, patient does
not have aldosteronism.
2. Diagnosis
A. Nonmalignant hypertension
B. Overproduction of aldosterone
1) Failure to suppress abnormal aldosterone
production with a high salt diet
C. Underproduction of renin
1) Failure to stimulate renin production with a low
salt diet and upright position
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levels seen in secondary aldosteronism are due to
overactivity of the renln-angiotensin system, so that
these patients all have abnormally high levels of
renin. In patients with primary aldosteronism, the
chronic overexpansion of the ECF suppresses the
renin-angiotensin mechanism and renin levels are
low. To widen the gap between normal and primary
aldosteronism, this determination is performed while
the patient is on a low salt diet and after three-tofour hours in the upright position. These two maneuvers double and triple the output of renin in normal
individuals but have little or no effect on patients
with primary aldosteronism.
Diagnostic Studies. Since the majority of these
tumors are small and relatively hypovascular, they
are not detectable by the usual techniques-IVP,
nephrotomography, arteriography, or retroperitoneal
pneumography. It is important to prove the presence
of an adenoma, since surgery is not the treatment of
choice for hyperplasia-induced primary aldosteronism.
There are three special techniques available for
lateralization. Adrenal venography successfully outlines the adenoma in around 85 % of the cases.
Adrenal venous blood is sampled at the time of
venography, and if you detect high levels of aldosterone on the side of the lesion, with close to
peripheral levels on the unaffected side, the accuracy
of diagnosis approaches 100% .
A recently introduced scanning test, presently
expensive and unavailable except at a few selected
medical centers, may become the best diagnostic tool
of the future. Its obvious appeal is its complete
safety. Photo scanning is performed after administration of 19-iodocholesterol labeled with radioactive
iodine !1 31 • Lugols is given ahead of time to block
1
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the uptake of iodine by the thyroid. The kidney areas
are localized with Hg chlormerodrin scan. Five-tosix and eight-to-ten days after administration of
radioactive material, scanning of both adrenals is
accomplished using a computer-assisted Anger
gamma camera.
Surgery. Preoperative preparation is aimed at
correcting the hypokalemia. Hypolcalemia increases
the irritability of the heart so that surgery might
cause ventricular fibrillation or other arrhythmia.
Hypokalemia also weakens the muscles, increasing
the danger of respiratory insufficiency if curare-like
agents are used.
Hypokalemia may be corrected in two ways.
Spironolactone, aldosterone blocker, reverses the effects of aldosterone and returns plasma K+ levels to
normal in three-to-four days. Low salt-high K+ diet
also returns the plasma K+ to the normal range but
this takes a little longer, usually seven-to-eight days.
We prefer the dietary approach since it is more
predictable.
We prefer the transabdominal approach because it allows us to eX'amine carefully both adrenal
glands before making any decision. These tumors
occur only in the adrenal glands and 94% are unilateral. If aldosterone tumor is clearly visualized on
one side, it would be feasible to perform a unilateral adrenalectomy via the flank approach since
less than 6% are bilateral. Because these tumors
are so small, you have to free the gland sufficiently
to permit inspection and palpation of the entire
gland. As the lateralization techniques-venography
and adrenal scanning-become more usable, a flank
approach might be preferred. Unlike other forms of
curable hypertension, the blood pressure usually
takes weeks-to-months in returning to normal levels.
1
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Urinary Incontinence: A Problem to Hold On To*
JOHN H. TEXTER, JR., M.D.
Assistant Professor of Urology, Division of Urology, Medical College of Virginia, Health
Sciences Division of Virginia Commonwealth University, Richmond, Virginia

Introduction. In this presentation attention will
be focused on the problem of urinary incontinence.
We will look briefly at the various types and causes
for this distressing disorder (Table 1). Mention will
also be made as to treatment with particular emphasis on the surgical correction (or attempts at correction) of the postoperative urine leakage such as one
sees following prostatectomy or trauma.
Before we talk about incontinence, it would
be helpful to look at the normal mechanisms which
allow us to contain urine for long periods of time
and at the appropriate and socially acceptable time,
to eliminate our liquid waste products with minimum
effort and exertion. In the female there is no distinct
urethral sphincter or muscle which can be identified
as such. The entire urethra acts as a valve mechanism.
The resistance to outflow through the urethra increases as one proceeds from the bladder neck, reaching a maximum resistance in the midportion, and
then gradually lessening again as the meatus is approached. Theoretically, the longer the urethra, the
more effective the sphincter action. Indeed, it is this
lengthening principle which is often utilized during
treatment of some forms of female incontinence.
The male is much better endowed for here we
have two distinct mechanisms, and definite musculature can be identified as sphincter. In the event of
damage to one or the other sphincters, the other
one will serve quite as well as a competent mechanism. Definite circular fibers can be identified at the
level of the bladder neck which are adequate to contain all of the liquids within the bladder during the
resting state. This is the sphincter that is routinely
destroyed or damaged in some way at the time of a

* Presented by Dr. Texter at the 26th Annual Stoneburner Lecture Series, February 22, 1973, at the Medical
College of Virginia, Richmond.
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prostatectomy. Providing the external sphincter is
intact, this will not make the patient incontinent.
Distal to the prostatic urethra and at the level of
the urogenital diaphragm, sphincter muscles are
identified; all are limited to an area of several millimeters in length. These can very easily be seen on
cystoscopy as one withdraws the cystoscope. Beyond
the level of the veru the sphincter muscle closes down
the urethra. During the act of voiding both sphincters
relax, the bladder detrusor muscle then contracts,
and the urin,e is passed.
Urge Incontinence. This results from a primary
abnormality of the bladder, rather than damaged or
incompetent sphincters. This is not true incontinence
in that the patient is not continually wet. The patient will suddenly have an uncontrollable urge to
void, and a small quantity of urine escapes before an
appropriate facility can be located. There is an abnormal stimulus acting upon the detrusor muscle,
causing bladder contractions, and overriding the
sphincter. This is seen in irritated bladders, such as
during an episode of cystitis or following extensive
radiation to the bladder wall. A similar mechanism
is in operation when "bladder spasms" are experienced with an indwelling Foley catheter. Here
the bladder surface, in particular the sensitive area
around the trigone, is mechanically stimulated by
the catheter balloon. If this spasm or detrusor contraction is great enough, urine will be forced out of
the bladder and around the catheter. When this
urine leakage occurs, one is inclined to replace the
catheter with a larger one to totally occlude the
urethra. This serves only to increase the stimulation,
and thus the bladder spasms and urine leakage are
worsened. Actually, a smaller, less irritating catheter
should be used in conjunction with some agent to
decrease bladder tone such as Pro-Banthin® or
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Valium®. In the case of urge incon'tinence associated
with cystitis, attention should be directed to resolving the bladder inflammation which in turn should
improve bladder control.
Paradoxical (or Overflow) Incontinence. When
the bladder is unable to empty due to obstruction
it continues to fill until such point as the intravesical
pressure is increased beyond the sphincter pressure,
resulting in urine leakage. This usually produces
a weak dribbling type of urine flow. This can occasionally be seen secondary to a cerebrovascular accident when the bladder innervation is impaired and
bladder muscle tone is decreased. Often, the patient with paradoxical incontinence will give a history of satisfactory urine control during the day
when he exerts greater effort to remain dry but wets
himself at night when more relaxed and the sphincter
pressure is less, thus producing the "elderly bedwetter." Generally, if untreated the problem gets
worse and eventually the dribbling begins to occur
both day and night. Initial management requires
drainage and decompression of the bladder with use
of a catheter. In addition to a decompensated thinwalled bladder, the problem of post-obstructive
diuresis must be expected and treated accordingly
with fluid replacement and supportive measures.
After the patient is stabilized, the etiology of the
original obstruction must be determined and relieved. If bladder impairment is not reparable, longterm urine drainage will be required.
Stress Incontinence. As mentioned earlier, in
the female the sphincter is poorly defined, and the
entire length of urethra acts as a control mechanism. When relaxation of the pelvic floor occurs,
such as after multiple pregnancies, there is shortening
of the urethra as well as prolapse of the bladder base
and urethra. Green has shown that as this relaxation
occurs, the relationship of the bladder base to the
urethra is critical to urine control in the female. This
vesicourethral angle can be accurately measured on
a cystourethrogram and is helpful in planning corrective surgery. These patients are normally dry during normal activity, and the voiding pattern is unremarkable. The urethral sphincter, however, is just
borderline with normal vesical pressures; the sphincter resistance is adequate to control urine. When
intravesical pressure is slightly increased, however,
such as when coughing or laughing, the integrity of
the sphincter is overcome and urine leakage occurs.
In general, treatment requires surgical correction to
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TABLE 1
TYPES OF URINARY INCONTINENCE

1.
2.
3.
4.

Urge Incontinence
Paradoxical (or Overflow) Incontinence
Stress Incontinence
Enuresis
5. Structural Defects
6. Acquired Sphincter Damage

provide adequate support to the bladder and urethra
as well as to lengthen the urethra. This can be done
through the anterior vaginal wall by reinforcing the
, urethra with adjacent tissue. The most commonly
used procedure is the Kelly Plication. The correction
can also be made from above by tacking the urethra
·and anterior bladder to the undersurface of the
symphysis and rectus sheath, as in the MarshallMarchetti-Krantz procedure.
Enuresis. The word enuresis is of Greek origin
meaning urine leakage, but by common usage over
the years it has been limited to wetting during the
hours of sleep. Except for the paradoxical incontinence seen in the elderly, enuresis is a problem of
the younger patient.
Other Structural Defects. Anatomical defects
of the lower urinary tract may result in urinary
incontinence even in the presence of a normal urethral sphincter mechanism. These can be both congenital or acquired in origin.. In the former group
one sees patients with extrophy of the bladder or
with a severe degree of epispadias. Likewise, one sees
patients with fistulous communications such as occur
between the urethra or bladder and the perineum
as is found in certain types of imperforate anus. In
the female, an ectopic ureter may exit beyond the
urethral sphincter or in the vagina producing incontinence. Urinary incontinence can result from abnormal or absent innervation to the bladder and
sphincter which is secondary to spinal cord defects
as occurs in those patients with congenitally absent
sacrums and myelomeningoceles. Acquired defects,
especially in the female, may be the result of gynecological surgery or traumatic deliveries resulting
in urethral or vesicle fistulae. Radiation therapy for
malignant disease may produce fistulae between the
urinary tract and some other organ system with its
associated urine leakage. Treatment for these conditions should be aimed at closure of the structural
defects such as repair of the fistula and excision or
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relocation of the ectopic ureters. If closure of the
defect is not surgically possible some form of urinary
diversion may be necessary.
Acquired Urinary Incontinence. The problem
of acquired urinary incontinence is a result of direct
damage to the sphincter mechanisms such as one
sees following prostatectomy. An entire spectrum
of urinary leakage can be seen depending on the
degree of sphincter integrity remaining. If the fibers
have been weakened but some circumficial fibers
remain, the patient may have typical stress incontinence with adequate control at rest with low intravesical pressures; however, when coughing or straining the intravesical pressure exceeds the sphincter
resistance and urine is on its way. When sphincter
damage is more extensive, such as when a cut or
tear extends through the entire membranous urethra,
the patient will have a continuous dribble. In fact,
it is probable he may not be able to void at all if
urine runs out freely and there is no accumulation in
the bladder. This is indeed a distressing problem,
both for the patient and the doctor. Since most of
the other forms of urinary incontinence are "acts
of God," and the surgeon is not directly responsible
for the patient's dilemma, there is not the overwhelming motivation one sees at attempts to correct the
postoperative incontinence. With one act of commission the surgeon has unleashed untold woe upon
himself and his unfortunate damp patient.
All of the techniques and approaches to prostatectomy can result in postoperative incontinence. In
some types of prostatectomy, however, this complication is much more common. The likelihood of this
problem occurring is greater when a total or radical
prostatectomy is done for malignancy. In looking at
the multitude of techniques, apparatus and corrective
operations, it is clear that variety and enthusiasm
have more than compensated for what has been

TABLE 2
METHODS FOR CONTROL

I. Suicide

2.
3.
4.
5.
6.
7.
8.

Urologist Leave Town
Social Ostracism
Wearable Urinal
Retention Catheter
"Texas" Catheter
Cunningham Incontinence Clamp
Attempt Surgical Correction

meager in success (Table 2). Suggestions to resolve
this problem range from the extreme of suicide on
the part of the patient to having the doctor leave
town and set up practice elsewhere. In most cases,
neither of these two recommendations is very useful.
If some portion of the sphincter is intact, it is possible
to strengthen these fibers by use of perinea! or urethral sphincter exercises. The patient is instructed to
"cut-off" his stream several times during each voiding
and to remember to "pucker up" his perineum when
straining and assuming the upright position. If the
patient is totally incontinent, which, according to
Dr. Kauffman, occurs in a "small but vocal percentage of postprostatectomy patients," the problem
is far more serious and difficult to treat. If one
simply throws up his hands and admits defeat, some
type of external appliance or device will be needed.
This includes wearing a pad, rubber pants, or graduating to a penile clamp such as a Cunningham clamp.
At a more sophisticated level, one could advance to
the use of a urosheath; the McGuire urosheath of
Richmond origin is probably the best known.
Numerous surgical procedures have been advocated for returning the patient to continence. In the
early 1920's, the late Dr. Hugh Young suggested
excising a portion of the bladder neck to narrow the
bladder outlets. This was based on the theory that
by excising the scar tissue and lengthening the urethra, control would return. I have not been able to
obtain any data on the success rate other than to say
this procedure is not generally popular among cur- .
rent practicing urologists. Dr. Thompson suggested
suspending the bladder and prostatic urethra from
the anterior abdominal wall and undersurface of the
symphysis pubis. This is similar to the procedure
reported by Drs. Marshall, Marchetti and Krantz
for correcting stress incontinence in the female.
Further attempts have been made to compress the
urethral lumen by external pressure. Dr. Foley devised a fascinating pneumatic compression clamp
which surrounds the urethra. Initially, a segment
of the urethra was isolated from the penile shaft
and provided with a skin covering to form a type of
"bucket handle" to the urethra. The activating device for the pressure cuff was kept in the patient's
pants pocket. A mere push of the button and the
pressure was on. It was said to be good for taking
long automobile or bus rides, but because of the
need for an external appliance, it never became very
popular. Using a more physiological approach, at-
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tempts were made to provide the external compression by some portion of the patient's own musculature. A strip of gracilis muscle or rectus muscle
could be freed up and looped around the urethra,
similar to a cowboy's lasso. Fascial strips were also
used with some degree of success. The failure with
this method is probably related to the use of voluntary muscles and fascia which are not able to provide the constant contraction which is · essential to
the muscle tone found in naturally occurring sphincter
muscles. To counter this problem, investigators very
cleverly chose to use a portion of the anal sphincter
to provide continence to both the urethra and anus.
Two methods are available. One means is to cut a
strip of anal sphincter which has been freed and
loop it around the urethra. This is then sutured back
to its original attachment. More recently, Dr. Mathison has suggested that a strip of anal sphincter be
freed but left intact at both of its ends. The urethra
is then cut and pulled through the sphincter loop and
then reanastomosed. A number of our patients have
undergone this latter procedure. The first one, who
was totally incontinent of urine prior to the operation, had a perfect result; he was delighted. Since
then our patients have not been as fortunate. Not
only has the incontinence continued, but there have
been subsequent problems with stricture formation
at the urethral anastomosis site.
A new twist was added to the story of urinary
incontinence therapy in 1956, when Dr. Beneventi
reported his approach to the problem. He exposed
the urethra through the perineum after marking the
urethra with two stay sutures. The urethra was
transected between the sutures. The cut ends were
then rotated, one 180° to the right and the other
180° to the left, and reanastomosed into the new
position, giving a 360° twist to the new urethra.
Various materials have been utilized to squeeze
off the urethral lumen. In the early 1960's, Dr.
Berry achieved some success in establishing urinary
continence by inserting a small rectangular acrylic
prosthesis between the bulbous urethra and the overlying musculature. The prosthesis was held in place
by suturing it to adjacent muscles or directly to the
bony ischial and/or pubic rami after drilling holes
for suture placement. Interest for this prosthesis
faded when patients complained of perinea! pain
or the prosthesis became infected and required removal.
Using much the same approach, Dr. Hinmann

suggested using a piece of a rib rather than the
acrylic prosthesis to compress the urethral lumen.
The delicate balance, however, between enough compression to establish continence and yet not obstruct
urine outflow was rarely achieved.
More recently, Dr. Kauffman has advocated a
more pliable form of compression of the urethra by
crossing the crura over the bulbous urethra and
suturing them in place. Because of failure, this has
been modified several times. The crura were sutured
directly over the urethra, and eventually the use of a
"wad of marlex" tucked under the crura was suggested. This uses foreign material for support, and
we are again troubled with the infection and fistulae
formation. One of our patients treated with this
marlex support actually eroded the prosthetic material directly into the urethral lumen. A recent report from the University of Minnesota has described
the use of a new silastic urethral compression cuff
which is entirely buried beneath the skin. It is somewhat reminiscent of Dr. Foley's old pneumatic cuff.
The squeeze bulbs, however, are recessed into the
scrotum, one valve into each compartment with the
pressure reservoir hidden beneath the rectal muscles.
It appears to be rather complicated, and while its
use is thus far quite limited because of the previous
problems with such devices, one would question
how practical it will be clinically.
In conclusion, it may be said that the problem
of urinary incontinence has not been solved. With
regard to the various plastic operations proposed
for correction of the paralyzed sphincter with complete permanent incontinence, it would be as true
today as it was in 1939 for Dr. Herman to say:
"The results, with few exceptions, are unsatisfactory."
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Prostatic Acid Phosphatase: A Potpourri*
CHARLES W. MONCURE, M.D.
Assistant Professor of Pathology, Medical College of Virginia,
Health Sciences Division of Virginia Commonwealth University,
Richmond, Virginia

In 1938, Gutman et al. (6) described increased
levels of acid phosphatase in metastatic carcinoma
of the prostate. Since then, when most of us hear
the term "acid phosphatase" we immediately think
of prostatic cancer, and justifiably so. The link, however, between the test and the diagnosis is not as
clear and simple as many of us would like to believe.
I would first like to discuss this enzyme, reviewing some of its chemistry, its clinical value and
the pitfalls and problems associated with the routine
tests. Then I would like to tell about some work
in which we have been involved that we hope will
increase the diagnostic value of this enzyme and
perhaps point the way to advances in clinical enzymology in other areas.
Chemical Assays. First let us remember that
the term "acid phosphatase" simply means an enzyme
which, at pH below 7 .0, hydrolyzes phosphate esters
liberating the phosphate ion and replacing it with
an -OH group. Prostatic acid phosphatase is only
one of many enzymes in this category. The organic
portion of the phosphate ester involved is not specifically defined by the term acid phosphatase, and this
brings up our firs_t problem. We do not know the
natural physiological substrate of prostatic acid
phosphatase. Indeed we know very little about the
biological function of this enzyme. Consequently, we
must measure its activity using synthetic phosphate
esters which are, as far as we know, completely
unrelated to prostatic physiology and reproduction.
Each new substrate gives rise to a new assay, a new
set of units, new degrees of specifieity and sensitivity
and new problems of interpretation.
As previously mentioned, there are many forms

* Presented by Dr. Moncure at the 26th Annual Stoneburner Lecture Series, February 22, 1973, at the Medical
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of this enzyine which are not derived from the
prostate. Indeed, it is present to some degree in
virtually all tissues as a lysosomal enzyme. In blood
chemistry, however, the most common source of nonprostatic acid phosphatase is the red blood cell. For
this reason several clinical assays have been developed which readily differentiate between prostatic
and erythrocytic acid phosphatase. Table 1 lists the
methods and substrates commonly employed in the
clinical laboratory. The Bodansky ( 4) and BabsonRead (2) as well as the newer thymolphthalein
phosphate method described by Roy, Brower, and
Hayden ( 14) will not detect red cell acid phosphatase. The King-Armstrong (7) and Bessey-Lowry
( 3) methods will detect the red cell enzyme, however, and employ an inhibitor, usuall:r L( +) tartrate,
to differentiate prostatic and erythrocytic acid phosphatase. Table 2 lists inhibitors which can be used
for this purpose. Although selective substrates and
inhibitors can make this distinction, it should be
emphasized that they do not provide a truly specific
test for prostatic acid phosphatase. Indeed, ~-glycero
phosphate and a-naphthyl phosphate are histochemical substrates (7) commonly employed for staining
acid phosphatase in a variety of tissues.
For tissue analysis and for occasional pathological sera, inhibitors and substrate selectivity do not
clearly distinguish between prostatic and rionprostatic acid phosphatase. Table 3 lists some of
the nonprostatic diseases which have been reported
to cause elevations in serum acid phosphatase and
while they rarely present a problem of differential
diagnosis in carcinoma of the prostate, we should
not ignore their existence.
A far more common problem is the interpretation of serum acid phosphatase levels where the enzyme is of prostatic origin and where we are concerned with the diagnosis and staging of prostatic
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TABLE 3.

TABLE 1.
PROSTATE

METHOD

SUBSTRATE

Bodansky
King-Armstrong
Bessey-Lowry
Babson-Read
Roy-BrowerHayden

/j-Glycerophosphate
Phenyl phosphate
p-Nitrophenylphosphate
a-Naphthyl phosphate
Thyrriolphthalein
phosphate

RBC

A
A
A
A

A
A

A

cancer. Most prostatic carcinomas produce this enzyme, and low serum levels in the face of apparent
widespread diseases are usually the result of heat
denaturation at neutral or alkaline pH as this enzyme
rapidly loses its activity if the serum sample is not
acidified and refrigerated.
An elevated serum prostatic acid phosphatase in
general suggests prostatic cancer which has extended
beyond the prostate; however, prostatic surgery,
diagnostic palpation, and prostatic infarction may
cause transient enzyme elevations. Careful attention
to the time when the sample is drawn and to specimen handling will greatly improve the reliability of
routine serum assays.
Immunology. In order to provide a highly specific means of diagnosing prostatic cancer, we began
investigating the antigenicity of prostatic tissue and
secretions first irr dogs ( 8) and later in nian ( 10, 11).
Using antisera raised in rabbits immunized with dog
prostatic fluid or human sperm-free ejaculate we
could demonstrate an immunological organ specificity of prostatic acid phosphatase. This specificity
had also been observed by Shulman and his coworkers ( 15) and has been confirmed by several
other investigators ( 12, 13). Our methods of demonstrating antiprostatic acid phosphatase involved reacting the antisera with prostatic homogenate in an
Ouchterlony agar gel immunodiffusion system. After
precipitin lines formed, the gel was washed and
stained histochemically for acid phosphatase (14) .

TABLE 2.
INHIBITOR

Ethyl alcohol 40% .. . . . .. . .. . . .. . . .
L (+)tartaric acid 0.02 M. . . . . . . . . . .
Formaldehyde 2% . . . . . . . . . . . . . . . .
Cupricion0.001 M .. .. .. .. .. .. .. ..

PROSTATE

( +)
( +)
(- )
(-)

RBC

(- )
(- )
( +)
(+)

NON-PROSTATIC CAUSES OF ELEVATED ACID PHOSPHATASE

Gaucher's disease
Osteitis deformans
Thrombocythemia
Lipid histocytosis
Hemorrhagic shock
Lymphoblastic leukemia
Nonprostatic carcinoma

Extensive absorption of the antisera with nonprostatic tissues confirmed the tissue specificity of
both dog and human prostatic acid phosphatase.
Antihuman prostatic acid phosphatase was then
raised against a partially purified enzyme preparation. Human sperm-free ejaculate was passed
through an ion-exchange column packed with DEAE
Sephadex ( A-50) equilibrated with 0.1 M Tris-HCI
pH 8.0. Acid phosphatase was trapped in the column
while most other seminal proteins passed through
freely. The enzyme was then eluted with a sodium
chloride molarity gradient, concentrated by ultrafiltration and used with complete Freund's adjuvant
to immunize New Zealand White rabbits ( 15). This
antiserum was also checked by Ouchterlony immunodiffusion together with a diazo coupling stain
for acid phosphatase as described previously ( 15).
The serum was tested against prostate, liver, spleen,
kidney, pancreas, salivary gland, gastric mucosa;
large and small bowel, breast, lung, muscle, lymph
node, heart and freshly prepared packed platelets.
The only positive reaction was with prostatic acid
phosphatase. Antiserum of this quality can be used
to specifically identify and quantitate the prostatic
enzyme.
The sensitivity of gel diffusion tests is too low
to detect normal or moderately elevated serum acid
phosphatase; however, these simple, inexpensive
tests can be used to identify prostatic cancer since
the tissue itself is usually quite rich in the enzyme.
Clinical Study. A logical application of such a
test would seem to be the identification of prostatic
carcinoma in bone marrow as the tumor characteristically spreads to bone artd the presence of bony
metastases is a critical factor in staging the disease.
In order to compare the concentration of prostatic
acid phosphatase in bone marrow with that in serum,
quantitative radial immunodiffusion plates were prepared by incorporating the antiserum in 1.5 % agar
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Fig. 1- Serial dilution of prostatic acid phosphatase showing reduction of precipitive ring with decreasing enzyme concentration.
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Fig. 2-Comparative immunodiffusion results. M
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disorder.

=

0

0

0

c

Fig. 2-C. Negative reaction in patient with metastatic prostatic cancer and marked elevation in serum acid phosphatase. The rings are of equal size and do not prove the
presence of tumor in the marrow.

0

Fig 2-B. Positive reaction in metastatic prostatic cancer and
slightly elevated serum acid phosphatase. No precipitive ring
has formed around the serum well.

0

Fig. 2-D. Positive reaction in patient with metastatic prostatic cancer and very high serum acid phosphatase . The much
larger marrow ring proves tumor in the marrow.
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Fig. 2-E. Negative reaction in the patient with benign prostatic hyperplasia and elevated serum acid phosphatase following transurethral resection. No precipitive ring is formed
around the marrow well.

Fig. 2-F. Negative reaction in patient with Gaucher's disease, elevated serum acid phosphatase and Gaucher's cells
in the marrow sample. The antiserum does not precipitate
nonprostatic acid phosphatase.
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at a concentration of 1: 100. This technique was
based on the method developed for the quantitation
of serum immunoglobulins ( 16) . Low levels of enzyme produced small red precipitin rings when
stained for acid phosphatase. As the enzyme concentration was increased the ring diameter increased
(fig. 1). Bone marrow aspirates and serum samples
were obtained in the course of routine hematological
evaluation of 61 patients with prostatic cancer and
32 patients with benign prostatic disease, nonprostatic neoplasms, or hematological disorders, including one patient with Gaucher's disease. Marrow
smears were stained with Wright-Giemsa and
screened for tumor cells. Paired smears stained for
acid phosphatase were also used to screen for prostatic cancer cells. Comparative radial immunodiffusion was carried out on quantitative gel plates with
two sample wells. Serum was placed in one well and
marrow in the other and diffusion carried out at
room temperature for 24 hours. The plates were then
washed and stained. If the precipitin ring around
the marrow well was larger than that of the serum,
the test was considered positive. If no ring occurred
around the marrow well or if serum and marrow
produced rings of equal diameter, the test was considered negative for bony metastases (fig. 2A-F) .
Results of Bony Marrow Study. Malignant cells
were seen in three of the control group and Gaucher's cells in one. Only the Gaucher's cells were
stained by the phosphatase reaction. None of the 32
controls was positive by immunodiffusion. One patient with benign prostatic hyperplasia who was
studied immediately after cystoscopy showed detectable serum prostatic acid phosphatase but no detectable enzyme in the marrow, thus documenting a
serum elevation due to prostatic manipulation.
Among the 61 patients with prostatic cancer, 12 had
malignant cells in their marrow and gave a positive
immunodiffusion test. Four other cases of prostatic
carcinoma were positive by immunodiffusion; how/ ever, no tumor cells were found in the marrow
aspirates. All four of these patients had bony lesions
by x-ray.
These data suggest that a comparative immunoassay for prostatic acid phosphatase may provide a simple, inexpensive yet specific means of
establishing that a patient has carcinoma of the
prostate in an advanced stage. In two cases, we have
obtained positive immunodiffusion tests on men with
carcinoma of undetermined primary. Both of these
were subsequently proven to have prostatic cancer.
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While we have only applied this technique clinically
on bone marrow aspirates, autopsy studies indicate
that it is equally successful in identifying prostatic
cancer in lymph nodes and other nonprostatic
organs.
It is our belief that the techniques applied here
to prostatic cancer could be extended to other neoplasms which continue to produce some tissue specific substance. Ultimately, a large battery of antisera
might be developed which could be employed for
identifying neoplasms and for immunochemical staging of these diseases. The antigenic specificity of
enzymes and other cellular products provides a new
parameter for clinical laboratory testing which should
lead to improved diagnostic procedures in both neoplastic and non-neoplastic diseases.

Author's note: The immunological studies described in the above article were accomplished in a
cooperative study carried out by Drs. Charles L.
Johnston, Jr., M. J. V. Smith, Warren W. Koontz,
Jr. and the author.
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Carcinoma of the Prostate: The Great Widow-Maker*
JOHN K. LATTIMER, M.D., Sc.D.
Professor and Chairman, Department of Urology, College of Physicians
and Surgeons of Columbia University, New York, New York.

The percentage of urological cancers is considerable. Of all of the cancer deaths in our country, 10%
are urological; in men alone, 18 % are urological. It is
immediately obvious that a very important aspect of
this specialty is the treatment of cancer.
Of the 18 % urological deaths among males,
more than half are due to cancers of the prostate.
When a patient is seen with evidence of a metastasizing cancer and a search is made for the primary
site or source, there is always a hope that it will
be cancer of the prostate, because we can do a
great deal for this cancer that cannot be done in
many other cancers.
A comparison of the various urological cancer
deaths will show that cancer of the prostate is the
most frequent. Second is carcinoma of the bladder,
followed by kidney tumors. In comparing cancer of
the prostate with other cancers in older men (men
over 75), prostatic carcinoma is the most common
cause of cancer deaths. If figures for cancer of the
colon, rectum and stomach are combined, the resulting figure is slightly in excess of that for prostatic
tumors. The impressive fact is that cancer of the
prostate is the most significant cause, makes the
most widows, of all the cancers among older males.
With every passing decade, the number of cancers
that one finds in any autopsy series of older people
increases steadily. It does not increase among the
people with cirrhosis, perhaps because of the increased circulating estrogens in older people who
have hepatic cirrhosis. If men were to live for an
indefinite period of time, practically all of them would
die of cancer of the prostate. The secret weapon is
the rectal examination to detect the prostatic nodule
before it has developed to a more advanced stage.

* This is a transcription, edited by Dr. Warren W.
Koontz, Jr., of a lecture presented by Dr. Lattimer at the
26th Annual Stoneburner Lecture Series, February 22,
1973, at the Medical College of Virginia, Richmond.
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Dr. Charles Huggins' classic cross sections of the
prostate ( 4) showed that the cancerous, dark area
is almost always in the posterior lamella against the
rectum where the rectal finger can easily palpate the
nodule. It is universally recognized that rectal palpation of the nodule will disclose cancer in only 50%
of the cases. Nevertheless, in the 50% where cancer
exists, the extent of the cancer is usually more than
one would suspect from what one can feel. Recently,
I have had it brought to my attention very forcefully
that an asymmetry of the prostate without any particular increase in firmness may be worthy of great
attention. I have had several patients who related that
their internist had detected an asymmetry two or
three years prior to biopsy and diagnosis. The instrument we use for biopsies is one developed by Dr.
Ralph Veenema.
This instrument can be used with local anesthesia, but it is much easier with pentothal anesthesia. We prefer the Veenema instrument,
however, since it gives a substantial fragment of tissue as compared to the Silverman or Vim-Silverman
needle biopsies. Inadequate specimens may prevent
the pathologist from rendering a diagnosis. We also .
want larger fragments because we grow the biopsies
in tissue culture. This gives not only a dimension of
additional size, but also gives an opportunity to
experiment with that patient's cancer to see what
medications act best against it and to see how it
might differ from others.
Of the prostate tumors biopsied, 11 % were
confined to the prostate. Bone scans, bone surveys,
and marrow acid phosphatases have shown that
55% of the prostate cancers have extended locally.
There is still another substantial group that has
extended beyond the confines of the pelvis. The
treatment varies in these different groups. It is the
first group that is amenable to radical excision;
the second group may be amenable to radiotherapy
plus hormone therapy. For the third group, one must
MCV QUARTERLY 9(3): 240-244, 1973
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depend upon hormone therapy and hopefully, in the
next few years, immunotherapy.
Only 13 % of patients with prostatic cancer
were detected at an operable stage. The periodic rectal examination is a campaign which we must all
wage. It affords the greatest chance of success for
making a contribution in preventive medicine. The
executive physical examinations that many companies sponsor is one of the best programs in the
area of prevention. Occasionally, we find cancer in
the chips from a transurethral prostatectomy which
we did not suspect from rectal palpation. Then we
have the dilemma of whether cancer has been left in
the capsule, and we may resect a little more after
a while to see whether we have chips. A few patients
have undergone radical prostatectomy. Since radical
prostatectomy is difficult technically foilowing transurethral prostatectomy, we resort to radiotherapy
plus hormones or just hormones alone. Following
radical prostatectomy, we administer antiandrogen
treatment in the form of castration and estrogens
for every patient who will take what we consider to
be our best advice. We have a substantial number of
cases treated in this way and are awaiting the 20year follow-up to compare with surgery alone.
When suprapubic or retropubic enucleation reveals cancer, we are better able to determine whether
all of the tumor has been removed. If so, there is no
need to go back and do a radical procedure. Frequently, when the patient has been through a big
operation, he is not anxious to undergo further
operative therapy. We are building some experience
with radiotherapy after enucleation. One of our worries was that strictures might be more common and
indeed be a bad feature of this type of therapy, but
this has not turned out to be true.
We prefer the radical retropubic prostatectomy.
We do not perform radical perinea! prostatectomies
except for instructional purposes or for a particular
case where it seems to be indicated. With the radical
perinea! prostatectomy, there is no opportunity to investigate for nodal metastasis.
The first and classical study that Nesbit and
his group ( 5) compiled indicated that stilbestrol increased the five-year survival of patients with prostatic cancer. Orchidectomy was a little better and
the combination was better than either one alone.
The Veterans Administration report ( 2) has indicted stilbestrol therapy as a cause of coronary
artery disease, phlebitus, and perhaps cerebral artery
disease. In the wave of shock and enthusiasm on
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their part they have gone overboard and have discouraged a number of physicians from using stilbestrol.
Castration, however, is a more certain way of
obtaining an antiandrogenic effect and has none of
the drawbacks that stilbestrol itself might have. We
combine hormone therapy, or antiandrogens with
castration. Castration is not of great importance to
most of our patients. Their sex life has almost ended
by the time we see them for their cancers, and they
do not mind trading a better life expectancy for
castration. Bony metastases of considerable extent
will clear remarkably with antiandrogen treatment,
and likewise, pulmonary metastases have cleared.
Drawing on Dr. Huggins' experience (3), we
have an interesting bit of information. A patient with
metastases from a cancer of the prostate, proven by
biopsy, was given stilbestrol by Dr. Huggins. He was
left with just one or two metastases. Dr. Huggins
then performed an orchidectomy and the nodules
disappeared. Thi.Is we have two different modes of
action with these two agents. A combination will be
more effective than either one alone. It is not just
an additive but it is a different action.
A patient with cancer of the prostate which had
obstructed the ureter was benefited by radiotherapy
in shrinking the prostate. He was given 6,000 r of
radiotherapy to the prostate area and the obstruction was relieved. The enthusiasts for this particular
method of therapy, arid particularly Dr. Malcolm
Bagshaw ( 1), have put together a very large number
of patients treated more or less with radiotherapy
alone. Their success rate has been so good that
they tell us that radiotherapy is curative. Raimey
( 6), however, has produced at least a dozen cases
where he has biopsied the prostate after radiotherapy
and the cancer appeared exactly as before radiotherapy. He argues that the cancer is not cured.
Bagshaw replies that it looks like cancer but is not
cancer and will not grow. Time will tell whether
radiotherapy is really effective. Supervoltage therapy
and perhaps larger doses and better targeting are
improving results and the question is whether radiotherapy is as good as radical prostatectomy.
The Veterans Administration study suggests that
conservative therapy is as good as radical surgery,
but my view, after reviewing all of the studies, is
that we do not yet know whether radiotherapy is indeed as good.
The next question concerns combining radiotherapy with antiandrogen therapy. Will that be as

242

good as a radical operation? At this moment, we do
not know. We do know that if we remove the tumor,
at least we are rid of the major part of the focus.
The question remains, what about the cells that are
spilled or that have migrated away? In reply to that
question, one can demonstrate various experiments
where a large mass of cancer treated by any modality
has no great chance of shrinking. If the large
tumor mass is removed and you leave behind only a
few cells, then you may indeed kill those few cells
by whatever supplementary means you use. We must
look in the future to taking out the mass of cancer
and then successfully treating what is left behind
by immunological, hormonal means or by :X-ray. We
must think in terms of combination, and in my mind
it is not entirely clear whether the radiation therapy
plus hormone treatment is as good as surgery alone
or surgery plus hormone treatment.
Occasionally, there will be a massive cancer
and the resectoscope will be necessary to tunnel an
opening through it. This can be done and supplemented by other treatments. Another modality for
this problem is freezing the prostate. We insert a
cryoprobe much in the same location as the resectoscope sheath. The temperature is dropped to minus
170° F and the mass of prostate freezes completely
solid. It looks like a ball of ice, and literally, it is a
ball of ice. Over the course of the next few weeks,
the prostate will then slough. A catheter may have to
remain in place for quite a long time while the gelatinous slough is removed. Later, there will be a very
satisfactory tunnel through the middle of the prostate, whether it is benign or malignant.
There has been some suggestion that the very
act of freezing will set up an immune reaction in
the body wherein the body will attempt to reji;:ct, not
only the frozen prostate, but also perhaps the metastases. There is some encouraging evidence of this,
and we have research going on presently in this field.
We have been freezing the prostate three times, a
so-calied triple-freeze, and this is alleged to improve
the immunological response and is a new dimension
that is worth testing. It is not certain that it will be
as good as we would like but, nevertheless, bone pain
does diminish.
If the prostate tumor appears to be resectable,
we prefer to use the suprapubic approach. Our operation involves dividing the uretha just beyond the
apex, dividing the vasa, dissecting the seminal vesicles down to their tips and dividing the vessels .
We take the fascia around the seminal vesicles pur-
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posely because we have found that this is the first
route of extension of the disease outside of the
prostate. We also remove a cuff of bladder.
We take pieces of tissue from a benign area
and pieces from the cancerous area and grow them
in a medium that is laced with radioactive food in
the form of thymidine and cytidine. We then make a
radioautograph of this and determine the DNA and
RNA synthesis rates in these various areas. We find
a very clear picture of benign activity in the benign areas and a very clear picture of greater activity (five or six times as much mitosis) in the cancerous area. Dr. Myron Tannenbaum, one of our
researchers, has found that the area surrounding the
cancer was as active as the cancerous area. This surprised him, and he then subjected the cells from this
area to a higher magnification and discovered some
very interesting material in what we refer to as the
demilitarized zone, just outside the cancer.
The cancers of the prostate are histologically
so much like cancers of the breast that we run a
lot of parallel work in the two fields. Dr. Tannenbaum looked at cancers of the breast and found the
same virus-like material in them. Turned on edge,
the rods of the material look more target-like. Looking at the cancers themselves in .both the breast and
in the prostate, he found the virus-like material in
the lumen of the prostate and the breast. A different
kind of virus-like particle, the so-called "C" particle
has been found in the milk of a mouse with breast
cancer as well as in the semen of her mate. A similar
"C" particle has been found in the semeh of one of
our patients with cancer of the prostate. We are now
heavily involved in antibody testing of all of our patients and their wives to see if there is any possible
relationship between cancers of the prostate in men
and cancer of the breast or genitalia in their wives.
We studied 5,000 men and found 186 men with
cancer of the prostate, where the wife had been living
and having intercourse with him for at least two
years before the diagnosis of cancer of the prostate
was made. We found 8-9% of the wives of those patients had cancer. of the breast. When one compares
this with the expected incidence of such a group, it is
500 times more. From this very carefully controlled
group, it was found that the controls had an incidence of less than 1 %-a finding of more than just
passing interest. From this work we now advise that
all of the wives of patients with cancer of the prostate
have a very. careful breast examination, cervical Pap
smear and ovarian examination at least every six
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months. We have been cautious about stirring up a
lot of anxiety where it might be unfounded, but
knowing these facts and saying nothing would not be
right either. We consider it advisable to be cautious
in the campaign of encouraging the wives of men
with cancer of the prostate to be examined more
carefully and conscientiously than wives in the general population.
It is possible to take a time-lapse pidure of a
· cancer cell and see what happens as it begins to
divide. First, a refractive outer coat appears as the
cell goes from the resting configuration to the stage
where it is about to divide. The chromosomal material begins to shape into a spindle and starts to divide. Then the spindle fornis very decidedly and
some minutes later, there are two sets of chromosomes, divided and beginning to pull apart. They
pull apart further, and two cells begin to form, now
having a configuration more like the resting phase.
If you know how many frames per second or per
minute are involved in these changes, you can time
the intervals between each of these phases. We
usually take two-to-four frames per minute. The cancer cells take longer to divide than the normal cells,
but the cancer cells go through this procedure much
more often than the normal cells. An eye dropper
can be used to add various anticancer medications
to the culture to see how the course of events can be
influenced. If the mitotic process stops, one can see
in what phase it stops. The anticancer agents can
be labeled and observed as they go into the cell. If
the particles are fine enough and are hooked up to
an immunological apparatus, it is possible to discover
where they went in the cell. The technical aspects of
this procedure pertain to the fact that some drugs
go into the cell wall, some into the mitochondria,
some into the nucleus, and other drugs act on the
nucleolus. If one is using multiple drugs, it is helpful
to have different modes of action. We have done this
with the Wilms' tumor drugs and have sorted them to
determine the actions of the different medications and
have been able to obtain some information about the
different modes of action and the most effective combinations. In spite of this technical apparatus, we
still find the most important single case-finding factor influencing the successful treatment of this prostate cancer to be the periodic rectal examination.
Another aspect of scientific advancement is the
fact · that the cancers have caused the development
of various immunological changes in the blood
stream. Sometimes various antigens and antibodies
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are present. There has been a rekindling of enthusiasm about this. Certain carcinomas of the bowel
and certain embryological pieces of bowel give off
antigens into the blood that can be measured quite
easily. We have discovered that in various urological
cancers this same antigen, called a cancer-associated
antigen or a carcinoma embryonic antigen, is detectable. We have demonstrated that in various samples
of prostate from various samples of the patient population, we would find an increased and measurable
amount of .tumor-associated. antigen that would not
be of any value as a screening test because it was not
always positive. Yet it did have value as a test of
failure of treatment. If one surgically removed the
prostate in a cancer patient and the test became
negative, that was a good sign. If the test remained
positive following surgery, one would know that all
of the ttimor had not been removed. Therefore, one
might be more vigorous with the antiandrogenic or
irradiation treatments. We have used it as an index
of failure in radiotherapy cases where the first portal
was mapped out and treatment included the prostate
only. If the test remained positive, then we knew we
had failed to kill all of the cancer arid we then
irradiated to a larger field. Thus the test does have
some usefulness even in its present crude form. The
obvious implications are that we may be able to
develop an antigenic test specifically for the prostate.
This is what we are working on and I am sure others
are investigating it also. This field is of considerable
importance and interest.
We have used the same tumor-associated antigen, hooking it onto a bridging-type of enzyme substance, onto which can be hung a color, namely a
reddish-brown color. If the tumor is positive with
this antigen, we can treat the patient with this matetial and the cancerous areas will turn a very
distinctive color. In a lyinph node where the cancer
is not obvious and where, by ordinary investigation,
that is light microscopy, it may not be possible to tell
that these areas are cancerous, this test will show
that the node is very specifically cancerous.
The same technique might be applied to the
Pap smear to ascertain whether there are cancerous
cells in tissues. With the electron microscope, one can
tell for sure, but you cannot scan wall-to-wall with
the electron microscope. With the antigen, it would
be possible to pinpbint the areas that turned red and
go directly to them with the electron microscope.
We may be able to apply our greater scientific capability to the clinical staging of the cancer and thus

244

bring about a more specific and accurate staging
and treatment. The implications of this are considerable.
Our only protection against cancer of the prostate and its rapid growth is the annual physical
examination. We know that various cancers divide
at different rates. We do not know the reasons for
all of the differences. We do not even know why one
person develops a prostatic cancer and the next does
not. The fact that it is endocrinologically dependent,
the fact that it is possible to survey what goes on in
great detail through the capabilities that we have
makes the urological specialty very valuable in the
cancer area.
We are able to study the rate of growth, regression or improvement of solid tumors of the kidney through pyelography, aortography and angiography better than other fields. Epithelial tumors of
the bladder can be observed with the cytoscope and
biopsied periodically to follow the efficacy of treatment or to get specimens for study. Hormone-dependent therapy in cancer of the prostate gives us more
leverage and opportunity to study the activity of
cancer. The advances that have been accomplished,
in fact some of the great success stories of cancer,
have been urological. I think the prostate was certainly the bellwether of all the demonstrations that
a hormone-dependent cancer could be influenced. I
think it is part of our responsibility as urologists to
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realize that we have this opportunity. I know that all
of you share with me this enthusiasm to do everything we can and to be in a position for contributing
more than any other specialty to the study of cancer.
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The emotional charge invested in the genitalia
far exceeds that of any other part of the human
anatomy. Both the conscious and the unconscious
feelings about the genitalia are subject to gross distortions which do not respond readily to logic or to
intellect. This means that the complete urologist
must view the emotional aspect of his area of work
from two angles:
1) Illnesses, injuries, and manipulations of the
genitalia, regardless of etiology or need,
may produce major emotional upsets in
susceptible people.
2) Symptoms involving the genitalia may be
the first and most prominent expression of
an emotional disturbance.
An example of an emotional disturbance which
was precipitated by (you will note that I do not say
"caused" by) genital manipulation occurred with a
45-year-old aide at a Veterans Administration teaching hospital. Hematuria had been discovered in the
aide's urine upon a routine physical examination.
The cause could not be determined readily, and he
was admitted to the hospital for a cystoscopy which
was done by the chief resident in urology. The procedure did not yield a diagnosis, and the aide was
discharged with instructions to be readmitted in three
days for a more complete work-up. He returned to
his ward work but adamantly refused to have any
further procedures even though the cause of his
urinary bleeding was still undetermined. His nursing
supervisor asked me to see him in consultation when
he was heard making threats toward the cystoscopist.
The aide spoke freely and convincingly of what
the urological resident had done to him. He was
perfectly accurate in his details, except that he
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quite irrationally misinterpreted the entire procedure.
' He had not been able to get an erection since the
cystoscopy, and it represented to him a gross homosexual assault which had deprived him of his "manhood." He was so enraged that he was determined
to kill the urological resident. The aide was not
psychotic nor out of contact with reality in any other
sphere.
Two one-hour sessions with the aide resulted
in detaching some of his rage from the urological
resident and in getting him to see that there might
be other causes for his impotence. He remained
quite suspicious, however, and would not agree to
more urological examinations. Before his next appointment a few days later, a perfect stranger jostled
him on the street as he was entering a neighborhood
bar. Unfortunately, he had been hunting rabbits that
morning and he had a shotgun in his nearby car.
He quickly took the shotgun from the car and
literally blew the head off the man who had accidentally bumped him. He had displaced his rage
from its original object, the cystoscopist, but it obviously was still there.
This anecdote represents a type of paranoid
reaction which is not uncommon after genital manipulation or injury, but fortunately most are not so
severe and do not end so tragically. The operating
urologist had not communicated fully to the patient;
he did not make certain that the patient had a complete understanding of the procedure, and he did
not work with the patient after the procedure to
make certain that there were no overt or covert misunderstandings.
Janis (2) stressed that surgical procedures about
genitalia produce an inordinately high level of
anxiety in most patients and that it may be catastrophic in some susceptible individuals.
An exa!!lple of the genitalia becoming symptomatic as an expression of an emotional reaction occurred in a young housewife who presented herself
245
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to her family doctor for dysuria. The physician found
nothing of note and referred her to a urologist. He
found no reason for the painful urination, and the
patient did not return. However, over the next one
and one-half years, the patient visited many urological clinics throughout the country and spent
several thousands of dollars. The symptoms persisted
despite innumerable urethral dilations, the installations of many medications, and several ineffective
prescriptions for urinary tract sedatives and antibiotics.
She came to the attention of a urologist in a
teaching center who was interested in the emotional ~
aspects of his patient. He took a very careful history
which included a detailed account of her sexual life
and of her feelings about it, and he discovered that
the dysuria had originated under the following circumstances: The lady and her husband had been to
the country club one evening and had had more than
their usual number of martinis. In some sexual play
at home her husband titillated her clitoris with his
tongue, and she had the first orgasm of her life. A
few days later they repeated the act after several
martinis, and again she had a gratifying orgasm.
The next day, however, she began to have pain and
burning upon urination.
The final urologist allowed her to vent her feelings of guilt and allowed her to express the fact that
she felt that this act had made her some sort of a
"pervert." (Like many superficially sophisticated
people, she also was very fundamental and conservative in her basic beliefs.) During these brief
sessions he was able to communicate to her that she
was in no way abnormal but that she might need a
bit of work concerning the fact that she had been
unable to have orgasm by other methods. The dysuria stopped on approximately the fifth visit and
had not recurred at a two year follow-up.
Sexual problems in the female frequently are
expressed as urinary dysfunction. The intimate
anatomical and neurophysiological connection between the lower urinary tract and the sexual apparatus is obvious, but many times it is not so
obvious that the female uses this part of her anatomy,
especially the urethra, to express conflicts in the area
of sexuality and hostility ( 4). The symptoms may
vary from urinary retention to dysuria, frequency
and incontinency. There does not appear to be a
one-to-one relationship between the syf!!.ptomatology
and a specific sexual conflict, but some degree of
anger, frustration a~d/ or general hostility frequently
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is seen. Some of our vernacular statements,. such as
"Piss on you," indicate an unconscious awareness
that the urinary functions can be related to strong
emotions, frequently hostile. There can be no substitute for a full sexual and marital history as a part
of the diagnostic work-up in every patient with complaints involving the genitourinary tract, even when
they are of obvious organic etiology.
Another group of patients, those with a diagnosable mental illness, frequently present with complaints involving the genitalia. For example, the
conviction that there is a urinary tract infection,
frequently a venereal disease, is quite common in
severely depressed and in schizophrenic patients.
One young man, a 25-year-old farmer with borderline schizophrenia, went to his family physician with
the conviction that he had gonorrhea. No infection
was discovered, and the patient was dismissed. This
did not change his conviction, of course, so he visited
a urologist in a nearby larger town and was given
the same information. The urologist had done a good
diagnostic work-up, but he had ignored the possibility of a deeply fixed delusion which, in fact,
existed. The young man went home and put a .38
caliber bullet in his head. The physician's responsibility is not finished simply because there are no
positive physical findings to explain the complaint.
Many mildly disturbed adolescents are convinced that they have an undersized penis or distorted testicles and present to the physician with this
complaint. Undue examinations or manipulations do
nothing to ameliorate the deep anxiety and may
serve to fix the idea more firmly. The complaint
usually represents grave doubts of sexual identity
and/ or of general adequacy and should be viewed
as a warning sign. Simple reassurance by an authority figure may be sufficient, but the adolescent
should be encouraged to voice his deeper feelings.
No discussion of the psychological aspects of
urology can ignore impotence. The ability to achieve
and maintain an erection suitable for sexual activity
is one of the prime measures of manhood in Western society. Earlier, and perhaps more thoughtful
societies, included religious ceremonies and frequently had specific deities to insure man's continued potency. The Egyptians, in keeping with their
extremely compulsive attention to all details, took
pains to insure that this part of man's existence
would continue in the after-life by mummifying the
penis in the erect position. Judea-Christian religions
solved the problem by completely doing away with
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any form of sexuality in the life hereafter. In order
to accomplish this, it was necessary to classify sex
as a sinful thing to be avoided except for procreation. Thankfully for those of us who canie after
them, they were not able to succeed entirely, but
they did leave us a legacy of problems which still
plague us.
Differentiation of psychogenic impotency from
that of organic etiology usually presents no great
problem. Impotency of organic etiology is rarely
selective in nature, but the reverse is true for that
of psychogenic origin. The physician determines
whether or not the man achieves erections during
dreams, upon arising in the morning, during masturbatory attempts, with daytime fantasies, or with one
woman and not another. A positive response to any
of these areas goes a long way toward ruling out
organically produced impotency. A major exception
to this is the impotency which accompanies severe
depression. The impotency of depression may cover
all areas of sexuality, but the crucial point here is
that the desire will be just as absent as the ability.
The lack of potency will be of little or no concern
to the patient who is truly depressed; whereas, it
usually creates great anxiety in non-depressed males.
Whether or not the urologist chooses to treat
male impotence, he cannot avoid his diagnostic responsibilities and the need to counsel the patient
about possible treatment. Many patients respond to
a type of superficial educational counseling quite
within the ability of any physician, but all will appreciate the opportunity to talk to an interested
and knowledgeable authority and to receive guidance
1
toward the proper treatment.
Time does not permit discussion of all the many
urological entities that have a major psychiatric component. In general, we have said that all genital
manipulation should be considered from this viewpoint, but obviously some have a greater significance
than others. The manipulations involving children
are always of extreme importance, and the urologist
who treats children must have an understanding
of the developmental phases of childhood and what
they mean to future emotional adjustment. In general, such procedures should not be done unless
absolutely essential, and if the child's history indicates that emotional problems already exist, then
a consultation with a child psychiatrist is mandatory.
It is equally important for the urologist involved
with procedures such as kidney transplants to know
that both the patient and the donor frequently have

247
rather severe emotional reactions. Most of these
reactions appear to be preventable if adequate concern is given to them before surgery. Donors, for
example, frequently develop feelings of anger and
rejection ( 1). They seldom are given the sort of
credit and adulation which they think their major
sacrifice warrants, and reactions of passive-aggression and depression are not uncommon.
There have been equally important reactions
in those receiving kidney transplants ( 3). One center, for example, has noted that a recipient who is
still living in excellent physical health after more
than ten years has failed to function at even the
most rudimentary level since receiving his new lease
on life. While this may be considered a surgical
success, it is by no means all that could be desired.
Marked attention to this aspect must be considered
just as significant as the more technical problems.
The crux of this aspect of urology is that in no
other medical speciality is a complete emotional
history so important. Patients will not volunteer
much of the significant material unless asked. For
example, a 44-year-old professor of engineering had
a routine, elective hemorroidectomy. He was seen in
consultation by a urologist when he was unable to
void spontaneously by the sixth postoperative day.
Nothing was effective and eventually some operative
procedure was done transurethrally. The patient still
could not urinate when the catheter was out. Another
procedure, a bladder neck resection, was performed
with no results, and after several weeks, a psychiatrically oriented urology resident sat down with the
patient and took a complete history as follows:
The man was unmarried, lived alone with his
mother, had never had a sexual life beyond masturbation, and had not even had a girlfriend. He had
never been able to· urinate in any public place without being totally alone and while sitting on a toilet
seat. Even at home he had trouble starting a stream
while standing and had never in his life urinated
while another person was in the room with him.
This history should have alerted the original
surgeon and certainly would have warned the urologist to avoid surgery if at all possible. If not possible, he would have done as little as possible while
working with the patient's emotional problems or
asking for psychiatric consultation.
Major diagnostic problems with, or genital surgery upon one member of a marriage should always
include the partner. Valuable information may be
obtained by interviewing the partner, and many
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false beliefs may be corrected with a beneficial effect
upon the patient. For example, the wife of a man
scheduled to have a prostatectomy of any type has
many fantasies of what will happen to his sexual
abilities. She should be encouraged to express her
thoughts; then she should be given the facts as the
urologist sees them. This is equally true of any form
of genital manipulation.
The urologist may wish to consider himself
primarily a surgeon and wish to avoid the role of
sexual consultant or marriage counselor. That is
hardly possible for one whose field of work is the
genitourinary system. Patients expect the urologist
and the gynecologist to be experts in all areas of
sexuality, and perhaps they have a right to do so.
The well-read patients of today expect the urologist
to explore the sexual and marital aspects of their
conditions and to counsel them accordingly. This
means that the complete urologist needs expertise
in the techniques of interviewing as well as in the
techniques of surgery.
In summary, the urologist cannot escape from a
majo_r responsibility for his patients' emotional com-
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ponents. The very area of his work is highly charged
with emotional potential, primarily of a sexual nature. A careful sexual history is essential to the full
understanding of the symptoms of many urological
complaints and is equally necessary for the prevention of emotional complications to genital surgery.
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The Urologist ·and the Law*
JACK B. RUSSELL, J.D.
Lecturer in Legal Medicine

The basic concepts of the law as they pertain
to urology 'a re no different from any other part of the
law which pertains to the medical profession. I shall
not spend a lot of time going over that, except to say
that you owe the same duty that any other physician
owes to a patient, and that is to exercise that degree
of care which the average uroiogist would exercise
under the same or similar circumstances. The courts
generally say further, "in the same or similar communities," and then qualify it still further by saying,
"regard being had for the state of medical science
at the time." It narrows down to the fact that you
do not have to be the best, but you cannot be the
worst. If you conform to this standard, you have a
reasonably good chance of staying out of trouble
as far as the law is concerned.
Now let's go into two or three meas which have
arisen recently and which should give all of the
medical profession some concern. I am sure you
have heard the term "informed consent." Basically,
the term "consent" itself implies that if you do a
procedure upon a patient without the patient's permission, you have committed a battery on that patient, and the patient is entitled to recover for any
damages done. No expert testimony is required, and
you can be liable for punitive damages which your
malpractice insurance carrier will not pay. This is
a very narrow field because very seldom do physicians . today do procedures without some type of
permission or consent.
But the area of "informed" consent is a much
more complex proposition, and the problems are
steadily increasing, both medically and legally. The
underlying concept to this whole proposition is
fundamental to American jurisprudence; that is, that
every human being of adult years and of sound mind
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has a right to determine what shall be done to his
own body. There are numerous ex,amples of this.
One of the classic examples is that of the Jehovah's
Witnesses who, because of their convictions, will not
accept blood transfusions. The courts, all the way to
the Supreme Court of the United States, have uniformly held that a person has such a right of refusal
even if it means his death, and you have no right to
intervene. When you get down to the basic premise
that each individual should be allowed to determine
what happens to him, no one can question the
validity of the principle. It's good and it's sound.
There are ramifications, though, when the patient
has given consent but where a complication or risk
develops. If the patient has not been told about the
risk, he may bring a suit contending that he was not
adequately informed and had he been, he would not
have consented. This is not a battery, although in
some places this has been attempted in order to get
punitive damages. The courts uniformly recognize
that this is no more than a breach of duty, the duty
that you have to treat your patient properly. There
is a duty to inform the patient of what you are going
to attempt to do and the possible complications and
risks, and a failure to do so amounts only to a breach
of that duty. It is treated in the same category as any
other negligence action.
From this, then, let us consider the two basic
principles which must be kept in mind. First of all,
the patient has a right of self-determination, and this
imposes upon you the duty to make a disclosure to
him. Second, the amount of the disclosure is to be
measured in terms of "reasonable." Basically, that
is what the courts have said, and that is what the
duty is based upon. These principles are generally
recognized, although I must say they are not recognized in all places, and have been treated rather
casually in some places. The majority rule among the
states today is that in determining how much is to
be disclosed to a patient, the same rule is followed
249
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as determines the standard of care in treating the
patient, namely, what the standard is within the
medical community. This is generally followed and
has been a reasonably good defense up until now. I
might say, for those of you who are from Virginia,
the question has not arisen here, and I do not
anticipate any great problems.
There are two recent cases, however, which
throw a shadow over the whole question of consent
and disclosure. They do hot set forth any specific
rules to be followed, but they do establish that the
duty goes much further than anyone had ever contemplated. The first was a case from the Court of
Appeals of the District of Columbia handed down in
May 1972. To summarize briefly, a nineteen-yearold male had only a back pain. He was seen by a
series of physicians and finally by a neurosurgeon
who recommended that he have a laminectomy. He
was not told that about 1 % of the laminectomies end
up with some sort of paralysis. He agreed to the
operation, and unfortunately, after a chain of varying events, he became paralyzed. The District Court
which heard the case ruled, as a matter of law, in
favor of the physicians, both on the question of
malpractice and negligence in the way the operation
was performed arid also on the failure to inform
the patient of all the risks involved. The Court of
Appeals reversed the case on all issues and sent it
back for trial on the merits. Some of the statements
made by the court are general statements which
apply across the board:
Due care demands that the physician warn
the patient of any risks to his well-being
by the contemplated therapy. The patient
' must have some understanding and familiarity with the therapeutic alternatives and
their hazards. The physician must disclose
the choices and the dangers inherently and
potentially involved.
Those are rather broad, sweeping admonitions.
The court said that the standard is "what is reason~
able under the circumstances and that this is not
to be determined solely by the physician." The court
went on to say that this is a mattet in which laymen
have knowledge and are in a position to express an
opinion or view. It is not in the same category as the
type of treatment that should be rendered for a
particular condition. All of the risks which potentially affect the decision to be made by the patient
must be revealed. The court defines this by saying,

"A risk is thus material when a reasonable person,
in what the physician knows or should know to be
the patient's position, would be likely to attach significance to the risk or cluster of risks in deciding
whether or not to forego the proposed therapy."
That is a way of saying that you must put yourself
in the patient's position, so to speak, in prospect and
not in retrospect. If a reasonable person, knowing
what the risk is, might forego the procedure, you
must tell him what the risk is. The court has gone
further and said, "A very small chance of death
or serious disability may well be significant; a potential disability which dramatically outweighs the potential benefit of the therapy or the detriments of the
existing malady may summon discussion with the
patient."
Whenever nondisclosure or particular risk information is open to debate by reasonable-minded
men-laymen, not physicians-the issue is for the
finder of the fact, the jury. What in effect the court
has said is that the question of whether or not the
patient should have been told about certain risks
is going to be a jury issue in every case. No matter
how many times the court may instruct the jury that
they are not to view the case in retrospect, it is
impossible for them not to do so. They cannot get
out of their minds what has already happened.
The second case came up even more recently
than the first-in October 1972 in California. In
this particular instance, the surgery was for the
treatment of a duodenal ulcer, a very small duodenal
ulcer that had been very difficult to diagnose, even
by x-ray. The surgeon explained that there were
certain risks in the general anesthesia. He explained
the nature of the operation, but none of the inherent
risks, one of which is that in a certain percentage
of the cases-I think about 5%-thete may be some
injury to the spleen or its adjoining structures. The
patient did have injury to the spleen because one of
the arteries broke loose, and he alrriost bled to death
internally. Neither did the physician explain that
the evolution of a new ulcer might occur; he got
one of those. The patient had several other complications and he sued the doctors and the hospital.
This court came to the same general principle as the
court in the District of Columbia, holding that, as to
the duty to disclose available choices of therapy and
dangers inherently and potentially involved, the physician must comply. The right of self-decision by the
patient is the measure of the defendant's duty to
reveal.
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Now, both of these cases recognize two general
exceptions which you should keep in mind. One is
in the case of an emergency or where the patient is
incapable of making a decision because of mental
incompetency or infancy. If the treatment is immediately necessary, you can proceed without any type
of consent. If the patient is incapable of making any
type of decision because of infancy, the P,arents can
certainly be fully advised and the consent obtained
from them, if there is no emergency situation. The
second refers again to the majority rule and there
the court says that where the welfare of the patient
dictates that he should not be told, there is reason
not to tell him, but the burden of proving this is on
the physician, not on the patient. In other words,
this is an excuse or a reason for nondisclosure. The
burden is on the plaintiff to prove he was not told,
and if he was not, it is up to you to justify not having
told him. The court pointed out that the fact that
the patient may decide not to have therapy is not
reason for not telling him.
One court pointed out that nondisclosure is
justified only where the reaction to the risk information, as reasonably seen by tre physician, is menacing, almost Hfe threatening to the patient. That is
almost the only instance in which you would be
justified in not telling the patient. In this regard, I
should warn you that you must have expert testimony to back up your decision. In the case in the
District of Columbia, the surgeon testified that it was
not in the best interest of the patient to tell him
that he might be paralyzed from this laminectomy.
The court paid no attention to that statement whatsoever, saying that it was for the jury to decide, since
the physician was the only one who said this, and
he had not given any background or any medical
reason why it would have been harmful to the
patient. There was no reason to believe that he was
emotionally unstable or anything of that kind. I
realize full well the restraints this places upon the
medical profession, but I do not think we can ignore
the fact that to some extent a person does have a
right to determine what is going to happen to him.
Both of these cases attempted to set forth
certain types of things that a patient should or
should not be told and little can be derived from
reviewing these, because they do not make that
much sense. One of the cases, for instance, referred
to minor procedures and complicated procedures,
and what you do in one case and what you do in
the other. Of course, you can imagine what's going
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to happen when someone says, "Well, it wasn't
minor, afterall; it was complicated."
There is another type of situation you encounter in "informed consent" cases. A patient was
to have an arteriogram performed. There was no
emergency; it was not necessary at the time that it
be done; it was an optional procedure. The surgeon
did not tell him that there was a risk of paralysis
inherent, and he became paralyzed. The plaintiff
recovered-that is, a verdict against the doctor.
In another case, a patient of oriental descent
developed hypopigmentation-I believe it was during pregnancy. She consulted a dermatologist, who
recommended dermabrasion, but he did not tell her
that it was only 50% effective and that the condition
might even be worse after he finished. It was worse,
and she sued him. There was no. question in that
case. The court said that he had failed to conform
to the duty imposed upon him to advise the patient
fully of the successful nature of the operation if performed, and also of its chances of failure.
The courts have said, in effect, that if there is
a serious risk of death or danger of death, even if the
percentage is very small-down to 1 % in one of the
cases-the physician must so advise the patient.
Also, he should explain any alternative methods of
treatment. Frequently, this is omitted. I pave found
this to be true in any number of cases in which I
have been involved. The physician has not told the
patient that there were other methods of treating the
condition, and he has left the patient with the impression that the one recommended by him was the
only one. What it boils down to is this: If the patient doesn't want to take the chance, on what basis
can the medical profession justify forcing him to do
so? If you can answer that question, then you have
solved the problem, because then you can omit
anything you want to.
Some simple "do's" and "don't's": You must or
should disclose the general procedure and generally
what you expect to do, and what the patient should
expect from the procequre. Also, you should identify
the surgeon who is going to perform the surgery,
and whether or not others will assist, particularly
residents. In several of the teaching institutions, I
have found that they do not tell a patient ahead of
time that the surgery may be performed by residents. The risk of serious harm or death, where
applicable, should be disclosed. This would be true
in any major case, or certainly where any general
anesthetic will be used. The peculiar risks of the
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procedure involved should be explained to the patient. There's a greater duty to disclose if the procedure is experimental, new or novel, ultrahazardous,
if there is a possibility of altering the sexual capacity
or fertility of the patient, if it is purely for cosmetic
purposes or if it is an optional procedure.
The "don't's" that you might add to this include: Do not say that any procedure is simple,
under any circumstances. Do not ever tell a patient
that no complication can occur. Do not just answer
the patient's questions and expect that to fulfill your
obligation to fully inform the patient. Do not expect others to make a disclosure for you, such as
the anesthesiologist who may come to see the patient,
or any of the house staff. Do not minimize any part
of the procedure or make a guarantee of any klnd or
any statement that resembles a guarantee or an assurance that you or the procedure will cure the patient.
There is one exception, of course, and that is
if the patient specifically does not want to be informed, you do not have to do so. Some people
may not want to be informed of what can happen to
them. If they do not want to, you should not burden
them with it, but you should certainly document the
circumstances very amply and very completely in the
chart.
I point out these two cases because they are
a sharp departure from what has been the rule. How
many states will proceed to follow this I have no idea.
But a word of caution is always in order: If you adequately ,protect yourself in this regard, you are certainly on the safe side. As I understand it, it is always
better to overtreat than to undertreat.
With respect to infants, I would mention that
the consent should come from the parents; also, that
now in most of the states 18, not 21, is the age of
majority. Suppose an eighteen- or nineteen-year-old
college student comes into your office needing treatment. He has no means of support, and you are concerned about who is going to pay your bill. You get
in tc;rnch with the parents and ask them by longdistance telephone if they will take care of the
bill. They tell you that they will. Suppose a long
series of treatment is undertaken, and the bill mounts
into the thousands of dollars. The parents do not
want to pay the bill, and they do not have to. At
least in Virginia, and in most other states, the
promise to pay the debt of another has to be in
writing to be enforceable. This is the so-called
statute of frauds. All you have to do is get the parents to write you a letter and tell you that they are
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responsible for the care and treatment of their child.
Another thing to keep in mind is the value of
a good set of records. One of the primary problems
that I have run into is the inadequacy of some of the
records kept by some of your colleagues, but I am
sure none of you would neglect these. It is customary
not to write down negative findings, but it is very easy
to write down "otherwise negative" after you have
made an examination. At least give some notation
there, since the chart has to be your only means of
remembering several years later that you did make
other examinations. If there is a particular area of
the patient's body that was being treated or was injured at one time and has cleared up, a notation of
this should be made in the chart to back up the
fact that you did an examination.
I spent eight days recently in a case where one
of the main contentions was that a neurological
examination had not been performed upon a patient
from the day he was admitted to the hospital to the
day he was discharged. The physician said that he
had, but there was nothing in the chart to prove it.
We were able to get out of it all right, but it was a
difficult proposition. It is easy to correct. Any time
the patient refuses treatment, this fact should be put
into the chart. If you have a discussion with the
patient with regard to the type of treatment, the
alternatives, the risks, and so forth, this should also
be put in the chart.
It is my recommendation that, if you are going
to perform planned surgery on a patient, you should
take his consent in your office before the patient
goes into the hospital. Then he cannot complain
that he was under sedation, or that he was upset, or
any number of other things that might influence his
making a wise and full decision.
A chart should contain, at each instance, the
complaints of the patient, the history, the type of
examination made, the treatment, the medication, if
any, and any instructions which you gave the
patient. Also, if the patient fails to keep an appointment, you should have your office staff thoroughly
instructed to document this on the chart and then in
the appointment book, and do not throw the appointment books away. There have been several instances where this information was deemed crucial,
and we were able to go back into the records and
prove that a patient had failed to keep -an appointment, after the patient had testified that he was never
told to come back.
I need not emphasize that any treatment which
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may in any way affect the sexual ability of the
patient is particularly sensitive, apparently for everyone and should be well documented. This should be
thoroughly explained to the patient; even the remote
possibilities should be thoroughly explained. If there
is any question about it, it would not hurt to obtain
written consent. There have been several cases recently where physicians who have performed vasectomies have been sued because the operations were
not effective. There have been cases where people
have been allowed a recovery of damages for the
cost of rearing a perfectly normal child who was
unwanted, after the husband or the wife had supposedly been sterilized. This is becoming a very
sensitive situation, and it is a place where many of
your colleagues have gotten into trouble. In one
case which I read, no tests were run after the
vasectomy was performed to determine whether
there were any sperm. Others have given assurances
to the patients that if they let the physicans perform
the operation they would not have any more children. That is what I mean by not giving any guarantees. Do not say anything that can be construed as a
guarantee. Be sure that the consent form you use spells
this out clearly and simply, that there is no assurance
that the operation will be effective, and .that there
is no guarantee of any kind.
With respect to the treatment of infants, I
should say that the courts will intervene on behalf
of an infant in a case where treatment is necessary
or where the lack of treatment will be detrimental
to the infant. Cases in point are where courts have
ordered transfusions for Jehovah's Witnesses. In one
case, the court ordered a T / A because the child
needed it and the parents objected.
There are two cases in particular which I have
seen recently where the court approved kidney transplants. One was where the donor was about 27 years
old and mentally incompetent. He had the only
really good matching kidney, and the court gave its
approval for the use of the kidney from the incompetent to help his brother. They had psychiatrists who
came in and testified that this would be of benefit
to the incompetent because he was emotionally and
psychologically dependent upon the well-being of his
brother. Another case was that of twins about nine
years old. The court said there again, based upon
medical testimony, that it would be detrimental to
the surviving infant if he knew that he could possibly have saved the life of his twin but was not given
the opportunity to do so.
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There is one last area of which we should be
aware. That is alienation of affection by doctors on
patients or spouses of patients. The significant thing
is not only the conduct of the physician but the liability of his partners in his conduct. In one case,
involving the pediatrician of a group practice the
husband went to the senior partner, who was the
managing partner, and complained about the pediatrician's conduct toward his wife. The managing
partner did not do anything about it. He did not
even discuss it with his partner, and after it was
over, the court said it was up to the jury to decide
whether this amounted to consent to the conduct of
his partner. If it did, then the partnership, as well
as the man who was involved personally, could be
held -liable, and this was true even though it did not
involve partnership time.
There was a recent case where a patient and her
husband recovered from a physician-I understand
it was a psychiatrist- $30,000 in compensatory
damages and $120,000 in punitive damages for
alienation of affection. I do not know how long this
had been going on, but it went on long enough for
the jury to decide to punish someone. You should be
aware of the fact that malpractice insurance does not
cover punitive damages. Even if there is coverage
for compensatory damages-and it is questionable
whether there is, in that kind of case-there certainly would not be for the punitive damages. You
would have to pay that out of your own pocket.
In this regard, never examine any female patient
without your nurse being present. It has almost
reached the point where you should not even talk to
her without your nurse being present.
Some of the matters I have referred to may
seem unusual or unlikely and thus may not be long
remembered. Let me reiterate, however, the importance of two items in particular. If nothing else remains long in your minds, do not forget that complete and adequate records are essential, both in the
hospital and in the office. Nothing else will take their
place when they are needed. Finally, keep in mind
always the significance of informed consent. It is a
rapidly changing principle and one which touches
literally every field of medicine. It may be difficult
to accept in all its aspects. You may not, probably
do not, agree with much of it, but it is here to stay.
It is an established legal concept, and it is far better
to recognize it as such and learn to live with it rather
than be caught by it. Good luck!

Renal Hypertension*
EUGENE F. POUTASSE, M.D.
Urologic Surgeon, Norfolk Medical Center, Norfolk, Virginia

The advances in our knowledge of renal hypertension over the last 75 years represents outstanding
accomplishments in experimental and clinical medicine. A review of the highlights of this important
investigation in hypertension should begin with
Tigerstedt and Bergman's work in Scandinavia which
demonstrated in 1898, that extracts of kidney possessed a hypertensive action. They gave the name
"renin" to the impure substance which produced this
effect. For the next 30 years much work was done
on the vasoconstrictor action of extracts of the
adrenal medulla, the nervous system and the kidney.
At the height of the depression, Harry Goldblatt, with a few hundred dollars, began his investigations on the production of hypertension. His
classical report in 1934 gave investigators an easy
method of producing permanent renal hypertension.
He used a tiny adjustable silver clip on the renal
artery of dogs to produce partial or incomplete
ischemia of the kidney. His work was confirmed
promptly by many others.
In 1938, Fasciolo, Houssay and Taquini in
Argentina, by cross-venous techniques, demonstrated
that the ischemic kidney produced a hypertensive
substance, renin. In 1939, Braun Menendez and
his group in Argentina extracted a substance which
they called hypertensin, produced by the incubation of
renin with plasma globulin or hypertensinogen. Page
and Helmer, almost simultaneously in the United
States, reached similar conclusions but used different
terminology, renin plus renin activator produces
angiotonin.
Over the next 15 years much work was done
on these extracts and enzymes. Finally, a decapeptide
substance was identified. In 1956, Skeggs showed
that a converting enzyme made the substance an

* Presented by Dr. Poutasse at the 26th Annual Stone·
burner Lecture Series, February 23, 1973, at the Medical
College of Virginia, Richmond.
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active vasopressor material by splitting off two amino
acids.
A year later, Bumpus in the United States and
Rittel in Switzerland synthesized angiotonin or hypertensin, depending on which group was involved.
A year later, Page and Braun Menendez got together
and came up with the bastard term-angiotensin.
Levels of renin activity in patients were determined
by the bioassay technique perfected by Gunnels until
1969, when Haber described a practical radioimmune assay for angiotensin which has gained wide
acceptance by the medical profession.
On the clinical side, Butler in 1937, published
the first report of nephrectomy for unilateral pyelonephritis with relief of hypertension. This began the
era of nephrectomy for all sorts of diseases with the
hope of relieving hypertension. In 1939, Blackman
examined at time of autopsy renal arteries of 50 patients with so-called hypertension. A high percentage
of arteries (87%) had arteriosclerotic plaques and
54% were found to have severe stenosis. This report was not accepted at the time by the profession.
In 1944, Yuile classified renal artery obstruction
occlusive disease into extrinsic and intrinsic types.
Finally in 1948, after many years of indiscriminate
renal sacrifice, Homer Smith laid down the criteria
for cure of hypertension, 145/ 90, and this closed
the era of imprecise diagnosis of renal hypertension.
In 1950, Parke Smith and Arthur Evans in
Cincinnati published a large series of translumbar
aortograms with a low incidence of complications,
resulting in a wave of popularity for aortography by
urologists and later vascular surgeons. Up to that
time, it had not been widely accepted by the medical
profession in the United States. In 1952, at the
Cleveland Clinic, we began to apply aortography in
hypertensive patients. In 1954, Freeman and his
associates reported the first case of endarterectomy
of the renal artery with relief of hypertension. In
1954, Howard and his colleagues at Johns Hopkins
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published their classical report of cure of hypertension by nephrectomy. They called attention to the
importance of careful scrutiny of the intravenous
pyelogram for renal atrophy and to the fact that
urine from the affected kidney had a lower sodium
concentration and lower urine volume.
In 1957, the first report on the use of homografts for correcting fibromuscular hyperplasia of
the renal artery appeared. Since then many techniques have evolved for the correction of all kinds of
renal artery disease.
Renin is a proteolytic enzyme with a molecular
weight of about 40,000. Its only known activity is
to break a specific leucine-leucine bond on renin
substrate produced in the liver. Renin originates in
the granular cells surrounding afferent arterioles adjacent to renal glomeruli. These juxtaglomerular
cells, along with a few specialized distal tubular cells
(macula densa) in the same region, form the juxtaglomerular apparatus. This structure may be considered a combination baroceptor and sodium
sensor.
After renin acts on the substrate, angiotensin I is formed. As it passes through the circulation,
it is acted on by the converting enzyme to form
angiotensin II, the vasoconstrictor material causing
arterial constriction and hypertension. Angiotensin
II is also a major stimulus for aldosterone secretion
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by the adrenal gland, providing a feedback mechanism and completing the cycle initiated by renin
release. Renin is inactivated in the liver, and angiotensin II is probably inactivated at its receptive sites.
This is a dynamic, rapidly responding circuit. Renin
is released within a few minutes after appropriate
stimulation. Decline is equally rapid. Among r~cent
discoveries, plasma and tissue enzymes have been
found to exist which are capable of degrading angiotensin I and II to form a hectopeptide which exerts
a powerful influence on the adrenal cortex to secrete
aldosterone and preserve sodium.
We have used Haber's radio-immune assay
technique for the last two and one-half years in Dr.
Wan's biochemical laboratory at Norfolk General
Hospital. This is a specific assay for angiotensin I
generation rate, which in most situations provides a
correct measurement of renin activity. Nearly 400
measurements of plasma renin activity were made
between August 1970 and December 1971; over 900
determinations, which included 56 bilateral renal
vein determinations, were done in 1972. Approximately 20 patients were selected for operation in
1972. In the first two months of 1973, we have
operated on nine patients who have had this investigation recently at Norfolk General Hospital, reflecting in part the increased interest in renal hypertension since the use of renin assays on a wide scale.

Urological Care of the Paralyzed Patient*
ROBERT H. HACKLER, M.D.
Urologist, McGuire Veterans Administration Hospital, Richmond, Virginia, and Assistant
Pr?fessor of. f!rology, !Jep~rtment of Surgery, Medical College of Virginia, Health
Sczences Dzvzswn of Vzrgmza Commonwealth University, Richmond, Virginia

The paraplegic injured during World War I
had only a 10% chance of surviving the first year.
Only 20% of the American paraplegics could even
be evacuated. A great majority of the deaths were
caused by urinary tract sepsis. Starting in the mid
and late 1940's, however, with the discovery of
broad spectrum antibiotics, many of the early complications were eliminated and the survival rate
greatly improved. Since 1946, over 2,000 patients
have been admitted to the McGuire Veterans Administration Hospital. This spinal cord injury service
receives approximately 400-500 admissions per
year with about 70 being new patients.
Mortality. The general mortality figures dealing
with longer surviving time point to the greatly improved overall care. We recently reported the mortality figures on 170 World War II paraplegics
followed for 25 years and 100 Korean War paraplegics followed for 20 years (2). The overall survival was 40% and 74%, respectively. However,
the survival rate greatly increased if the patient had
a good neurogenic bladder (Table 1). The distinction
between a good neurogenic bladder and a poor
bladder will be discussed subsequently. Also, of
those living at 25 and 20 years, respectively, the
incidence of pyelonephritis and caliectasis was sig-·
nificantly higher in the patient with a poor bladder.
The main cause of death remains renal failure.
The poor bladder group had a much higher incidence of renal deaths; whereas, most of the good
bladder patients succumbed from non-renal causes.
The great majority of the nonrenal deaths were of
cardiovascular origin. It was interesting that if the
kidneys were essentially normal after 12-15 years

* Presented by Dr. Hackler at the 26th Annual Stoneburner Lecture Series, February 23, 1973, at the Medical
College of Virginia, Richmond. This material originally
published in Urology, Volume II, Number 1, 1973.
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of cord injury life, whether the patient had a good
or poor neurogenic bladder, he would succumb just
as often from nonrenal causes.
Definitions. A good neurogenic bladder will
fulfill these criteria:
1) A bladder with sufficient capacity to act as
a reservoir, and this with consistency.
2) Residual urine, less than one-third of the
bladder capacity or less than 100 cc.
3) Establishment of urethral voiding, although
defective control dictates the use of an external appliance.
4) No permanent vesicoureteral reflux.
If these objectives cannot be accomplished,
then the bladder must be treated with continuous
Foley catheter drainage. The patient is then classified as having a poor or unbalanced bladder. There
seems to be no question that the poor bladder patient saddled with long-term catheter drainage with
its problems of constant urethral and bladder infections, increased incidence of small, contracted,
spastic bladders leading to vesicoureteral reflux,
hydronephrosis, chronic pyelonephritis, and amyloidosis has a very poor prognosis. Most of these
patients will eventually succumb to renal failure.
We use a simple classification for neurogenic
bladder when dealing with spinal cord injury (Table
2). If the spinal cord injury is above the sacral
reflex arc (S-2, S-3, S-4), then the lesion is of an
upper motor neuron type. Most upper motor neuron
lesions will develop a good reflex contraction. A
small percentage never develop a detrusor contraction, however, and must remain on intraurethral
catheter drainage. These patients are classified as
having a poor nonreflex bladder. The true lower
motor neuron lesions, because of the disruption of
the sacral reflex arc, will also have a nonreflex
bladder. Many of the patients can remain catheterMCV QUARTERLY 9 (3): 256- 260, 1973
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free, however, because of tbeir ability to crede as
well as increase their intra-abdominal pressure.
Acute Spinal Shock Phase. During spinal shock,
the bladder is atonic and must be decompressed
either by continual catheter drainage or by intermittent catheterization. Suprapubic diversion, whether
by suprapubic cystostomy or cutaneous vesicostomy,
should not be instituted, for there is a high incidence
of developing a small, contracted, spastiC bladder.
If urethral complications occur, then diversion may
be implemented by way of the perineal route. A
#16 Foley catheter is used for continuous drainage,
and the bladder is irrigated twice daily with an antiseptic solution. The Foley is taped over the lower
abdomen to prevent any lower tract complications.
If urethral sepsis develops, a three-way multi-hole
Bunts catheter is used in order that the urethra itself
can be irrigated with Clorpactin® or other antiseptic
solutions.
The results of intermittent catheterization, as
recently reported in the literature, have been impressive (3). At our paraplegic center, we have been
unable to institute this program due to lack of personnel. There are approximately 30 patients in spinal
shock at all times, and this would require about 150
catheterizations daily under strict aseptic techniques.
Chronic Phase of Spinal Cord Injury. Approximately 65 % of our p;:itients spontaneously developed
a good reflex neurogenic bladder following spinal
shock. A small percentage of these patients will
have bladder decompensation manifested by high
residual urine. Excessive spasticity of the external
sphincter causes the detrusor contraction to be ineffective, and thereby the patient continues to maintain a high residual. It has been demonstrated in
many reports that the site of greatest urethral resistance is in the prostatomembranous urethra (7).
We have just recently reported the results of external
sphincterotomy in 150 patients (8). The best results
were achieved when the cystometrogram demonstrated a reflex bladder and the sphinctermetrogram
demonstrated a hypertonic, spastic external sphincter. Following external sphincterotomy in the reflex
bladder group, there was an average decrease in
retrograde urethral pressures of 19 mm of mercury.
The results of 110 patients with a reflex bladder
were impressive in that the success rate was 86%.
Theoretically, if we consider these results and the
fact the 65 % will become catheter free spontaneously, then approximately 90% of all upper motor
neuron lesions will have a reflex bladder and should

TABLE 1
PERCENT SURVIVAL

World War II (25 yrs.)
170 patients
Korean War (20 yrs.)
100 patients

Overall

Good
Bladder

Poor
Bladder

40%

50%

20%

74%

83%

60%

develop a catheter-free state. This figure will never
be reached due to lower tract complications, small
penis, allergy to the condom external appliance, and
the fact that some of these patients like the convenience of continuous intraurethral drainage. Naturally,
the patients with a nonreflex bladder must remain on
Foley catheter. Recently, in some patients with external sphincterotomy, we have been resecting the
anterior part of the lateral lobes of the prostate (5).
Several of our external sphincterotomy failures were
corrected by this maneuver.
Complications. The most common causes of
renal failure in the cord injury patients are:
1) Pyelonephritis
2) Renal amyloidosis
3) Hydronephrosis without vesicoureteral reflux
4) Permanent vesicoureteral reflux
Pyelonephritis. Pyelonephritis of some degree is
present in most paraplegics. Uncomplicated pyelonephritis (not associated with vesicoureteral reflux,
hydronephrosis, or amyloidosis) resulting in renal insufficiency has been a rare occurrence in over 2,000
paraplegics we have treated at McGuire VA Hospital.
Amyloidosis. Amyloidosis is a common cause
of death in the parapiegic who survives for a sig-

TABLE 2
SIMPLE CLASSIFICATION OF CORD INJURY
NEUROGENIC BLADDER

I. Upper Motor Neuron
A. Reflex Bladder
1. Good bladder (balanced)
2. Poor bladder (unbalanced)
B. Nonreflex Bladder
Poor bladder
II. Lower Motor Neuron
A. Nonreflex Bladder (autonomous)
Poor bladder
III. Mixed Lesion
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TABLE 3
IVP

GRADING

Grade
0-Normal
1-Minimal Caliectasis
2-Mild-to-Moderate Caliectasis, Minimal Dilatation
of the Ureter and Pelvis
3-Moderate-to-Marked Caliectasis, Moderate Dilatation of the Ureter and Pelvis
4-Severe Hydronephrosis and Hydroureter

nificant period of time. In an autopsy study at our
hospital ( 1) it was significant that of 26 patients
with proven amyloidosis, 18 of these deaths were
due directly to renal failure. In addition, 16 of these
18 patients had 2+ or greater proteinuria. Prolonged
suppurative disease-as seen with chronic decubitus
ulcer disease and/ or osteomyelitis-is the most likely
major underlying factor. Continual urethral sepsis
probably should be included in the overall problem.
Hydronephrosis and Hydroureter without Vesicoureteral Reflux. Hydronephrosis and hydroureter
without vesicoureteral reflux are encountered in a
small percentage of paraplegics. The etiology of this
upper tract deterioration is the result of high residual
urine or excessive spasticity of the bladder. This increase in spasticity is often due to severe cystitis and/
or the development of eggshell calculi. Treatment
consists of removing the calculi as well as clearing up
the bladder infection.
Some paraplegics develop a small, contracted,
spastic bladder due to erratic persistent impulses
from the distal stump of the spinal cord. This hypertrophy of the detrusor muscle in the area of the
intramural ureter produces obstruction to the ureters. This obstruction is evidenced on intravenous
pyelograms, but there is no obvious blockage at the
ureterovesical junction, for large size ureteral catheters or bulbs will easily pass this area. If there is
no improvement in the condition of the upper tracts
with good bladder hygiene, then therapy must be
directed toward interrupting the nerve impulses from
the spinal cord. The results of selective sacral rhizotomy are impressive, if the bladder has not become
irreversibly contracted due to loss of elastic tissue
and replacement by collagen. This must be determined prior to the rhizotomy by performing cystometrograms before and after spinal anesthesia. There
should be at least a 100% increase in bladder
capacity following spinal anesthesia. For best results,

the anterior and posterior roots of S-2, S-3, S-4 must
be sectioned. Many of these spastic bladders are converted into more easily managed flaccid autonomous
bladders. Misak, Bunts and others (6) reported on
28 patients undergoing selective rhizotomy, and 25
of these acquired a good autonomous bladder with
good voiding potential. It was interesting that 23 of
these patients actually became catheter-free. The best
results were obtained in the cord injury patient who
could use his upper extremities and abdominal
muscles. The procedure also decreases the spasticity
of the external urinary sphincter.
High residual urine can produce rather marked
hyronephrosis and hydroureters. These patients
usually have done well for years, voiding into an
external urinary appliance, and therefore are classified as having a good reflex bladder. After this
decompensation, long-term drainage may be needed
for bladder tone to return. If the sphinctermetrogram reveals high intraurethral pressure, external
sphincterotomy is indicated. If high residual urine is
persistent, the patient must remain on permanent
urethral catheter drainage:
The upper urinary tract in the paraplegic shows
marked !ability, and in many cases, is reversible. It
must be determined that the deterioration of the
upper urinary tracts cannot be reversed before some
type of urinary diversion such as an ileal conduit is
considered.
Vesicoureteral Reflux. In the paraplegics dying
from renal failure at our hospital, irreversible reflux
was present in over 60 % . Reflux is considered to be
irreversible if present on three consecutive cystograms or if persistent on three consecutive six-month
checkups. The incidence of reflux remains about
15% after the patient has had 5-10 years of paraplegic life. Permanent vesicoureteral reflux is definitely detrimental to the kidneys in the paraplegic. It
is usually the high pressure type and associated with
chronic cystitis (4).
We place the patient in one of four groups
based on the condition of the kidneys and bladder
for the purpose of management. Table 3 illustrates
how we grade the pyelogram.
Group A-Good Reflex Bladder, Grade 0-1
Urograms. Permanent reflux rarely develops in a
good reflex bladder. After it has been determined
that the patient does not carry significant residual
urine and that the reflux is indeed permanent,
vesicoureteroplasty is indicated. Vesicoureteroplasty
is only indicated in a good reflex bladder. Dr. Rich-
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ard Reece is currently evaluting the results of this
procedure. In our hands, a successful vesicoureteroplasty is obtained in 70-80% of the cases if the reflux is unilateral. The results are worse if a bilateral
reimplant is performed, because in about 50% of the
cases, one side will fail. We do not perform repeat
vesicoureteroplasties for the results are poor.
Group B-Poor Reff.ex Bladder, Grade 0-1 Urograms. The whole purpose here is to try to convert
the poor bladder into a good reflex bladder, in other
words, to make the patient catheter free. The reason
for the poor bladder status may be high residual
urine secondary to excessive external sphincter
spasticity. As discussed earlier, external sphincterotomy may help rehabilitate this bladder. If successful, the external sphincterotomy has placed the patient now in Group A, and a vesicoureteroplasty
could be entertained.
The largest number of paraplegics with permanent reflux have a small, contracted, spastic bladder.
Naturally, this would be high pressure reflux. Nerve
interruption procedures should be considered in this
situation after bladder infections and/ or calculi have
been eliminated as the cause of the hypertonicity.
As stated previously, we prefer sacral rhizotomy. If
after a sacral rhizotomy the patient develops a good
autonomous bladder, thereby being maintained on
external appliance drainage, then a vesicoureteroplasty may be performed. A modification of the
Hutch I vesicoureteroplasty has yielded the best results in our hospital.
The patient may have a good reflex neurogenic
bladder, but due to persistent vesicoureteral reflux,
catheter drainage must be continued. This problem
would be alleviated if the vesicoureteroplasty was
successful. However, in some cases of bilateral vesicoureteroplasty, one side would . fail. Since repeat
vesicoureteroplasty is uniformly unsuccessful in the
paraplegic, we have turned to performing transureteroureterostomy. There have been 11 transureteroureterostomies at our hospital performed over the
last several years and the results have been excellent.
Of the 11 cases, only one kidney deteriorated, and
this was due to a technical error in that the anastomosis into the recipient ureter was inadequate. All
of these ureters were essentially of normal caliber,
and there was no deterioration postoperatively. It is
safe, however, to trarisfer a dilated ureter to a normal
size ureter.
Group C-Grade 2-3 Urograms. Up to this
point the discussion has centered on how to prevent
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any deterioration of kidney function . Most patients
with a good reflex neurogenic bladder and with careful follow-up should not develop this deterioration.
Faced with persistent and/or progressing deterioration of the upper tracts, and failure of bladder
hygiene and sacral rhizotomy to alleviate this problem, an ileal conduit must be considered. As one
can teH from the previous discussion, we are conservative in recommending this procedure, but there
is a definite indicatibn for its use. We have performed
about 25 conduits and are generally impressed with
the results. The renal units will uniformly improve
after ileal diversion if ureteral peristalsis is adequate
and renal function is not too impaired. In reviewing
some of our cases, it is evident that renal insufficiency
could not have been expected to improve by conduit
diversion because of poor ureteral peristalsis.
Group D-Grade 4 Urograms. Marked hydronephrosis must be treated with immediate loop
nephrostomies ( 9) . These cases are uniformly
uremic and usually acidotic. The ureters are dilated
and tortuous. We feel that the loop nephrostomy is
a definite surgical advancement over the routine
Cabet type nephrostomy in the paraplegic. It is
technically simple and there are no leakage problems. The catheters are easily maintained, which
is important because some of these nephrostomies
are permanent.
Each patient is periodically evaluated to determine if there has been enough return of kidney
function and ureteral function so that the patient
may be reconverted to an ileal conduit. In some
cases, the creatinine clearance improves but the
ureteral function remains inadequate. Cineureterograms show poor peristalsis, and in many cases
retroperistalsis: We do have two patients with enough
improvement in creatinine clearance and ureteral
peristalsis that ileal diversion will be undertaken.
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Pediatric Ure-Radiology*
HERMAN GROSSMAN, M.D.
Professor of Radiology and Pediatrics, Duke University
Medical Center, Durham, North Carolina

"Routine" radiologic studies do not, often
enough, concentrate on the part of the anatomy and
physiology of importance for the diagnosis. The
close cooperation between the pediatrician, urologist
and the radiologist will insure more useful uroradiographic studies on which rational clinical decisions can be based. The child's signs and symptoms,
as well as the anatomic and physiologic information
needed, dictate the type and order of the radiographic studies. It is beyond the scope of this paper
to go into the indications for specific uro-radiographic studies. The radiographic techniques will be
presented.
Cystourethrography. There are several methods
for studying the bladder, urethra and vesicoureteral
reflux. The method used most often is filling the
bladder via a urethral catheter in a retrograde manner, either by gravity or by injecting the contrast
material. Radionuclide introduced into the bladder
can be used as an adjunct to radiographic investigation of reflux.
Cystourethrography can be done at the end of
the intravenous pyelogram. This method avoids a
urethral catheter and would appear to be more
physiologic. The child voids immediately before the
intravenous injection of contrast material. The administration of as much as 5 ml per kg of 50% or
60% contrast material is recommended. There are,
however, several limitations of this method- the
patient must be cooperative and usually several years
of age. Another disadvantage is that often parents
or an aid must be kept in the Radiology Department
with the patient for several hours, adding to generally
crowded waiting· areas. The bladder must become
sufficiently distended to stimulate the urge to void.

* Presented by Dr. Grossman at the 26th Annual
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Contrast in the lower portion of the ureter during
the voiding phase presents the problem of differentiating between urine flow from the kidney and reflux
into a ureter that maintains its normal caliber.
Cinecystourethrography came into wide use in
the mid 1950's. The chief contribution of cine recording was its revelation of the importance of
performing the procedure under fluoroscopic control.
Fluoroscopy during the voiding phase of cystourethrogram allows optimal timing of films for the
permanent record. Dissatisfaction with the cine procedure is that it has poor resolution, and that it
delivers a large radiation dose to the patient's gonads.
Fluoroscopy with video tape recording for the documentation of motion, and spot filming with 70, 90
or 105 mm film is diagnostic with less radiation than
cinefluoroscopy. Video tape recording delivers no
additional radiation to the patient beyond that required for image-intensification fluoroscopy.
Retrograde filling of the bladder by gravity
permits the observation of reflux at low or high
water pressure. In the absence of infection, low
pressure reflux is considered a more significant observation when making a decision about reimplanting a ureter. Sufficient distention of the bladder can
be obtained by gravity filling to stimulate voiding.
The normal male urethra demonstrates many
variations. Sequential spot x-rays avoid confusion
of normal anatomical structures (fig. 1). It is necessary to identify accurately the urethrovesical junction and prevent the error of considering the trigonal canal as part of the urethra.
Controversy exists among urologists about the
existence or frequency of bladder neck obstruction
and meatal stenosis in boys or girls. Posterior urethral valves, lesions probably existing only in males,
appear to be the most common bladder outlet or
urethral obstruction. From the Hospital for Sick
Children in London, 165 children were recently
261
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Fig. I-Sequential spot filming during voiding demonstrates
a normal male urethra. The urethrovesical junction can be
identified and not confused as existing along the trigonal
canal.

reported with lesions at or below the bladder neck
which interfered with normal urine flow. From 1959
to 1970, of 130 boys and 35 girls, all were under
the care of Mr. Ennis Williams. The most common
lesions were posterior urethral valves and ectopic
ureteroceles. Stenosis or atresia of the urethra and

Fig. 2-A. One-day-old male that did not urinate. Abdominal mass was palpated; on radiograph the mass extended
from the pelvis to the eleventh ribs posteriorly.

Fig. 2-B. Voiding cystourethrogram demonstrates bilateral reflux and a dilated posterior urethra due to posterior
urethral valves.

bladder neck obstruction were uncommon. A palpable bladder was the most common physical finding
in this group of patients.
A one-day-old boy had not voided since birth
and a large abdominal mass was felt (fig. 2, A ) .
Catheterization of the bladder revealed a large volume of urine. The catheter was left in place and a
cystourethrogram was done. During fluoroscopic observation reflux occurred when the bladder was
partially filled (low pressure) , and during the act
of voiding it was noted that massive reflux occurred
in dilated ureters and calyces (fig. 2, B). The posterior urethra was dilated and distal to this point, the
urinary stream was narrow. The association of posterior urethral valves and reflux is common. Posterior
urethral valves may be present, however, with competent ureterovesical valves and normal ureters and
kidneys.
In boys, defects in the anterior urethra are less
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Fig. 3-A). (left) Four-month-old male with urinary tract infection. Voiding cystourethrogram demonstrates an anterior urethral
diverticulum. No reflux occurred.
Fig. 3-B). (right) Residual contrast in diverticulum persisted after the bladder emptied. After surgical removal of the diverticulum
the infant remained free of infection.

common than in the posterior urethra. Most often
a single "pouch" in the anterior urethra is nonobstructive and represents Cowper's ducts or glands.

Fig. 4-A. (left) Normal female urethra during voiding.
Fig. 4-B. (right) With the stopping of micturition the
"spinning top" deformity develops and is a normal variation.

Other lesions in the anterior urethra appear to represent congenital diverticulae or anterior urethral
valves which may cause obstruction or be a cause
of infection because of stasis in the diverticulum
(figs. 3, A, B).

Fig. 5-A. (left) Cystogram with water soluble contrast
material demonstrates massive reflux into both ureters and
kidneys.
Fig. 5-B. (right) Cystogram with technetium 99 M
pertechnetate, followed by scanning over the kidneys detects reflux into the kidneys.
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Fig. 6-Intervesical ureterocele causing a lucent defect in
the bladder. Ureterocele developed from the ureter draining
the upper pole of a double right renal collecting system.
Obstruction caused hydronephrosis and nonfunction of the
upper pole with downward displacement of the lower pole
collecting system. Double collection system is present in the
left kidney.

Fig. 8-A. Prolapsed ureterocele dilates the posterior urethra.
Density of the contrast material around the ureterocele obscures the lucency normally seen. Reflux into dil ated ureter
also is noted.

GROSSMAN: PEDIATRIC URO-RADIOLOGY

Fig. 7-Nephrotomography demonstrated the rim of functioning renal tissue in the right upper pole suggesting a
duplicate renal system. Ectopic ureter was obstructed in the
posterior urethra.

Fig. 8-B. Retrograde urethrogram demonstrates the lucency in the bladder caused by the ureterocele.
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Fig. 9-Ectopic ureter from a solitary ureter insertion at
the bladder neck demonstrating reflux during voiding.

Fig. IO-Newborn with left flank mass. Large lucent areas
in large left renal mass. Lucent defect in bladder due to
ureterocele from a solitary ureter.
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Fig. 11-Early during intravenous pyelogram, the well vascularized organs opacify and a lesion with poor blood
supply produces a lucent defect as was noted in this newborn with a multicystic kidney.

In the early 1960's, the "spinning top deformity" of the female was considered a sign of
urethritis or ·of meatal stenosis. It is now regarded
as a normal variation in most instances. A single
roentgenogram during voiding may be exposed when
the patient is beginning or stopping micturition, and
it is during this phase of voiding that the "spinning
top" configuration is most common (figs. 4, A, B).
Video tape recording and multiple spot x-rays usually
show the normal anatomy and demonstrate physiologic function. At any rate, bladder neck obstruction
and meatal stenosis are not radiographic diagnoses.
There is a high correlation of urinary tract
infection in children with vesicoureteral reflux. In
some patients, an obvious anatomic abnormality in
the urinary tract is present; in many children, however, no discernible defect is found. Vesicoureteral
reflux while a child has a urinary tract infection
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Fig. 12-A. (left) Right ureteral reflux during voiding cystourethrogram.
creased amount of cortex.

Fig. 13-A. (left) Poor delineation of the left kidney due
to overlying gas and feces.
Fig. 13-B. (right) Paddle with an inflated balloon displaces the bowel contents and delineated the calyceal system.

B. (right) Right kidney demonstrates caliectasis and de.

Fig. 14-Carbonated beverage or carbon dioxide capsules
contrast the calyces and renal outlines.
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Fig. 15-Nephrotomography demonstrates the renal outline in a patient with normal calyces on urogram. Evaluation of the cortex
was important in this patient.

may be due to inflammation of the vesicoureteral
orifice; therefore, it is preferable to do a cystourethrogram when the patient has been free of infection
for more than two weeks.
The main use of cystourethrography is the detection of ureterovesical reflux. Instillation into the
bladder of a short-lived pure gamma-en;iitting radiopharmaceutical, such as technetium 99m pertechnetate, followed by scanning over the kidneys (fig.
5), can be an ad junct to the radiographic investiga~
tion of reflux. This procedure does not give the
detail of standard radiographic methods, nor does it
detect transient ureteral reflux. The markedly lower
gonadal dose of radiation may make this method
useful as a means of following patients for gross
reflux into the kidneys.
Ectopic ureters, with or without a ureterocele,
are most frequently present with renal duplication.
The upper renal pole drains into a ureter whose orifice is medial and inferior to the normal orifice. Approximately three-quarters of the patients with

ectopic ureters in association with renal duplication
are female. Bilateral renal duplication is present in
approximately one-quarter of the patients with an
ectopic ureter.
The intervesical ectopic ureter balloons out as
a cyst-like mass within the bladder lumen causing a
lucent defect (fig. 6). The poorly functioning hydronephrotic upper pole is outlined by thinned renal parenchymal. Generally there is function in the lower
pole of the involved kidney. The lower pole calyces
may be displaced downward and laterally by the
dilated medially positioned ureter.
The distal end of the ectopic ureter may be
stenotic and terminate in the bladder neck, ("posterior") urethra, or in the vagina, with dilation of
the proximal portion of the ureter. Nephrotomography may be necessary to visualize the rim of functioning renal tissue (fig. 7) .
Ureteroceles may prolapse into the urethra
causing dilatation of the posterior urethra on a
cystourethrogram, which mi!Tlics posterior urethra
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Fig. 17-A. (left) Incomplete filling of calyceal system on
intravenous pyelogram.
Fig. 17-B. (right) Compression band on lower abdomen
and inflatable balloon causes partial stenosis of ureter and
filling out of normal ureter and pelvocalyceal system.

Fig. 16-Nephrotomography in infant with poor renal
function demonstrates a hypoplastic right kidney and small
normal left kidney. Visualization was not successful on
intravenous pyelography.

valves (fig. 8, A). Slow filling of the bladder via
retrograde urethrography demonstrates a large
lucent defect due to a ureterocele (fig. 8, B).
An ectopic ureter from a solitary ureter occurs
in 20-30% of all ectopic ureters. Its site of insertion is similar to ectopic ureters associated with renal
duplication. Ureterovesical reflux may occur when
the ectopic ureter inserts in the bladder or urethra
(fig. 9).
A newborn infant was noted to have a left flank
mass. Nonfunction of the left kidney could have been
due to hydronephrosis or a multicystic kidney (fig.
10). The lucency in the bladder suggested the correct diagnosis. This latter observation was important
so that the ureterocele could be surgically removed
in order to prevent the opposite ureterovesical junction from becoming obstructed.
Various simple techniques may help make a

Fig. 18- A. On intravenous pyelogram no visualization is
seen in the left kidney. The right kidney demonstrates moderate ureteropelvic obstruction. Large left flank mass was
palpated.
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Fig. 18- B. Ultrasound shows a large echo free area in left flank indicating a cystic mass. At surgery, a hydronephrotic kidney was
found.

correct radiographic interpretation. The "bodygram"
is the result of high dose ( 4 ml per kg) intravenous
urography. Thirty seconds to one minute after the
injection of urographic contrast material, there is
opacification of well vascularized abdominal organs.
Lesions with little or no blood supply produce lucent
defects within the opacified structures, as was noted
in a newborn that had a multicystic kidney (fig. 11).
Because of decreased concentrating ability of
the kidneys of newborns for many days after birth,
poor visualization on intravenous pyelography will
not be improved by an immediate repeat dose. If
possible, wait five or more days before repeating
the intravenous pyelogram. Satisfactory visualization is usually obtained on the delayed study.
Prolonged nephrograms, lasting many hours-todays, may be seen in newborns or infants who were
dehydrated or oliguric prior to excretory urography.
It is postulated that a mucoprotein (Tamm-Horsfall), normally produced by renal tubular cells,
forms a precipitate that blocks the lumen of the
renal tubules. Since diagnostic visualization can be
obtained without iatrogenic dehydration, no fluid
restriction is necessary prior to excretory urography.
Ureterovesical reflux causes damage to the
kidneys because of the frequently associated infection
and to a lesser degree the effect of the "back pressure" on the kidneys. Therefore, it is essential to be

able to evaluate the renal outline, cortex and calyceal system. Often this can be done on the pyelogram
(fig. 12, A, B).
The radiologist has various devices to obtain
maximal information from excretory urography,
often obviating the necessity for retrograde pyelography. A paddle with an inflatable balloon can be
used to displace confusing bowel gas from the renal
areas (fig. 13, A, B). Carbon dioxide in the stomach
may contrast the renal outline and delineate the
calyceal structures (fig. 14). Usually, nephrotomography will outline the kidney contour (fig. 15), and
has been useful when kidneys fail to visualize well
because of poor renal function (fig. 16). If visualization of the pelvocalyceal system is not adequate,
compression bands may be placed on the lower abdomen, causing partial ureteral stasis with better filling
of the structures in question (fig. 17, A , B).
The question of whether a flank mass that does
not visualize on intravenous pyelography is cystic
or solid can now be answered by ultrasonography.
This procedure is noninvasive and emits no radiation. Low energy waves from a probe passed over
the structure in question reflects echoes (sound reflection occurs at tissue interfaces) which are recorded as densities if the mass is solid in nature;
if the mass is cystic, the recording will be echo "free"
(fig. 18, A , B).

The Optimum Treatment for Undescended Testis*
JOHN K. LATTIMER, M.D., Sc.D.
Professor and Chairman, Department of Urology, College of Physicians
and Surgeons of Columbia University, New York, New York

Our specialty, urology, is a great combination
of medicine and surgery. In addition, it involves endocrinology, psychiatry, geriatrics and pediatrics.
We interrogate our residents and resident candidates
very closely as to why they go into urology. The most
important point that they express over and over
again is that urology is not just surgery but a combination of medicine and surgery. They also emphasize the quality of the diagnostic techniques which
we use. Usually, when we operate, we know what we
are going to find, where we are going to find it, and
where the artery is going to come into it so that we
can go right to it to clamp it off and thus minimize
the bleeding. Thanks to our x-ray colleagues, these
capabilities are multiplied continually. We are better
off than the man who does only surgery. It is wise, in
my opinion, that we urologists do not get categorized
as just surgeons who want to cut. We are willing to
undertake medical treatment for the children with
cryptorchidism. If it does not work, we are then capable of operating on them and curing them with surgery. Of course, this philosophy enters into the field
of adrenal diseases and into many other disorders
that we handle.
In determining when we should operate on a
child with an undescended testis, one of the concerns
is the growth of the testis itself. Dr. Earl Engle did
the first clinical research work in this field 30 or 40
years ago. He measured the tubular diameters and
determined that in the normal child's testis, the tubular diameter increased progressively with age. We
determined that the increase continued in the child
who had an undescended or hidden testis until about
age seven, and then it stopped. From this crude physiological index, we have an indication that we

* This is a transcription, edited by Dr. Warren W.
Koontz, Jr., of a lecture presented by Dr. Lattimer at the
26th Annual Stoneburner Lecture Series, February 23,
1973, at the Medical College of Virginia, Richmond.
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should operate on the child and bring the hidden
testis into the scrotum before age seven. Our advice
to parents and to pediatricians who. want guidance in
this matter is that age seven is the. critical age when
the testis should be brought down into the scrotum.
The next question is, when is the optimum
time to start treatment before this seventh year? No
one likes to do an elective operation before the child
is one year old, if it can be avoided. The child is
much bigger and stronger and more stable after age
one. The child develops the capacity to worry and be
upset, and as a consequence, we do not like to do
elective surgery until the child is able to talk. If we
operate before the child can talk, he is somewhat
terrorized by having been taken into the hospital and
having been taken away from his parents and then
subjected to this smothering, anesthetizing operation
on an area of the body, which even at that age may
have some more than usual implications. As a consequence, we would like to defer the operation until
the child is at least four years old.
The next anniversary of consequence is the
fifth birthday because after the fifth birthday some
children begin to inspect each other's genitalia. This
is not always true, but this has been carefully documented in nursery school children. If you neglect this
matter and leave this child deficient in the sense of
having one missing testis or a testis that disappears
unpredictably, that is, the migratory testis, then you
are depriving this child for psychological reasons.
You are allowing him to continue in an embarrassing
condition in which his self-image could be threatened,
and the invitation for possible trouble does exist.
You may say that this is exaggerating the problem
and that Freud was not always accurate, but there is
evidence that this is of importance. If you operate on
such a child and his behavior improves markedly,
you can look back and realize that he was a very
bad actor because of some psychological concern
which must, because of the circumstances, have been
MCV QUARTERLY 9(3): 270-274, 1973

LATTIMER: TREATMENT FOR UNDESCENDED TESTIS

due to the undescended testis. The supportive evidence has influenced us in our decision that the
optimum time for fixing the condition is between the
fourth and fifth birthday.
We initiate treatment, as a matter of policy,
sometime around the fourth birthday-usually hormone treatment, brought to our attention by Dr.
Engle who did the pioneer work with the gonadotrophic hormone. He demonstrated in immature monkeys that injections of gonadotrophin will bring the
testis down. He transferred this to human patients,
and it was found that it did bring down a certain
number of undescended testes. Our hormone treatment consists of giving 10,000 units of gonadotrophic hormone in three doses, every other day. These
three injections do bring down 15 % of the children's
testes that are going to come down. If these injections fail to bring it down, we then give the old
standard course of 10,000 units over six weeks so
that you give 500 units every other day or three times
a week for six weeks. The advantage of giving the
first 10,000 units all in one week, every other day in
three injections, is that there is no enlargement of
the penis and no growth of pubic hair. Whereas, with
the six-week course, you get a very definite slight
enlargement of the penis and a very definite growth
of pubic hair in many children. The change is not
enough to be grotesque or objectionable, and very
often it is very supportive for the child and for the
parents. The parents may have felt inadequate, deprived, guilty, or embarrassed about the deficiency
of the genitalia of their child; thus, a little growth
of the penis does not harm anyone.
The scrotum will often be stimulated to grow
slightly, and it will give you a little more capacity to
accommodate the new testis if you have to operate
on it. There is no harm in giving the gonadotrophin.
We have not been able to detect any stunting of
growth or damage to the testis with a dosage of
20,000 units distributed over six weeks. We start at
the fourth birthday and try to be finished by the
fifth birthday, and we would certainly like to have
the condition corrected by the seventh birthday.
Dr. Gross, in Boston, reported a number of bilateral cryptorchids on which he did not operate until
age 12, and he reported some fertility among these
youngsters. It is the only information on the topic,
and Dr. Gross is a very sincere and earnest person
with a large series of cases. The retrospective analysis of these cases was done mostly by mail, so it is
not definite that they were fertile . Furthermore, he
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based his findings largely upon sperm counts, and
the total sperm counts were not really as large as one
might want to attest to the fact that these children
were fertile. One would like to see a substantial number of sperm, about 100 million and the Gross counts
run under 20 or 30 million. Although there is some
indication that waiting until puberty does not do
irreparable harm, it is not clear, as has been implied in the literature, that if one waits until age 12,
that you will have a successful result. I think the
opposite is true and it would be better to complete
the whole program by age seven.
We treat the migratory testes with gonadotrophic
hormones because the three shots usually bring them
down. Even though they may not stay down, the doctor can tell the child that it can be brought down at
any time, and the child is not quite as worried about
the situation. A pediatric psychiatrist on our staff
is convinced that the migratory testis is just as much
a disturbance to the child as the undescended testis
because it disappears in a way that the child cannot
control. A three-day-dose course of 10,000 units
over five days does not increase the size of the penis.
The six week course will definitely increase its size.
The success rate of gonadotrophic therapy in bilateral undescended testis, where there is more likely
to be a hormonal deficit, is about 33 % . The unilateral cases, where you are more likely to have a
mechanically poor point of attachment for gubernaculum, are more difficult. Usually the gubernaculum is attached directly under the skin so that the
testis turns back up over the external oblique fascia
or in the top of the scrotum. Thus, there is a mechanical reason why it does not come all the way down.
In those cases the hormone therapy is not as likely
to work. It has always surprised me that it worked
in even 15% of the cases. We do have an occasional
pleasant surprise, even with unilateral undescended
testis and we continue to at least acquaint the parents with the possibility of medical treatment. Sometimes, parents will say, "I do not want to do that
because my child dreads needles," or "The one thing
he dreads is going to the doctor and the one thing
he pleads for is th at we will not take him back for
needles." If this is the reaction, the parents may
not want to have the hormone treatment, that is, at
least the long-term treatment. The total success rate
with these methods is in the 20% range. Parents
should be informed of the possible treatments available and then allowed to make their own decision.
The histology of the normally descended testis
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is usually normal, and these children are usually
fertile because of the good testis. Yet, the one that
is undescended is very often retarded. We regard
it as almost always expressing a degree of maldevelopment or poor development as a cause of it
being undescended. This is brought out by biopsies
of the series that we have tested.
We apply an additional dimension in analyzing
all of our tissue . We grow a biopsy for four or five
days in a tissue culture medium containing radioactive isotopes, which will be picked up with every
mitotic event, put a photographic emulsion on it
and develop it. Little black spots will appear where
there was activity. This is called "radioautography."
Thus, we have a way of expressing the psysiological
potential of this tissue in addition to the histology.
This activity has very little relation to what the
tissue looks like on the H and E stains, and it is
quite revealing. We know now that you cannot tell
from the histology what the potential is; in other
words, the radioautography gives you a different
answer. The appearance of the H and E stains may
look good when it may not really be very good; the
opposite may also be true. Thus, the histology alone
is not sufficient. There are other methods, and this
is a good field for research. We, as urologists, should
accept the responsibility of looking into these areas;
they are offered to us; we have the opportunity to
apply them, and we should provide the populace
with the information available to us by applying advanced techniques to our material.
You may try to cure the child, even though
the histology may not look very encouraging at the
beginning. A defect that is sometimes present with
undescended testis is that the epididymis does not
link up with the testis. With each operation for
undescended testis, you should look at the epididymis
to see if this is the case. You will very often find
the epididymis separated from the testis by an abnormal distance; look to see if there is an actual
failure of union. Tell the parents about this so they
not only will know it as a matter of fact, but also,
they will not hold you responsible if the child is not
fertile at a later date. This does not occur too often,
but it does occur often enough to be aware of it and
to document it for the record.
Almost all undescended testes have an associated hernia, or at least a potential hernia, in the
form of an open processus vaginalis going from the
peritoneal cavity down around the cord and enveloping the testis. This potential hernia has to be

repaired every time you do an operation. Occasionally, you will find one where the hernial sac is
only at the upper end, but more often, it is through
the full length of the cord. Since this is almost always
present, the next question is, if you give hormone
treatment and bring the testis down without an
operation, does this hernial sac persist, and will
these children develop a hernia sometime later in
life? This is, of course, a possibility. Ed Sacher at
the Navy hospital in Philadelphia did a study and
a follow-up on his patients. He demonstrated that
hernias did become clinically evident in a certain
substantial percentage, but probably the majority of
his patients never developed hernias. This sac may
have united and closed off, or the patient may never
have pushed anything out into it. It is not enough
of a threat to cancel out the effectiveness of hormone therapy. Nevertheless, it does exist, and the
parents should be told that the child is more likely
to develop a hernia than other children.
Cancer is another possibility. If you leave
a testis up in the abdomen, the first sign of cancer
may be a chest metastasis. The retained testis inside
the abdomen develops a testis tumor and, being
inside the abdomen, it cannot be detected. It does
not happen frequently enough to be a reason to
take out every undescended testis, although this has
been proposed. Even though you bring the testis
down into the scrotum, it retains the possibility of
developing a cancer at a later date. The chance of
this happening is not so great as to force you to
recommend that an orchidectomy be done, but it
is another reason for urging that orchiopexy be
done so that the testis is out in the open where
it can be watched. Yet, it would be advisable to
suggest the options to the parents as a possibility
and let them make a decision on their own volition.
I have been surprised at how many of the parents
know about this and question me about it. Cancers of
the undescended testis only rarely develop before
puberty, and most of them develop about the age
20. The parents do not know this, and you may
get a pair of parents who become panicky about
the possibility of cancer and start to watch the child
very closely at age six or seven. They are greatly
relieved that they do not have to start worrying
about it until many years later.
Some conditions include an undescended testis
as part of the condition, such as the prune belly syndrome. The children have an absence of abdominal
musculature, or at least a deficiency of it. The wrinkled
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appearance of the skin is the basis of the so-called
prune belly description of the syndrome. These
children have massively enlarged ureters, and the
ureters may get in the way of the descending testis
and prevent it from descending. The cord is practically nonexistent, and the testis is at the bottom
of the kidney on each side. In my opinion, it may
be worth giving a trial to gonadotropl)ic hormone
therapy, and it may be worth waiting a while, but
it is not advisable to try to do orchiopexy on children with prune belly syndrome. It is often the
case that the cord is very short. Warn the parents
in advance that the odds are that you are not going
to be able to get the testis down or even to get it
out into the inguinal canal. In many cases, even if
you cannot get it down to the bottom of the scrotum
on the first try, you can usually get it down on the
second try after a couple of years. In this case,
with this particular syndrome, be aware at the beginning that you are probably not going to have
enough cord to work with, even with two operations.
The technique and surgical principles of orchiopexy utilized in our hospital are as follows.
The initial incision should be made in the skin
crease. If you cannot make out the skin line, push
the skin together and the lines will become apparent.
We usually mark the line for precision, taking a
lesson from the plastic surgeons. I encourage all
of my residents to take some plastic surgical training in their preliminary studies to learn the skin
stress lines that we use for our incisions. The initial
incision is done carefully. In many cases, the hernial
sac will have turned back under the skin, and it
will be in the line of your incision. If you cut vigorously into this area, you may cut into the hernial
sac or into the testis itself. Be aware that it may be
in the subcutaneous fat at the lower end of your incision.
Following incision of the external oblique aponeurosis, the spermatic cord is then dissected free by
sharp and blunt dissection. The dissection is carried
to the internal inguinal ring and the floor of the
inguinal canal, and the transversalis fascia is stretched
allowing the surgeon to proceed retroperitoneally.
The spermatic vessels are freed toward their origin.
If the internal ring is not large enough and the
operator cannot reach far enough retroperitoneally
to get much length of the vessels, the fascial opening
may be made larger. Usually you can open this hole
large enough to dissect behind the peritoneum to
get all the length needed and the inferior epigastric
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vessels do not need to be divided. The conjoined
tendon may be divided laterally for one-half inch
or more giving increased exposure. The peritoneum
may be found on the medial side of the spermatic
cord and the hernial sac may be opened. The
hernial sac is then divided from the vessels and
spermatic cord. If this is difficult to do and the
spermatic cord cannot be easily dissected away, a
hypodermic needle can be used to raise a bleb of
saline beneath the surface of the hernial sac and
it will lift off and make the dissection easy. The
hernial sac is then closed with a purse-string suture
of nonabsorbable material. The spermatic vessels
are held laterally by strands of fascia, referred to as
the "lateral spermatic fascia." This fascia maintains
a lateral position of the spermatic cord in the retroperitoneal space, thus forming an angle down toward
~he scrotum. If one cuts these fascial bands and
eliminates the angle, the cord can then drop more
medially, and the vessels will take a more direct
route into the scrotum. By skeletonizing the cord
down to the epididyrnis even more length can be
obtained. I have discovered to my surprise that many
of the old-time surgeons who did this sort of operation never went above the peritoneal wall. They confined themselves only to the inguinal area and gained
enough length by skeletonizing the spermatic cord
so that they could make the testicle come down. By
stretching the cord over a finger the operator can
become more aware of the thin firm strands of fascia
within the cord. By dividing these bands the cord will
lengthen just a little more.
Next a finger is placed in the empty side of the
scrotum and an Allis clamp is used to tug on the
bottom of the scrotum until a point can be found
that will stretch t)le farthest down, and that is where
the testicle should be brought to with the traction
suture. Having determined this point, an incision
is then made through the scrotal wall, as if ip. a
window. A pocket, what I refer to as the subcutaneous or scrotal pocket, can then be developed with
sharp and blunt dissection. Here the testicle will lie
outside of the dartos and the cremasteric fibers that
might pull it back up by muscular action.
An easy plane can be developed from the incision under the skin, and a pocket can be developed
both downward and upward. Most of the skin on
that side of the scrotum must be liberated in order
to make the pouch big enough. By passing the fingers
down within the scrotum an incision can be made
down onto the finger. Using a long clamp and
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following the finger up into the groin the clamp can
be used to take hold of the testicle and draw it down
through the canal and out the scrotal opening. The
testicle, having been pulled out through the side of
the scrotum, can now be fixed in the pocket.
We take an atraumatic rou:id needle with 3.0
silk and pass it through the tunica vaginalis. Then
the needle is passed through the very bottom of the
scrotum in a new location. Interrupted sutures of
chromic atraumatic 5.0 are used to close the scrotum.
The testicle is then kept in the subcutaneous pouch
and the groin wound is closed in a routine manner.
The traction sutures should be an extension of
the line of pull which you want on the testis to keep
the cord down. In the technique that we recommend,
the sutures are applied to the testis and brought
to the opposite leg. If too much tension is placed on
the cord, you will squeeze it flat and bring about
ischemia. The next day there will be edema of the
testis and edema of the scrotum, which means necrosis, an infarction and the death of the testis. The
traction should be very gentle. We put on just enough
traction to keep the thread from sagging; as the child
moves around in bed, he will give a tug on it several
times a day, and that is all you need. If there is too
much tension, not only is it going to be painful, but
it will also probably destroy the testis. That is one
reason why the old Torek operation, where the testis
was sewn directly to the fascia of the leg, through
a counter incision, frequently brought about necrosis
of the testis. It was too tight and rigid, and it destroyed the testis rather than helped it.
Over the years we have used a variety of substitute testes (prosthetic testes), including ping pong
balls and marbles, in children and adults who had
a missing testis. Then they were made out of hard
plastic or metal. The Dow Company developed
prosthetic testes made of silicone rubber. We have

been using them for several years, and they are
more or less elastic. In the last few years, the 14and 15-year-olds have complained that these testes
are too hard and they want them to feel more
natural. The Dow Company then developed jell-filled
silicone silastic testes which have a beautifully normal
consistency. They come in several different sizes and
have little tabs on the end. You want to be able
to put a suture through the tab to suture it to the
bottom of he scrotum so that it will retain the desired position. A purse string is then put around
the neck of the scrotum and it is sutured. We replace these as the children grow bigger to keep
pace with their normal size. A larger than normal
size is needed for a child who has only one testis.
His good testis is going to undergo compensatory
hypertrophy or, at least, it is going to grow to
a larger than normal size. Consequently, we have
one super size, the fourth size, which is bigger than
normal, for that reason.
In summary, there are many reasons why
orchiopexy should be done, and certainly, the cancer worry is a very distinct one. Yet, I think the
psychological reason, the "locker room appearance"
situation, is the most frequent, and therefore, an
important factor. I do think that we should exercise
our favored position of being able to offer hormone
treatment first. If that does not work, then go on
with the surgery as required. The timing, in my
opinion, should be to start at the fourth birthday
and to have the program completed by the fifth
birthday. Although physiological considerations do
enter into our choice, the precise definition of this
time interval is primarily decided on the psychological aspects of the matter. I urge you to consider these, and I think th at you will find the fourthto-fifth-year interval works out very satisfactorily. -

Wilms' Tumor and Neuroblastoma:
Results of Therapy*
HAROLD M. MAURER, M.D.
Associate Professor of Pediatrics, Chairman of Hematology and
Oncology, Medical College of Virginia, Health Sciences Division of
Virginia Commonwealth University, Richmond, Virginia

As a result of intensive research during the past
20 years, there is now a more optimistic attitude
toward the treatment of children with cancer. Success with new therapies of Wilms' tumor and acute
lymphoblastic leukemia have been important factors
in generating this new optimism. Despite these and
other advances, little success has been achieved in
the treatment of children with neuroblastoma. The
poor prognosis of these patients is due to the high
percentage of widespread disease at the time of
diagnosis and lack of effective treatment for advanced disease.
Wilms' tumor and neuroblastoma are numerically among the most common noncerebral malignant solid tumors in children. The purpose of this
report is to describe the recent results of therapy.
Incidence of Wilms' Tumor and Neuroblastoma. To provide a perspective of these two diseases,
a list of malignant diseases in children under 16
years of age reported to the Medical College of Virginia Tumor Registry between 1964 and 1970 is
shown in Table 1. Acute leukemia was the most
common malignancy, followed by central nervous
system tumors. Wilms' Tumor accounted for 9.7%
and neuroblastoma, 6.4% of all the malignancies
reported. The importance of these two tumors is
considerably increased, however, when we consider
only noncerebral solid tumors of childhood; Wilms'
tumor accounted for 16% and neuroblastoma, 11 %
of these tumors.
Wilms' Tumor. Advances in chemotherapy of

* Presented by Dr. Maurer at the 26th Annual Stoneburner Lecture Series, February 23, 1973, at the Medical
College of Virginia, Richmond.
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Wilms' tumor, along with improved treatment modalities in radiotherapy and surgery have increased
the survival rate from a 20% two-year survival rate
three decades ago to an 80% plus rate within the
last 10-year period.
The use of dactinomycin and vincristine accounts for the improvement in chemotherapy. In
the early 1950's, nitrogen mustard was tried in the
treatment of metastatic Wilms' tumor with little apparent benefit. In 1955, Farber pioneered in the use
of dactinomycin in children with or without metastases. This drug has been shown, after extensive
trial, to be of considerable benefit in preventing
recurrences and in eradicating recurrent and metastatic disease.
Improved radiation treatment has resulted from
the development of more sophisticated equipment
and from an improved understanding of the natural
history of Wilms' tumor. Supervoltage equipment
with increased definition has allowed delivery of
lower dosages to the tumor, with less radiation scattered into surrounding normal tissue. Additionally,
less of the dose is directed to growing bone than with
previous orthovoltage equipment when normal bone
might absorb as high as 15-20% over that delivered to the tumor.
Improved understanding of the disease includes
the observation that the tumor remains localized in
its pseudocapsule until the very late stages, allowing
the use of localized irradiation of the renal fossa
after surgery rather than more widespread treatment. Another observation that lymph node involvement is rare, saves the need for routine irradiation
for possible para-aortic node involvement. At the
same time, greater understanding of the tumor has
275
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TABLE 1.
Pediatric Cases of Malignant Diseases Reported to the
Medical College of Virginia Tumor Registry, 1964- 1970
NUMBER OF
DISEASES

CASES

PERCENT

Central Nervous System Tumors
Optic Glioma
Astrocytoma
Medulloblastoma
Ependymoma
Craniopharyngioma
Meningioma

5
15
9
5
3

2. 33
6.9
4.1
2.3
1.4
0.4

Acute Leukemia

48

22 . 2

Lymphosarcoma
Hodgkin's Disease
Wilms' Tumor
Lymphoepithelioma
Rhabdomyosarcoma
Neuroblastoma
Malignant Schwannoma
Osteogenic Sarcoma
Mixed Mesodermal Tumor
Dysgerminoma
Carcinoma of the Pancreas
Carcinoma of the Maxillary
Sinus
Composite Parotid Tumor
Retinoblastoma
Ameloblastoma
Arrhenoblastoma
Ewing's Tumor
Fibrosarcoma
Hemangioendothelioma
Hepatoma and Hepatoblastoma
Osteochondroma
Teratoma

25
9
21
7
12
14
3
7
2
3

11. 5
4.1
9.7
3.2
5.5
6.4
1.4
3.2
0.9
1.4
0.4

4
1
4
3
2
2
2
2
2
2
2

1.8
0.4
1.8
1. 3
0. 9
0.9
0.9
0.9
0.9
0.9
0 .9

Total 216

1003

been developed through the efforts of pathologists,
with the recognition of a subgroup- the mesoblastic nephroma. This lesion would seem to be of
low grade malignancy and may contribute to the wellknown better survival in infants.
In the presence of lung metastases, which account for approximately 90% of the cases in which
Wilms' tumor metastasizes, it has been observed that
low-dose radiation plus chemotherapy can preserve
pulmonary function as it cancels disease in at least
60% of such patients. It has also become evident
that since two of three patients will have generalized
pulmonary involvement, bilateral total pulmonary

irradiation is necessary even in the patient with
evidence of only one lesion.
According to Tefft, experience has shown that
irradiation cannot be relied upon to control liver
metastases. Surgical excision is the only sure control
of a lesion in the liver if it is solitary or localized to
one lobe. When liver irradiation is indicated, a total
dose of 3000 rads to the total liver in three weeks
time should not be exceeded.
National Wilms' Tumor Study (NWTS). Since
the national yearly incidence of Wilms' tumor, estimated to be 500, is too small to permit single institutions and investigators to gain significant information
about the treatment of this disease without the investigation being unduly protracted, groups of investigators and institutions combined their efforts
in a single investigation so that early answers can
be obtained to longstanding questions regarding
therapy.
The primary objective of the NWTS, activated
in 1969, was to refine methods of treatment. Thus,
two specific questions were asked: 1) Is postoperative radiotherapy necessary for treatment of patients with well-encapsulated, localized lesions after
what appears to be their total removal? 2) Which
of the two chemotherapeutic agents ( dactinomycin,
vincristine ) known to be effective against Wilms'
tumor gives the better result and can this result be
improved by their combined use?
The secondary objective was to obtain a better
understanding of the neoplasm by defining the extent of the lesion at diagnosis (clinical grouping or
staging) and relating it to the response to treatment.
Five clinical groups (stages) of disease were defined:
Group I- Tumor limited to the kidney and
completely resected
Group II-Tumor extends beyond the kidney
but is completely resected
Group III- Residual nonhematogenous tumor
confined to the abdomen
Group IV-Hematogenous metastases
Group V- Bilateral renal involvement either
initially or subsequently
Children were randomized at diagnosis according to their clinical group determined by the surgeon
and pathologist. Those in group I were randomized
following surgery to receive either dactinomycin
alone or dactinomycin plus postoperative irradiation
to the tumor bed. Dactinomycin was started and
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given in five-day courses (15 µg/kg/d, i.v.) within
48 hours of diagnosis and repeated at 6 weeks, 3, 6,
9, 12 and 15 months, thereafter.
Children in groups II and Ill, following resection, all received irradiation to the tumor bed. At the
same time they were randomized to receive either
dactinomycin alone, vincristine alone or the combination. Dactinomycin was administered as outlined
for group I patients. Vincristine was given weekly
for 7 weeks ( 1.5 mg/m 2 i.v.) starting at the time of
diagnosis, then at 3, 6, 9, 12 and 15 months thereafter, giving two doses four days apart.
Children in group IV received either a preoperative course of vincristine (day 0 and 7) and
then had surgery on day 14 or surgery was carried
out immediately. Treatment then was identical to
that for groups II and III.
Results. It is still too early to draw any definite
conclusions from any of the preliminary data. Certain
patterns seem to be emerging, however, and are
worthy of mention.
Of 208 patients registered, 21 were incorrectly
diagnosed. More than half of these cases turned out
to be either neuroblastoma or polycystic kidney.
Other diagnoses included renal carbuncle, benign
teratoma, congenital renal vein thrombosis, hemorrhage into the subrenal gland, hypernephroma and
rhabdomyosarcoma. Two cases of mesoblastic nephroma were also registered.
One hundred eighty-seven patients were randomized according to protocol. Patients with clinical
group I disease (the lesion limited to the kidney
and completely resected) formed the most frequent
group and accounted for 83 of these patients. Disease groups II, III and IV were less frequent and
contained 47, 39 and 18 patients respectively. The
accrual rate by month has shown no seasonal variation in the incidence of the disease.
The mean age at diagnosis for the entire series
of 187 patients was 41 months. Group I patients
were the youngest (approximately 30 months) and
group IV, the oldest (approximately 60 months).
The mean ages of groups II and III were approximately equal at 39 months. From the data, it seems
clear that with increasing age at diagnosis, the disease is likely to be more advanced.
Approximately 16% of all the patients were
black and 48 % were females. The right kidney was
involved in 46% of the cases. No differences were
apparent among the four groups in these parameters.
With regard to the results of therapy, approxi-

mately 90% of the patients in clinical group I were
free of disease from one to more than 21 months
after treatment was instituted. There is no difference
in recurrence rate thus far between those who received
dactinomycin alone and those who received it in
combination with postoperative radiotherapy. If further follow-up substantiates that radiotherapy produces no added benefit in this clinical group, the
study will have borne important fruits. The possible
untoward late effects of radiation are well known.
Disturbances of normal bone growth, radiation nephritis, radiation hepatitis and pulmonary fibrosis
are some. Induction of primary tumor by the irradiation of normal structures, while not frequent, is
nonetheless a matter of real concern.
Of those with clinical groups II and III involvement, approximately 75% continued in complete
remission from one to 21 months after the start of
treatment and approximately 60% of these in clinical group IV were similarly free of disease for the
same period of time. No differences are apparent
thus far between the various treatment regimens in
these three groups.
All but one of the metastases or recurrences in
relapsed patients developed during the first year of
treatment. By far, the most common site of metastases was the lung. Other sites were liver, nodes,
bone, spleen and brain. Abdominal recurrences were
infrequent. In most instances death was attributed to
tumor, but in a few cases no tumor was found and
infection was thought to be the cause.
Toxicities to therapy included leukopenia and
thrombocytopenia with occasional anemia, nausea
and vomiting, radiation dermatitis and hepatitis and
alopecia. These were usually reversible.
At the Medical College of Virginia, 11 patients,
ranging in age from five months to eight years, have
been entered on study (Table 2). Three had clinical
group I disease, seven, clinical group II disease, and
one, clinical group IV disease. All but one attained
complete remission with therapy. Two of the 11 developed metastases at 13 and 16 months following
diagnosis and one of them has expired. Eight of the
11 are free of disease from five months to nearly
three years after treatment was started. The three
oldest patients ( 31h, 5 and 8 years) in this small
series developed recurrences or metastases.
Neuroblastoma. Although there has been
marked improvement in survival of children with
Wilms' tumor during the last decade, this has not
been the case for metastatic and nonmetastatic
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TABLE2.
National Wilms' Tumor Study Medical College of Virginia Patients
CASE

1
2
3
4
5
6
7
8
9

10
11

AGE AT DIAGNOSIS

DATE ON STUDY

19 mos.
10 mos.
23 mos.
5 yrs.
2 yrs.
2 yrs.
8! mos.
l yr.
3! yrs.

4/ 10/ 70
6/ 29 / 70
2/ 28 / 72
10 / 29 / 69
5/ 14/70
8 / 26 / 70
3/ 19 / 71
7 / l /71
10/ 11 / 71

5 mos.
8 yrs.

9 / 16/ 72
4/ 6/71

CLINICAL GROUP

I
I
I
II
II
II
II
II
II
II

IV

TREATMENT

S, R, Dact
S, R, Dact
S, R, Dact
S, R, Dact, Ver
S, R, Dact, Ver
S, R, Dact, Ver
S, R , Ver
S, R, Ver
S, R, Ver later Dact
Adriamycin Cytoxan
S, R, Ver
S, R , Dact, Ver

STATUS

NED
NED
NED
Expired 1 / 4 / 71
NED
NED
NED
NED
Expired 2/ 5/ 72
(no response)
NED
Recurrence right lung
8 / 72, later brain

S- Surgery
R- Radiotherapy
Dact- Dactinomycin
Vcr- Vincristine
NED- No evidence of disease

neuroblastoma for the same time period, primarily
due to the diffculty in early diagnosis and lack of
effective treatment for advanced disease. Chemotherapy, in contrast to Wilms' tumor, has not been
very successful. An overall cure rate of 35-40%
has been reported. In patients under one year of age
who have localized disease, survival rates as high as
68-70% have been achieved; however, in generalized. disease the survival rate has been estimated
at about 12%.
Between 1957 and 1968, 21 children with
neuroblastoma and two children with ganglioneuroblastoma were treated at the Medical College of
Virginia. Of the entire group, only two patients are
alive; one child with intrathoracic neuroblastoma,
age five months at diagnosis, has no evidence of
disease after resection and postoperative radiotherapy. Another, age 6 months at diagnosis with
widespread disease, has been free of disease for four
years, after one year of treatment with cyclophosphamide and vincristine. Six of the patients were under
one year of age, and 14 were two years or older at
diagnosis.
The commonest site of the primary tumor was
the adrenal gland ( 52 % ) . Other less common sites
included the retroperitoneum ( 17 % ) , posterior mediastinum (17 % ) and the brain ( 4 % ) .
In the majority of cases (7 4 % ) , the disease

was already widespread at the time of initial examination. Distent metastases occurred most often in
bones ( 48 % ) , bone marrow ( 48 % ) , and liver
( 48 % ) , although at autopsy an unusually high percentage ( 3 5 % ) had metastases to the lungs and
pleura. Those with regional disease developed metastases within 12 months of diagnosis. Only three
children, all with regional disease, had complete resection of tumor. All others had either partial resection or biopsy.
Four children died before any treatment could
be instituted. Fifteen of 23 received postoperative
radiotherapy. A variety of chemotherapeutic agents
including vincristine and cyclophosphamide were
included as part of the initial treatment program in
15 patients with distent metastases and in four with
regional disease.
The median survival time for the entire group
was six months, with the longest survivor still alive
at seven years. Those with the primary site located
in the adrenal gland had the shortest median survival
time ( 4 months).
Sawitsky and Desposito (3) have reported their
results using either cyclic or sequential vincristine
and cyclophosphamide in high or low dosage for
treatment of generalized neuroblastoma. Their results
also do not bear out the early enthusiasm shown for
these agents for treatment of neuroblastoma. Of 4 7
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TABLE 3
Staging of Neuroblastoma
STAGE

I:

Tumor confined to the organ or structure of
origin.

STAGE

II:

Tumors extending in continuity beyond the
organ or structure of origin but not crossing
the midline. Regional lymph nodes on the
homolateral side. may be involved.

STAGE

III: Tumors extending in continuity beyond the
midline. Regional lymph nodes may be involved
bilaterally.

STAGE

IV:

STAGE

Remote disease involving skeleton, organs,
soft tissue, distant lymph node groups, etc.
(See IV-S.)

IV-S: Patients who would otherwise be Stage I or II,
but who have remote disease confined only
to one or more of the following sites: liver,
skin or bone marrow (without radiographic
evidence of bone metastases on complete
skeletal survey).

patients treated, only two are alive for more than 24
months with no evidence of disease. The median survival in the whole group was 37 weeks. If a response
occurred, median survival was prolonged to 65 weeks.
Other drugs used have also produced disappointing results and include 6-mercaptopurine, prednisone, methotrexate, dactinomycin, daunorubicin,
and nitrogen mustard. Newer agents such as adriamycin and ifosphamide are currently under investigation.
Although results of treatment continue to be
poor, advances have been made in the understanding
of the disease process. A new staging system has
been developed based on certain patterns of origin
and clinical behavior found to affect prognosis,
which takes into account the peculiarities unique for
neuroblastoma (Table 3) ( 1). Data based on this
system indicates that: 1) Patients with stage IV-S
have a better prognosis than those with stage IV
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disease; 2) The proportion of patients in stages III
and IV increases with age; 3) The presence of bone
metastases, to be distinguished from bone marrow
involvement with positive x-ray findings, almost always heralds a fatal outcome; and 4) Data confirm
the well-known better survival of patients under one
year of age.
A second potential contribution has been the
development of a simple, reliable "dip-stick" test
for detecting the early presence of neuroblastoma
(2). The test is based on the fact that up to 80%
of the children with this disease excrete excess
catecholamine or one of its metabolites, 3-methoxy4-hydroxy-mandelic acid (VMA) in the urine.
Strips of chromatography paper impregnated with
paranitroaniline, sodium nitrate, and anhydrous
potassium carbonate are dipped into a urine sample
or just pressed against a wet diaper. Within ten
minutes, the color of the paper changes to orange
or purple if either VMA or normetanephrine is present in urine. The test may be used by private practicing physicians for routine screening on all children under five years of age. If used at regular
yearly intervals, it is conceivable that a significant
impact upon survival of neuroblastoma may be
achieved by early diagnosis before metastasis has
occurred.
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Surgery of the Genitalia 1n Children*
CHARLES J. DEVINE, JR., M.D.
Chief, Department of Urology, Medical Center Hospitals,
Norfolk, Virginia

I shall confine my paper to the external male
genitalia. Most of the problems that we have dealt
with have been congenital from simple meatal strictures to more severe, although not necessarily more
serious, situations. In the last 18 years, I have
worked closely with Dr. Charles Horton, and much
of this report represents our joint efforts.
We sometimes see exotic traumatic lesions. One
little boy, who was rather dull mentally, was the
victim of a couple of "flim-flam men." Two of his
companions convinced him that they should all put
rubber bands on their penises, but he was the only
one who did it. Three days passed before his parents
brought him to the Emergency Room for treatment.
On examination the rubber band was discovered
and immediately removed after which he was admitted to the hospital. Our group was consulted
because the penis failed to improve. Surgical exploration revealed a restrictive fibrotic band of dead
skin and subcutaneous tissue beneath the area where
the rubber band had been. We excised this band and
debrided the penis. Healing was slow but satisfactory.
Hypospadias is the most common congenital
lesion we have encountered. In this condition the
urethral meatus is located more proximally than
normal on the ventral surface of the penis and is
accompanied by a ventral curvature called chordee.
Because of an increased incidence of upper urinary
tract anomalies associated with hypospadias, we
do an intravenous pyelogram on all of these patients.
In the more severe conditions with the meatus in
the region of the scrotum or perineum, there are often
hypoplasia and undescended testes. We evaluate

* This is an edited transcription of a lecture presented
by Dr. Devine at the 26th Annual Stoneburner Lecture
Series, February 23 , 1973, at the Medical College of Virginia, Richmond.
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such patients with sex chromatin and chromosome
studies as their sex may not be obvious from external examination.
We have treated several patients with perinea!
hypospadias who actually were male pseudohermaphrodites with internal female organs and undescended testes. These patients require abdominal
exploration; and testes, which if present and cannot
be brought down, should be removed. We recently
saw a male pseudohermaphrodite who had had a
testis biopsy 25-30 years prior to our seeing him,
and the testis had been left in situ. A large mass
occupying the pelvis which proved to be seminoma
had produced a foot drop by nerve compression.
This mass completely disappeared on radiation therapy, and at second exploration we could find nothing
except necrotic tissue. Hopefully he has been cured.
Recent evidence indicates that the undescended
testis in male pseudohermaphrodites is more prone
to malignancy than the ordinary undescended testis.
Hypospadias represents the cessation of normal
development of the male external genitalia. At one
point in embryologic development, the external
genitalia of the male and female are identical. The
interstitial cells of the developing testes are quite
prominent and furnish a hormone that causes male
development. Hypospadias is caused by premature
cessation of the formation of this hormone which
results in an incompletely formed penis. We have
repaired all types of hypospadias with only one stage
of surgery including chordee without hypospadias
and glanular, distal penile, mid-penile, scrotal and
perinea! locations. When chordee is present, surgery
is necessary regardless of the location of the urethral
meatus.
The normal urethra is surrounded by corpus
spongiosum, Buck's fascia, dartos fascia and skin.
In hypospadias, these structures are missing; the
mesenchyme, distal to the urethral meatus which
MCV QUARTERLY 9(3): 280-282, 1973
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normally forms them, undergoes fibrous dysplasia
and forms a band of tissue which must be removed
in order to release the chordee and straighten the
penis ; otherwise chordee is likely to recur.
We usually repair chordee at age two; but if the
penis is small, we sometimes wait until age three or
four. Hormone therapy enlarges the penis but also
makes the fibrous tissue layers more prominent and
tougher, rendering surgery more difficult. Surgical
repair is more difficult on older patients whose structures have become more prominent due to natural
hormone production.
It is important for mothers to stay with their
children during hospitalization. Dr. Panayotis Kelalis
recently reported on a preliminary study that he and
psychiatrists at the Mayo Clinic have done on the
psychological aspects of surgery on the genitalia.
They feel that operation on the genitalia when the
child is under the age of two or three is not nearly so
important to the child's psyche as is separation from
his mother.
In over 250 total cases of hypospadias, we have
found 22 patients with chordee without hypospadias
including three different types. In class I, just the
epithelium has grown together leaving an epitheliallined urethra covered by skin with fibrous tissue
lying beneath it causing chordee. In class II, there
has been further development of the mesenchyme
around the urethra with formation of the urethra
in the corpus spongiosum with fibrous tissue causing
chordee lying beneath and lateral to it. In class III,
Buck's fascia has also formed around the corpus
spongiosum. The fibrous tissue causing the chordee
is only the deficient dartos layer, and correction does
not require dissection beneath Buck's fascia . In
chordee without hypospadias there is a typically
sharp bend; the prepuce is complete and the meatus
is located in the glans. The median raphe deviates
to the side ending in a structure resembling a knuckle
lying on the top of the penis. Chordee without hypospadias can also be corrected without severing the
urethra. A longitudinal incision should be made with
careful dissection, and fibrous tissue removed to
straighten the penis. The urethra will stretch to fit.
One of the most distressing patients with whom we
have dealt in the recent past is a young man of 19.
Seventeen years ago he underwent his first operation
for chordee without hypospadias. When we saw him
four years ago after 10 operations he still had chordee, but it was penoscrotal junction hypospadias with
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a lot of scar tissue. We have completed his surgery
in four additional stages.
We have done dorsal meatotomy on patients
who have a very distal strictured urethral meatus and
no chordee. We raise a V-flap of glans tissue, make
a dorsal incision in the urethral meatus and insert
the flap of tissue in order to enlarge the opening in
a distal direction. We then proceed with circumcision.
The glanular V-flap is now used in all of our
hypospadias repairs. Dissection is carried out beneath the glans and along the surface of the corpora
cavernosa. There is a good cleavage plane between
the glans and the corpora. The tissue which causes
the chordee actually inserts on the undersurface of
the glans and not on the corpora cavemosa. The
chordee will not be completely corrected if any
tissue is left to keep the cap of the glans tilted
ventrally. An anteriorly based flap is taken from the
midline, freed up, and sewn back on to the corpora.
Construction of the urethra is based on this allowing
the urethral meatus to be placed at the tip of the
glans where it should be. Before we developed the
glanular V-flap, we used a tube graft for all urethral
repairs. Now when the flap reaches the urethra after
dissection is complete, we use what we call a "flipflap" to complete the urethra. The penis is circumcised and the V-flap outlined on the glans. Tissue
causing the chordee is removed, straightening the
penis. A proximal flap based on the urethral meatus
is outlined, incised, elevated and left attached to
the urethra. After the glans has developed, an incision is made in the dorsal surface of the urethra.
The urethra and flip-flap are anastomosed to the
V-flap of glans. Lateral wings of glans are then
brought around and closed, placing the meatus at
the tip of the penis. The prepuce is used to cover
the ventral part of the penis with skin. If the glanular
V-flap will not meet the urethra, a distal portion of
the prepuce is used to make a skin graft tube, which
is anastomosed proximally to the urethra and distally
to the skin flap, to extend the urethra to the tip. The
rest of the prepuce will be adequate then for penile
coverage.
In repair of perinea! hypospadias, we usually
will find a good groove of hairless skin between the
two portions of the cleft scrotum which we utilize
as a Tirsch-Duplay type of tube to bring the urethra
from the meatus to the penoscrotal junction. We
make a tube from the distal portion of the prepuce
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and JOlll it to the Tirsch-Duplay tube. The distal
end of this tube is then anastomosed to the glanular
V-flap to complete the procedure.
Urine must be diverted. A urethrostomy tube
drains better than a suprapubic tube; however, if the
urethral meatus is far posterior, we use a suprapubic
tube. Red rubber tubes are softer and have a better
consistency than plastic tubes. Diversion is continued
for 10 days, and stinting tubes are left in for seven
days.
We have performed over 250 hypospadias op-
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erations. Seventy-five percent of these are complete
after one stage of surgery. Most of our complications
are small urethrocutaneous fistulae which require
further surgical repair. We are still developing our
technique and changing our operation to improve
the results. Each case requires individual consideration, and the technique must be adapted to the patient. All surgeons doing this type of work must be
familiar with all the types of repair as some facet
of another surgical procedure may be just what is
needed to solve a difficult problem.
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in chronic pain: continued relief without risk of tolerance
Though Talwin® Tablets can be
compared to codeine in analgesic
efficacy, Talwin is not subject to
narcotic controls. For patients who
require potent analgesia for prolonged
periods, Talwin can provide consistent,
long-range relief, with fewer of the
consequences you've come to expect
with narcotic analgesics.

• Comparable to codeine in analgesic efficacy: one 50 mg.
Talwin Tablet appears equivalent in analgesic effect to 60 mg.
(1 gr.) of codeine. Onset of significant analgesia usually
occurs within 15 to 30 minutes. Analgesia is usually maintained for 3 hours or longer.
•Tolerance not a problem: tolerance to the analgesic effect
of Talwin Tablets has not been reported, and no significant
changes in clinical laboratory parameters attributable to the
drug have been reported.
•Dependence rarely a problem: during three years of
wide clinical use, only a few cases of dependence have been
reported. In prescribing Ta/win for chronic use, the physician
should take precautions to avoid increases in dose by the
patient and to prevent the use of the drug in anticipation of
pain rather than for the relief of pain. (See last page for a
complete discussion of Warnings under Brief Summary.)
• Not subject to narcotic controls: convenient to prescribeday or night-even by phone.

• Generally well tolerated by most patients: infrequently
cause decrease in blood pressure or tachycardia; rarely cause
respiratory depression or urinary retention; seldom cause diarrhea or constipation. If dizziness, lightheadedness, nausea or
vomiting are encountered, these effects may decrease or disappear after the first few doses. (See last page of this advertise- .
ment for a complete discussion of Adverse Reactions and a Brief
Summary of other Prescribing Information.)
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Talwin® Tablets brand of pentazocine (as hydrochloride)
Analgesic for Oral Use-Brief Summary
Indications: For the relief of moderate to severe pain.
Contraindication: Talwin should not be administered to patients who
are hypersensitive to it.
Warnings: Drug Dependence. There have been instances of psychological and physical dependence on parenteral Ta/win in patients with
a history of drug abuse and, rarely, in patients without such a history.
Abrupt discontinuance following the extended use of parenteral Ta/win
has resulted in withdrawal symptoms. There have been a few reports
of dependence and of withdrawal symptoms with orally administered
Ta/win. Patients with a history of drug dependence should be under
close supervision while receiving Ta/win orally.
In prescribing Ta/win for chronic use, the physician should take precautions to avoid increases in dose by the patient and to prevent the
use of the drug in anticipation of pain rather than for the relief of pain.
Head Injury and Increased lntracranial Pressure. The respiratory depressant effects of Talwin and its potential for elevating cerebrospinal
fluid pressure may be markedly exaggerated in the presence of head
injury, other intracranial lesions, or a preexisting increase in intracranial pressure. Furthermore, Talwin can produce effects which may
obscure the clinical course of patients with head injuries. In such patients, Talwin must be used with extreme caution and only if its use is
deemed essential.
Usage in Pregnancy. Safe use of Talwin during pregnancy (other than
labor) has not been established. Animal reproduction studies have not
demonstrated teratogenic or embryotoxic effects. However, Talwin
should be administered to pregnant patients (other than labor) only
when, in the judgment of the physician, the potential benefits outweigh
the possible hazards. Patients receiving Talwin during labor have experienced no adverse effects other than those that occur with commonly used analgesics. Talwin should be used with caution in women
delivering premature infants.
Acute CNS Manifestations. Patients receiving therapeutic doses of
Talwin have experienced, in rare instances, hallucinations (usually
visual), disorientation, and confusion which have cleared spontaneously
within a period of hours. The mechanism of this reaction is not known.
Such patients should be very closely observed and vital signs checked.
If the drug is reinstituted it should be done wiih caution since the
acute CNS manifestations may recur.
Usage in Children. Because clinical experience in children under 12
years of age is limited, administration of Talwin in this age group is not
recommended.
Ambulatory Patients. Since sedation, dizziness, and occasional euphoria have been noted, ambulatory patients should be warned not to
operate machinery, drive cars, or unnecessarily expose themselves to
hazards.
Precautions: Certain Respiratory Conditions. Although respiratory depression has rarely ·been reported after oral administration of Talwin,
the drug should be administered with caution to patients with respiratory depression from any cause, severe bronchial asthma and other
obstructive respiratory conditions, or cyanosis.
Impaired Renal or Hepatic Function . Decreased metabolism of the
drug by the liver in extensive liver disease may predispose to accentuation of side effects. Although laboratory tests have not indicated that
Talwin causes or increases renal or hepatic impairment, the drug
should be administered with caution to patients with such impairment.
Myocardial Infarction. As with all drugs, Talwin should be used with
caution in patients with myocardial infarction who have nausea or
vomiting.
Biliary Surgery. Until further experience is gained with the effects of
Talwin on the sphincter of Oddi, the drug should be used with caution
in patients about to undergo surgery of the biliary tract.

Patients Receiving Narcotics. Talwin is a mild narcotic antagonist.
Some patients previously given narcotics, including methadone for the
daily treatment of narcotic dependence, have experienced mild withdrawal symptoms after receiving Talwin.
CNS Effect. Caution should be used when Talwin is administered to
patients prone to seizures; seizures have occurred in a few such
patients in association with the use of Talwin although no cause and
effect relationship has been established.
Adverse Reactions: Reactions reported after oral administration of
Talwin include gastrointestinal: nausea, vomiting; infrequently constipation; and rarely abdominal distress, anorexia, diarrhea. CNS effects:
dizziness, lightheadedness, sedation, euphoria, headache; infrequently
weakness, disturbed dreams, insomnia, syncope, visual blurring and
focusing difficulty, hallucinations (see Acute CNS Manifestations under
WARNINGS); and rarely tremor, irritability, excitement, tinnitus. Autonomic: sweating; infrequently flushing; and rarely chills. Allergic: infrequently rash; and rarely urticaria, edema of the face. Cardiovascular:
infrequently decrease in blood pressure, tachycardia. Other: rarely
respiratory depression, urinary retention.
Dosage and Administration: Adults. The usual initial adult dose is 1 tablet (50 mg.) every three or four hours. This may be increased to 2 tablets
(100 mg.) when needed. Total daily dosage should not exceed 600 mg.
When antiinflammatory or antipyretic effects are desired in addition to
analgesia, aspirin can be administered concomitantly with Talwin .
Children Under 12 Years of Age. Since clinical experience in children
under 12 years of age is limited, administration of Talwin in this age
group is not recommended.
Duration of Therapy. Patients with chronic pain who have received
Talwin orally for prolonged periods have not experienced withdrawal
symptoms even when administration was abruptly discontinued (see
WARNINGS). No tolerance to the analgesic effect has been observed .
Laboratory tests of blood and urine and of liver and kidney function
have revealed no significant abnormalities after prolonged administra·
lion ofTalwin.
Overdosage: Manifestations. Clinical experience with Talwin overdosage has been insufficient to define the signs of this condition.
Treatment. Oxygen, intravenous fluids, vasopressors, and other supportive measures should be employed as indicated. Assisted or controlled
ventilation should also be considered. Although nalorphine and levallorphan are not effective antidotes for respiratory depression due to
overdosage or unusual sensitivity to Talwin, parenteral naloxone
(Narcan®, available through Endo Laboratories) is a specific and
effective antagonist.
Talwin is not subject to narcotic controls.
How Supplied: Tablets, peach color, scored. Each tablet contains
Talwin (brand of pentazocine) as hydrochloride equivalent to 50 mg.
base. Bottles of 100.
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efore prescri ing, please consult
complete product information, a sum·
mary of which follows:
Indications: Tension and anxiety

states, somatic complaints which are
concomitants of emotional factors; psychoneurotic states manifested by tension,
anxiety, apprehension, fatigue, depressive symptoms or agitation; symptomatic
relief of acute agitation, tremor, delirium
tremens and hallucinosis due to acute
alcohol withdrawal; adjunctively in skeletal muscle spasm due to reflex spasm to
local pathology, spasticity caused by
upper motor neuron disorders, athetosis,
stiff-man syndrome, convulsive disorders
(not for sole therapy) .
Contraindicated: Known hypersensitivity to the drug. Children under 6
months of age. Acute narrow angle glaucoma; may be used in patients with open
angle glaucoma who are receiving appropriate therapy.
Warnings: Not of value in psychotic
patients. Caution against hazardous
occupations requiring complete mental
alertness . When used adjunctively in convulsive disorders, possibility of increase
in frequency and/ or severity of grand ma!
seizures may require increased dosage of
standard anticonvulsant medication;
abrupt withdrawal may be associated
with temporary increase in frequency
and/ or severity of seizures. Advise
against simultaneous ingestion of alcohol
and other CNS depressants. Withdrawal
symptoms (similar Jo those with barbiturates and alcohol) have occurred following abrupt discontinuance (convulsions,
tremor, abdominal and muscle cramps,
vomiting and sweating). Keep addictionprone individuals under careful surveil- .·:·
lance because of their predisposition to ~r
habituation and dependence. In preg~
,
nancy, lactation or women of childbearing
;
age, weigh potential benefit against
possible hazard.
Precautions: If combined with other
psychotropics or anticonvulsants, consider carefully pharmacology of agents
employed; drugs such as phenothiazines,
narcotics, barbiturates, MAO inhibitors
and other antidepressants may potentiate
its action. Usual precautions indicated in
patients severely depressed, or with latent
depression, or with suicidal tendencies.
Observe usual precautions in impaired
renal or hepatic function. Limit dosage to
smallest effective amount in elderly and
debilitated to preclude ataxia or oversedation.
Side Effects: Drowsiness, confusion,
diplopia, hypotension, changes in libido,
nausea, fatigue, depression, dysarthria,
jaundice, skin rash, ataxia, constipation,
headache, incontinence, changes in salivation, slurred speech, tremor, vertigo,
urinary retention, blurred vision. Paradoxical reactions such as acute hyperexcited states, anxiety, hallucinations,
increased muscle spasticity, insomnia,
rage, sleep disturbances, stimulation
have been reported; should these occur,
discontinue drug. Isolated reports of neutropenia, jaundice; periodic blood counts
and liver function tests advisable during
long-term therapy.
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When, in spite of counseling,
the patient's pattern ofoverreaction to stress
affects his ability to function

Dependable response
1s a good reason
to considerValium
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Roche Laboratories
Division of Hoffmann- La R'o che Inc.
· Nutley, N.J. 07110

(diazepam)
2-mg,5-mg,
10-mg tablets

